10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                   

Commission file number 1-1361

TOOTSIE ROLL INDUSTRIES, INC.

(Exact name of Registrant as specified in its charter)

Virginia	22-1318955
(State or other jurisdiction of	(IRS Employer Identification No.)
incorporation or organization)

7401 South Cicero Avenue, Chicago, Illinois 60629

(Address of principal executive offices) (Zip Code)

Registrant’s Telephone Number: (773) 838-3400

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock — Par Value $.69-4/9 Per Share	TR	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: Class B Common Stock — Par Value $.69-4/9 Per Share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of February 18, 2021, there were outstanding 38,989,889 shares of Common Stock par value $.69-4/9 per share, and 27,011,521 shares of Class B Common Stock par value $.69-4/9 per share.

As of June 30, 2020 the aggregate market value of the Common Stock (based upon the closing price of the stock on the New York Stock Exchange on such date) held by non-affiliates was approximately $597,009,000. Class B Common Stock is not traded on any exchange, is restricted as to transfer or other disposition, but is convertible into Common Stock on a share-for-share basis. Upon such conversion, the resulting shares of Common Stock are freely transferable and publicly traded. Assuming all 27,024,933 shares of outstanding Class B Common Stock were converted into Common Stock, the aggregate market value of Common Stock held by non-affiliates on June 30, 2020 (based upon the closing price of the stock on the New York Stock Exchange on such date) would have been approximately $751,335,511. Determination of stock ownership by non-affiliates was made solely for the purpose of this requirement, and the Registrant is not bound by these determinations for any other purpose.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Company’s Definitive Proxy Statement for the Company’s Annual Meeting of Shareholders (the “2021 Proxy Statement”) scheduled to be held on May 3, 2021 are incorporated by reference in Part III of this report.

TABLE OF CONTENTS

ITEM 1.	Business	3
ITEM 1A.	Risk Factors	5
ITEM 1B.	Unresolved Staff Comments	9
ITEM 2.	Properties	10
ITEM 3.	Legal Proceedings	10
ITEM 4.	Mine Safety Disclosures	10
ITEM 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	11
ITEM 6.	Selected Financial Data	13
ITEM 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
ITEM 7A.	Quantitative and Qualitative Disclosures About Market Risk	26
ITEM 8.	Financial Statements and Supplementary Data	26
ITEM 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	51
ITEM 9A.	Controls and Procedures	51
ITEM 9B.	Other Information	51
ITEM 10.	Directors, Executive Officers and Corporate Governance	52
ITEM 11.	Executive Compensation	52
ITEM 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	52
ITEM 13.	Certain Relationships and Related Transactions, and Director Independence	53
ITEM 14.	Principal Accounting Fees and Services	53
ITEM 15.	Exhibits, Financial Statement Schedules	53
ITEM 16.	Form 10-K Summary	53

2

Forward-Looking Information

From time to time, in the Company’s statements and written reports, including this report, the Company discusses its expectations regarding future performance by making certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “estimate,” “project,” and other words of similar meaning in connection with a discussion of future operating or financial performance and are subject to certain factors, risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in the forward-looking statements. These forward-looking statements are based on currently available competitive, financial and economic data and management’s views and assumptions regarding future events. Such forward-looking statements are inherently uncertain, and actual results may differ materially from those expressed or implied herein. Consequently, the Company wishes to caution readers not to place undue reliance on any forward-looking statements. Factors, among others, which could cause the Company’s future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein include general factors, such as economic conditions, political developments, currency exchange rates, interest and inflation rates, accounting standards, taxes, and laws and regulations affecting the Company in markets where it competes and those factors described in Item 1A “Risk Factors” and elsewhere in this Form 10-K and in other Company filings with the Securities and Exchange Commission. The Company does not undertake to update any of these forward-looking statements.

PART I

ITEM 1.               Business.

Tootsie Roll Industries, Inc. and its consolidated subsidiaries (the “Company”) have been engaged in the manufacture and sale of confectionery products for over 100 years. This is the only industry segment in which the Company operates and is its only line of business. The majority of the Company’s products are sold under the registered trademarks TOOTSIE ROLL, TOOTSIE POPS, CHILD’S PLAY, CARAMEL APPLE POPS, CHARMS, BLOW-POP, CHARMS MINI POPS, CELLA’S, DOTS, JUNIOR MINTS, CHARLESTON CHEW, SUGAR DADDY, SUGAR BABIES, ANDES, FLUFFY STUFF, DUBBLE BUBBLE, RAZZLES, CRY BABY, NIK-L-NIP, and TUTSI POP (Mexico).

The Company’s products are marketed in a variety of packages designed to be suitable for display and sale in different types of retail outlets. They are sold through approximately 30 food and grocery brokers and by the Company itself to approximately 2,000 customers throughout the United States, Canada and Mexico. These customers include wholesale distributors of candy, food and groceries, supermarkets, variety stores, dollar stores, chain grocers, drug chains, discount chains, cooperative grocery associations, mass merchandisers, warehouse and membership club stores, vending machine operators, the U.S. military and fund-raising charitable organizations.

The Company’s principal markets are in the United States, Canada and Mexico. The majority of production from the Company’s Canadian plants is sold in the United States. The majority of production from the Company’s Mexican plant is sold in Mexico.

The domestic confectionery business is highly competitive. The Company competes primarily with other manufacturers of confectionery products sold to the above mentioned customers. Although accurate statistics are not available, the Company believes it is among the ten largest domestic manufacturers in this field. In the markets in which the Company competes, the main forms of competition comprise brand recognition, as well as competition for retail shelf space and a fair price for the Company’s products at various retail price points.

The Company did not have a material backlog of firm orders at the end of the calendar years 2020 or 2019.

The Company has historically hedged certain of its future sugar and corn syrup needs with derivatives at such times that it believes that the forward markets are favorable. The Company’s decision to hedge its major ingredient requirements is dependent on the Company’s evaluation of forward commodity markets and their comparison to vendor quotations, if available, and/or historical costs. The Company has historically hedged some of these major ingredients with

3

derivatives, primarily commodity futures contracts, before the commencement of the next calendar year to better ascertain the need for product pricing changes or product weight decline (indirect price change) adjustments to its product sales portfolio and better manage ingredient costs. The Company will generally purchase forward derivative contracts (i.e., “long” position) in selected future months that correspond to the Company’s estimated procurement and usage needs of the respective commodity in the respective forward periods.

From time to time, the Company also changes the size and weight of certain of its products in response to significant changes in ingredient and other input costs.

The Company does not hold any material patents, licenses, franchises or concessions. The Company’s major trademarks are registered in the United States, Canada, Mexico and in many other countries. Continued trademark protection is of material importance to the Company’s business as a whole.

Although the Company does research and develops new products and product line extensions for existing brands, it also improves the quality of existing products, improves and modernizes production processes, and develops and implements new technologies to enhance the quality and reduce the costs of products. The Company does not expend material amounts of money on research or development activities.

The manufacture and sale of consumer food products is highly regulated. In the United States, the Company’s activities are subject to regulation by various government agencies, including the Food and Drug Administration, the Department of Agriculture, the Federal Trade Commission, the Department of Commerce and the Environmental Protection Agency, as well as various state and local agencies. Similar agencies also regulate the businesses outside of the United States. The Company maintains quality assurance, food safety and other programs to help ensure that all products the Company manufactures and distributes are safe and of high quality and comply with all applicable laws and regulations.

The Company’s compliance with federal, state and local regulations which have been enacted or adopted regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material effect on the capital expenditures, earnings or competitive position of the Company nor does the Company anticipate any such material effects from presently enacted or adopted regulations.

The Company employs approximately 2,000 full-time persons at all locations. Our business has seasonality which results in bringing on some additional employees to meet seasonal production demands. The Company experiences a relatively consistent sales level throughout the year except for an increase in the third quarter which reflects pre-Halloween and back-to-school sales. In anticipation of this seasonal sales period, the Company generally begins building inventories, and its seasonal workforce, in the second and third quarter of each year. Although Halloween is the most significant season in sales and related production, other seasons, including Christmas, Valentines, and Easter also have some impact on workforce levels. The Company’s union labor agreement at its Chicago plant was executed in 2018 and will continue through September 2022.

We believe our employees are among our most important resources and are critical to our continued success. We focus significant attention on attracting and retaining talented and experienced individuals to manage and support our operations. We pay our employees competitively and offer a broad range of company-paid benefits, which we believe are competitive with others in our industry. Our management teams and all of our employees are expected to exhibit and promote honest, ethical and respectful conduct in the workplace. All of our employees must adhere to a code of conduct that sets standards for appropriate behavior. A copy of our code of conduct can be found on our website, Tootsie.com. We have prioritized the safety of our employees and therefore implemented safety protocols during 2020 and continuing into 2021, to respond to the Covid-19 pandemic. We have taken many steps to provide our employees with a safe and healthy work environment, including increased sanitation, social distancing measures at all Company locations, employee temperature checks, having office employees work remotely where possible, curtailing visitors at Company locations, and limiting all airline and other business travel by employees.

4

Our net product sales from Wal-Mart Stores, Inc. aggregated approximately 23.5%, 24.2%, and 24.1% of net product sales during the years ended December 31, 2020, 2019 and 2018, respectively. Our net sales from Dollar Tree, Inc. (which includes net sales from Family Dollar which is owned by Dollar Tree) aggregated approximately 11.7%, 11.3%, and 11.2% of net product sales during the years ended December 31, 2020, 2019 and 2018, respectively. Some of the aforementioned sales to Wal-Mart and Dollar Tree were sold to McLane Company, a large national grocery wholesaler, which services and delivers certain of the Company’s products to Wal-Mart, Dollar Tree and other retailers in the U.S.A. Net product sales revenues from McLane, which includes these Wal-Mart and Dollar Tree sales as well as sales and deliveries to other Company customers, were 22.1% in 2020 and 17.7% in 2019 and 17.4% in 2018. At December 31, 2020 and 2019, the Company’s three largest customers discussed above accounted for approximately 21% and 30% of total accounts receivable, respectively. Although no customer, other than McLane Company, Inc., Wal-Mart Stores, Inc. and Dollar Tree, accounted for more than 10% of net product sales, the loss of one or more significant customers could have a material adverse effect on the Company’s business. The Company historically offers extended credit terms for sales made under seasonal sales programs, including Halloween. Each year, after accounts receivables related to third quarter sales have been collected, the Company invests such funds in various marketable securities.

For a summary of sales and long-lived assets of the Company by geographic area see Note 9 of the “Notes to Consolidated Financial Statements” which is incorporated herein by reference.

Information regarding the Company’s Form 10-K, Form 10-Q, current reports on Form 8-K, and any amendments to these reports, will be made available, free of charge, upon written request to Tootsie Roll Industries, Inc., 7401 South Cicero Avenue, Chicago, Illinois 60629, Attention: Barry Bowen, Treasurer and Assistant Secretary. The Company does not make all such reports available on its website at www.tootsie.com because it believes that they are readily available from the Securities Exchange Commission at www.sec.gov, and because the Company provides them free of charge upon request. Interested parties, including shareholders, may communicate to the Board of Directors or any individual director in writing, by regular mail, addressed to the Board of Directors or an individual director, in care of Tootsie Roll Industries, Inc., 7401 South Cicero Avenue, Chicago, Illinois 60629, Attention: Ellen R. Gordon, Chairman and Chief Executive Officer. If an interested party wishes to communicate directly with the Company’s non-employee directors, it should be noted on the cover of the communication.

ITEM 1A.            Risk Factors.

Significant factors that could impact the Company’s financial condition or results of operations include, without limitation, the following:

Risk factors which we believe affect all competitors in our industry

● Our business and financial results may be negatively impacted by changes in confectionary trade practices and consumer patterns, operational challenges associated with the actual or perceived effects of a disease or pandemic outbreak, such as the Covid-19 pandemic, and other public health concerns, consumer spending levels, shopping habits and behaviors (including changes in impulse purchase behaviors), consumer activities, work routines, events and traditions where confectionary products are consumed, the availability of our products at retail, including at large retail customers, and our ability to manufacture and distribute products to our customers and consumers in an effective and efficient manner. Government mandates to “shelter in place” or “closing of the economy”, public health guidelines, or fear of exposure or actual effects of a disease, such as the Covid-19 pandemic, have in 2020 and in the future could continue to negatively impact our overall business and financial results. Specific factors that may impact our operations, some of which have had, and in the future could have, an unfavorable impact on our operations as a result of Covid-19, include, but are not limited to:

a. Significant reductions in demand for one or more of our products - Changes in demand may be caused by, among other things, the temporary inability of consumers to purchase our products due to illness, quarantine, travel restrictions, financial hardship, “shelter in place” directives, or overall fear to return to past behaviors.

5

Shifts in demand for one or more of our products, changes in trade and distribution patterns, or changes in consumer buying habits, if prolonged, could negatively impact our results.

b. The inability to meet our customers’ needs and achieve efficient production of finished products - Disruptions in our manufacturing operations or supply arrangements caused by the loss or disruption of essential manufacturing materials, supplies and services, transportation resources, workforce availability, or other manufacturing and distribution capability could have significant adverse effects on our business and financial results.

c. Significant adverse changes in the political conditions and government mandates or directives - In markets in which we manufacture, sell or distribute our products, governmental or regulatory actions, closures or other restrictions such as quarantine or travel restrictions, that limit or close our manufacturing, distribution or office facilities, or otherwise prevent our third-party suppliers, sales brokers, or customers from achieving the level of operations necessary for the production, distribution, sale, and support of our products, could negatively impact our results.

d. Risk related to Halloween and other seasonal sales - The Company’s net product sales are highest during the Halloween season which have historically comprised approximately 50% of third quarter domestic net product sales. Changes in consumer behavior, traditions, behaviors, and interest in Halloween activities and events, or changes mandated or recommended by government or health officials, as well as negative media coverage, could significantly affect the Company’s seasonal sales.

e. Risks relating to potential employer liability – The effects of Covid-19 relating to employer liability remains uncertain, and if it is determined that employers are to have liability for employee or other matters related to Covid-19, this could have significant adverse effects on our financial results.

● Risk of changes in the price and availability of raw materials - The principal ingredients used by the Company are subject to price volatility. Although the Company engages in commodity hedging transactions and annual supply agreements as well as leveraging the high volume of its annual purchases, the Company may experience price increases in certain ingredients that it may not be able to offset, which could have an adverse impact on the Company’s results of operations and financial condition. In addition, although the Company has historically been able to procure sufficient supplies of its ingredients, market conditions could change such that adequate supplies might not be available or only become available at substantially higher costs. Adverse weather patterns, including the effects of climate change or supply interruptions, could also significantly affect the cost and availability of ingredients.

● Risk of changes in product performance and competition - The Company competes with other well-established manufacturers of confectionery products. A failure of new or existing products to be favorably received, a failure to retain preferred shelf space at retail or a failure to sufficiently counter aggressive promotional and price competition could have an adverse impact on the Company’s results of operations and financial condition.

● Risk of discounting and other competitive actions - Discounting and pricing pressure by the Company’s retail customers, including the effects of import tariffs, and other competitive actions could make it more difficult for the Company to maintain its operating margins. Actions taken by major customers and competitors may make shelf space less available for the confectionery product category or some of the Company’s products.

● Risk of pricing actions - Inherent risks in the marketplace, including uncertainties about trade and consumer acceptance of pricing actions, including related trade discounts, or product weight changes (indirect price increases), could make it more difficult for the Company to maintain its sales and operating margins.

● Risk related to seasonality of sales - The Company’s sales are highest during the Halloween season. Circumstances surrounding Halloween, such as, widespread adverse weather or other widespread events that affect consumer behavior and related media coverage at that time of year or general changes in consumer interest in Halloween, could significantly affect the Company’s sales.

6

● Risk of changes in consumer preferences and tastes - Failure to adequately anticipate and react to changing demographics, consumer trends, consumer health concerns and product preferences, including product ingredients, could have an adverse impact on the Company’s results of operations and financial condition.  

● Risk of economic conditions on consumer purchases - The Company’s sales are impacted by consumer spending levels and impulse purchases which are affected by general macroeconomic conditions, consumer confidence, employment levels, disposable income, availability of consumer credit and interest rates on that credit, consumer debt levels, energy costs and other factors. Volatility in food and energy costs, rising unemployment and/or underemployment, declines in personal spending, recessionary economic conditions or other adverse market conditions, could adversely impact the Company’s revenues, profitability and financial condition.

● Risks related to environmental matters - The Company’s operations are not particularly impactful on the environment, but, increased government environmental regulation or legislation, including various “green” initiatives could adversely impact the Company’s profitability.

● Risk of new governmental laws and regulations - Governmental laws and regulations, including those that affect food advertising and marketing to children, use of certain ingredients in products, new labeling requirements, income and other taxes and tariffs, including the effects of changes to international trade agreements, new taxes targeted toward confectionery products and the environment, both in and outside the U.S.A., are subject to change over time, which could adversely impact the Company’s results of operations and ability to compete in domestic or foreign marketplaces.

● Risk of labor stoppages - To the extent the Company experiences any significant labor stoppages, strikes or possible labor shortages, could negatively affect overall operations including production or shipments of finished product to customers. The Company’s union labor agreement at its Chicago plant was executed in 2018 and will continue through September 2022.

● Risk of the cost of energy increasing - Higher energy costs would likely result in higher plant overhead, distribution, freight and delivery, and other operating costs. The Company may not be able to offset these cost increases or pass such cost increases onto customers in the form of price increases, which could have an adverse impact on the Company’s results of operations and financial condition.

● Risk of a product recall - Issues related to the quality and safety of the Company’s products could result in a voluntary or involuntary large-scale product recall. Costs associated with a product recall and related litigation or fines, and marketing costs relating to the re-launch of such products or brands, could negatively affect operating results. In addition, negative publicity associated with this type of event, including a product recall relating to product contamination or product tampering, whether valid or not, could negatively impact future demand for the Company’s products.

● Risk of operational interruptions relating to computer software or hardware failures, including cyber-attacks - The Company is reliant on computer systems to operate its business and supply chain. Software failure or corruption, including cyber-based attacks or network security breaches, or catastrophic hardware failures or other disasters could disrupt communications, supply chain planning and activities relating to sales demand forecasts, materials procurement, production and inventory planning, customer shipments, and financial and accounting, all of which could negatively impact sales and profits.

● Risk of releasing sensitive information - Although the Company does not believe that it maintains a large amount of sensitive data, a system breach, whether inadvertent or perpetrated by hackers, could result in identity theft, ransomware and/or a disruption in operations which could expose the Company to financial costs and adversely affect profitability.  

7

● Disruption to the Company’s supply chain could impair the Company’s ability to produce or deliver its finished products, resulting in a negative impact on operating results - Disruption to the manufacturing operations or supply chain, some of which are discussed above, could result from, but are not limited to adverse tariffs which could effectively limit supply or make supply more costly, natural disasters, pandemics, weather, fire or explosion, earthquakes, terrorism or other acts of violence, unavailability of ingredients or packaging materials, labor strikes or other labor activities, operational and/or financial instability of key suppliers, and other vendors or service providers. Although precautions are taken to mitigate the impact of possible disruptions, if the Company is unable, or if it is not financially feasible to effectively mitigate the likelihood or potential impact of such disruptive events, the Company’s results of operations and financial condition could be negatively impacted.

Risk factors which we believe are principally specific to our Company (although some may apply to varying degrees to competitors in our industry)

● Risks relating to participation in the multi-employer pension plan for certain Company union employees - As outlined in the Note 7 of the Consolidated Financial Statements and discussed in the Management’s Discussion and Analysis, the Company participates in a multi-employer pension plan (Plan) which is currently in “critical and declining status”, as defined by applicable law. A designation of “critical and declining status” implies that the Plan is expected to become insolvent within the next 20 years. Under terms of a rehabilitation plan, the Company is to be assessed 5% annual compounded surcharges on its contributions to the Plan until such time as the Plan emerges from critical status. Should the Company withdraw from the Plan, it would be subject to a significant withdrawal liability which is discussed in Note 7 of the Company’s Notes to Consolidated Financial Statements and Management’s Discussion and Analysis. The Company is currently unable to determine the ultimate outcome of this matter and therefore, is unable to determine the effects on its consolidated financial statements, but, the ultimate outcome could be material to its consolidated results of operations in one or more future periods.

● Risk of impairment of goodwill or indefinite-lived intangible assets - In accordance with authoritative guidance, goodwill and indefinite-lived intangible assets are not amortized but are subject to an impairment evaluation annually or more frequently upon the occurrence of a triggering event. Other long-lived assets are likewise tested for impairment upon the occurrence of a triggering event. Such evaluations are based on assumptions and variables including sales growth, profit margins and discount rates. Adverse changes in any of these variables could affect the carrying value of these intangible assets and the Company’s reported profitability.

● Risk of production interruptions - The majority of the Company’s products are manufactured in a single production facility on specialized equipment. In the event of a disaster, such as a fire or earthquake, at a specific plant location, it would be difficult to transfer production to other facilities or a new location in a timely manner, which could result in loss of market share for the affected products. In addition, from time to time, the Company upgrades or replaces this specialized equipment. In many cases these are integrated and complex installations. A failure or delay in implementing such an installation could impact the availability of one or more of the Company’s products which would have an adverse impact on sales and profits.

● Risk related to investments in marketable securities - The Company invests its surplus cash in a diversified portfolio of highly rated marketable securities, including corporate bonds, with maturities of generally up to three years, and variable rate demand notes with weekly resets of interest rates and “puts’ to redeem the investment each week. Nonetheless, such investments could become impaired in the event of certain adverse economic and/or geopolitical events which, if severe, would adversely affect the Company’s financial condition.

● Risk of further losses in Spain - The Company has restructured its Spanish subsidiary and is exploring a variety of programs to increase sales and profitability. These efforts thus far are resulting in reductions in operating losses, and our efforts are continuing. Nonetheless, if our efforts are not successful, additional losses and impairments may be reported in the future. See also Management’s Discussion and Analysis.

8

● Risk of dependence on large customers - The Company’s largest customers, McLane Company,Wal-Mart, Dollar Tree, and Target Corporation, accounted for approximately 37.5% of net product sales in 2020, and other large national chains are also material to the Company’s sales. The loss of any of these customers, or one or more other large customers, or a material decrease in purchases by one or more large customers, could result in decreased sales and adversely impact the Company’s results of operations and financial condition.

● Risk related to acquisitions - From time to time, the Company has purchased other confectionery companies or brands. These acquisitions generally come at a high multiple of earnings and are justified based on various assumptions related to sales growth, and operating margins. Were the Company to make another acquisition and be unable to achieve the assumed sales and operating margins, it could have an adverse impact on future sales and profits. In addition, it could become necessary to record an impairment which would have a further adverse impact on reported profits.

● Risk of “slack fill” litigation - The Company, as well as other confectionery and food companies, have experienced a number of plaintiff claims that certain products are sold in boxes that are not completely full, and therefore such “slack filled” products are misleading, and even deceptive, to the consumer. Although the Company believes that these claims are without merit and has generally been successful in litigation and court decrees, the Company could be exposed to significant legal fees to defend its position, and in the event that it is not successful, could be subject to fines and costs of settlement, including class action settlements.  

● Risk related to international operations - To the extent there are political leadership or legislative changes, social and/or political unrest, civil war, pandemics such as the Coronavirus, terrorism or significant economic or social instability in the countries in which the Company operates, the results of the Company’s business in such countries could be adversely impacted. Currency exchange rate fluctuations between the U.S. dollar and foreign currencies could also have an adverse impact on the Company’s results of operations and financial condition. The Company’s principal markets are the U.S.A., Canada, and Mexico.

● The Company is a controlled company due to the common stock holdings of the Gordon family - The Gordon family’s share ownership represents a majority of the combined voting power of all classes of the Company’s common stock as of December 31, 2020. As a result, the Gordon family has the power to elect the Company’s directors and approve actions requiring the approval of the shareholders of the Company.

The factors identified above are believed to be significant factors, but not necessarily all of the significant factors, that could impact the Company’s business.  Unpredictable or unknown factors could also have material effects on the Company.

Additional significant factors that may affect the Company’s operations, performance and business results include the risks and uncertainties listed from time to time in filings with the Securities and Exchange Commission and the risk factors or uncertainties listed herein or listed in any document incorporated by reference herein.

ITEM 1B.            Unresolved Staff Comments.

None.

9

ITEM 2.               Properties.

The Company owns its principal manufacturing, warehousing and distribution and offices facilities which are located in Chicago, Illinois in a building consisting of approximately 2,354,000 square feet. In addition, the Company leases manufacturing and warehousing facilities at a second location in Chicago which comprises 137,000 square feet. The lease is renewable by the Company every five years through June 2041.

The Company’s other principal manufacturing, warehousing and distribution facilities, all of which are owned, are:

Location	Square Feet (a)
Covington, Tennessee	685,000
Cambridge, Massachusetts	142,000
Delavan, Wisconsin	162,000
Concord, Ontario, Canada	280,500	(b)
Mexico City, Mexico	90,000
Barcelona, Spain	93,000	(c)

(a)Square footage is approximate and includes production, warehousing and office space.

(b)Two facilities.

(c)Excludes 9,500 square feet of unused office space in a separate facility which is leased to a third party.

The Company owns substantially all of the production machinery and equipment located in its plants, warehouses and distribution centers. The Company also holds four commercial real estate properties for investment which were acquired with the proceeds from a sale of surplus real estate in 2005 as well as two warehouse facilities (in Concord, Ontario, Canada, and Hazelton, Pennsylvania, USA) that are currently leased to third parties.

ITEM 3.               Legal Proceedings.

In the ordinary course of business, the Company is, from time to time, subject to a variety of active or threatened legal proceedings and claims. While it is not possible to predict the outcome of such matters with certainty, in the Company’s opinion, both individually and in the aggregate, they are not expected to have a material effect on the Company’s financial condition, results of operations or cash flows.

ADDITIONAL ITEM.     Executive Officers of the Registrant.

See the information on Executive Officers set forth in the table in Part III, Item 10.

ITEM 4.               Mine Safety Disclosures.

None.

10

PART II

ITEM 5.               Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

The Company’s common stock is traded on the New York Stock Exchange. The Company’s Class B common stock is subject to restrictions on transferability. The Class B common stock is convertible at the option of the holder into shares of common stock on a share-for-share basis. As of February 18, 2021 there were approximately 2,400 and 900 registered holders of record of common and Class B common stock, respectively. In addition, the Company estimates that as of February 18, 2021 there were 18,500 and 1,000 beneficial holders of common and Class B common stock, respectively.

The following table sets forth information about the shares of its common stock the Company purchased on the open market during the fiscal quarter ended December 31, 2020:

Issuer Purchases of Equity Securities

				Total Number of	Maximum Number (or
	Total	Average		Shares Purchased	Approximate Dollar Value)
	Number	Price		as Part of Publicly	of Shares that May Yet
	of Shares	Paid per		Announced Plans	be Purchased Under the
Period	Purchased	Share		or Programs	Plans or Programs
Oct 1 to Oct 31	165,000	$	31.01	Not Applicable	Not Applicable
Nov 1 to Nov 30	111,062		30.80	Not Applicable	Not Applicable
Dec 1 to Dec 31	—		—	Not Applicable	Not Applicable
Total	276,062	$	30.92

While the Company does not have a formal or publicly announced Company common stock purchase program, the Company repurchases its common stock on the open market from time to time as authorized by the Board of Directors.

Quarterly Stock Prices and Dividends

The high and low quarterly prices for the Company’s common stock, as reported on the New York Stock Exchange and quarterly dividends in 2020 and 2019 were:

	2020								2019
	4th		3rd		2nd		1st		4th		3rd		2nd		1st
		Quarter		Quarter		Quarter		Quarter		Quarter		Quarter		Quarter		Quarter
High	$	32.47	$	34.37	$	39.23	$	37.54	$	36.93	$	38.44	$	40.43	$	37.80
Low		29.42		29.07		32.71		32.00		33.33		35.24		36.48		31.57
Dividends per share		0.09		0.09		0.09		0.09		0.09		0.09		0.09		0.09

NOTE: In addition to the above cash dividends, a 3% stock dividend was issued on April 3, 2020 and April 5, 2019.

11

Performance Graph

The following performance graph compares the cumulative total shareholder return on the Company’s common stock for a five-year period (December 31, 2015 to December 31, 2020) with the cumulative total return of Standard & Poor’s 500 Stock Index (“S&P 500”) and the Dow Jones Industry Food Index (“Peer Group,” which includes the Company), assuming (i) $100 invested on December 31 of the first year of the chart in each of the Company’s common stock, S&P 500 and the Dow Jones Industry Food Index and (ii) the reinvestment of cash and stock dividends.

12

ITEM 6.               Selected Financial Data.

Five Year Summary of Earnings and Financial Highlights

(Thousands of dollars except per share, percentage and ratio figures)

	2020			2019			2018			2017			2016
Sales and Earnings Data
Net product sales	$	467,427		$	523,616		$	515,251		$	515,674		$	517,373
Product gross margin		167,717			194,514			185,371			189,263			196,504
Interest expense		164			220			181			144			105
Provision for income taxes		17,288			20,565			16,401			3,907			30,593
Net earnings attributable to Tootsie Roll Industries, Inc.		58,995			64,920			56,893			80,864	(2)		67,510
% of net product sales		12.6	%		12.4	%		11.0	%		15.7	%		13.0	%
% of shareholders’ equity		7.7	%		8.5	%		7.6	%		11.0	%		9.5	%
Per Common Share Data (1)
Net earnings attributable to Tootsie Roll Industries, Inc.	$	0.89		$	0.96		$	0.84		$	1.17	(2)	$	0.97
Cash dividends declared		0.36			0.36			0.36			0.36			0.36
Stock dividends		3	%		3	%		3	%		3	%		3	%
Additional Financial Data (1)
Working capital	$	250,851		$	273,786		$	242,655		$	207,132		$	235,739
Net cash provided by operating activities		74,710			100,221			100,929			42,973			98,550
Net cash provided by (used in) investing activities		9,501			(15,009)			(44,510)			(9,320)			(51,884)
Net cash used in financing activities		(55,846)			(57,187)			(42,353)			(56,881)			(51,387)
Property, plant & equipment additions		17,970			20,258			27,612			16,673			16,090
Net property, plant & equipment		187,328			188,455			186,101			178,972			180,905
Total assets		984,558			977,864			947,361			930,946			920,101
Long-term debt		7,500			7,500			7,500			7,500			7,500
Total Tootsie Roll Industries, Inc. shareholders’ equity		763,327			759,854			750,622			733,840			711,364
Average shares outstanding		66,512			67,416			68,072			68,904			69,811

(1) Per common share data and average shares outstanding adjusted for annual 3% stock dividends.

(2) The 2017 net earnings and earnings per share includes $20,318 or $0.29 per share relating to a favorable accounting adjustment to revalue the Company’s deferred income tax liabilities resulting from the enactment of the U.S. Tax Cuts and Jobs Act in December 2017.

13

ffITEM 7.               Management’s Discussion and Analysis of Financial Condition and Results of Operations.

(Thousands of dollars except per share, percentage and ratio figures)

The following discussion should be read in conjunction with the other sections of this report, including the consolidated financial statements and related notes contained in Item 8 of this Form 10-K.

FINANCIAL REVIEW

This financial review discusses the Company’s financial condition, results of operations, liquidity and capital resources, significant accounting policies and estimates, new accounting pronouncements, market risks and other matters. It should be read in conjunction with the Consolidated Financial Statements and related Notes that follow this discussion.

FINANCIAL CONDITION

The Company’s overall financial position remains strong given that aggregate cash, cash equivalents and investments is $428,951 at December 31, 2020, including $73,828 in trading securities discussed below. Cash flows from 2020 operating activities totaled $74,710 compared to $100,221 in 2019, and are discussed in the section entitled Liquidity and Capital Resources. During 2020, the Company paid cash dividends of $23,810, purchased and retired $32,055 of its outstanding shares, and made capital expenditures of $17,970.

The Company’s net working capital was $250,851 at December 31, 2020 compared to $273,786 at December 31, 2019. This change principally reflects the effects of a $66,989 increases in long-term investments because more of our investments have maturities great than one year at December 31, 2020 compared to December 31, 2019. As of December 31, 2020, the Company’s total cash, cash equivalents and investments, including all long-term investments, was $428,951 compared to $392,435 at December 31, 2019, an increase of $36,516. See Liquidity And Capital Resources section below. The aforementioned includes $73,828 and $76,183 of investments in trading securities as of December 31, 2020 and 2019, respectively. The Company invests in trading securities to provide an economic hedge for its deferred compensation liabilities, as further discussed herein and in Note 7 of the Company’s Notes to Consolidated Financial Statements.

Shareholders’ equity increased from $759,854 at December 31, 2019 to $763,327 as of December 31, 2020, which principally reflects 2020 net earnings of $58,995, less cash dividends of $23,810 and share repurchases of $32,055.

The Company has a relatively straight-forward financial structure and has historically maintained a conservative financial position. The Company has no special financing arrangements or “off-balance sheet” special purpose entities. Cash flows from operations plus maturities of short-term investments are expected to be adequate to meet the Company’s overall financing needs, including capital expenditures, in 2021. Periodically, the Company considers possible acquisitions, and if the Company were to pursue and complete such an acquisition, that could result in bank borrowings or other financing.

RESULTS OF OPERATIONS

2020 vs. 2019

Twelve months 2020 consolidated net product sales were $467,427 compared to $523,616 in twelve months 2019, a decrease of $56,189 or 10.7%. Net product sales were adversely impacted by the effects of the Covid-19 pandemic, which curtailed and limited access to certain channels of trade where the Company has historically sold its products. Response to this pandemic has resulted in the disruption and changes in lifestyles, shopping habits, daily work routines, and consumer behaviors, all of which have adversely affected planned consumer purchases of the Company’s products for “sharing” and “give away” occasions. Many of the Company’s products are consumed at group events, outings, and other gatherings which have been significantly curtailed or in some cases eliminated due to concern of possible infection or spreading of the Covid-19 virus. Impulse purchases of Company products at retail outlets have also been adversely affected by these

14

changes in consumer behavior. Unfavorable foreign exchange also had some adverse impact on 2020 net product sales compared to 2019.

Fourth quarter 2020 net product sales were $127,866 compared to $134,663 in fourth quarter 2019, a decrease of $6,797 or 5.0%. After a 2% sales increase in first quarter 2020, sales declined 25% in second quarter 2020 at the height of the pandemic and economic downturn. In third quarter 2020 sales declined 14%, while in fourth quarter 2020 the sales decline was narrowed to 5% when compared to the corresponding quarterly periods in 2019.

Product cost of goods sold were $299,710 in 2020 compared to $329,102 in 2019, a decrease of $29,392 or 8.9%. Product cost of goods sold includes $610 and $408 in certain deferred compensation expenses in 2020 and 2019, respectively. These deferred compensation expenses principally result from changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years and are not reflective of current operating results. Adjusting for the aforementioned, product cost of goods sold decreased from $328,694 in 2019 to $299,100 in 2020, a decrease of $29,594 or 9.0%. As a percent of net product sales, these adjusted costs increased from 62.8% in 2019 to 64.0% in 2020, a 1.2 unfavorable percentage point change. Lower sales and production volumes had an unfavorable impact on plant manufacturing overhead costs included in the aforementioned adjusted product cost of goods sold. These plant overhead costs are primarily fixed and recurring each year, and only partially decline with lower volumes.

Product gross margin was $167,717 in 2020 compared to $194,514 in 2019, a decrease of $26,797 or 13.8%.  The above discussed sales decline was the principal driver that adversely impacted gross profit margins in 2020. Certain cost and expense reductions, including Company initiatives to reduce costs did provide some benefit to 2020 gross profit margins. The Company is continuing its investments in its plant manufacturing operations to meet new consumer and customer demands, achieve quality improvements, provide genuine value to consumers, and increase operational efficiencies.

Selling, marketing and administrative expenses were $112,117 in 2020 compared to $127,802 in 2019, a decrease of $15,685 or 12.3%. Selling, marketing and administrative expenses include $11,909 and $10,884 in certain deferred compensation expenses in 2020 and 2019, respectively. These deferred compensation expenses principally result from changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years and are not reflective of current operating results. Adjusting for the aforementioned, selling, marketing and administrative expenses decreased from $116,918 in 2019 to $100,208 in 2020, a decrease of $16,710 or 14.3%. As a percent of net product sales, these adjusted expenses decreased from 22.3% of net product sales in 2019 to 21.4% of net product sales in 2020, a 0.9 favorable percentage point change. Reductions in travel and trade show expense resulting from changes in Company policies in response to the Covid-19 pandemic, and more favorable freight and delivery unit costs were the principal drivers in this expense reduction as a percentage of sales in 2020.

Selling, marketing and administrative expenses include freight, delivery and warehousing expenses. These expenses decreased from $49,288 in 2019 to $42,593 in 2020, a decrease of $6,695 or 13.6%. As a percent of net product sales, these adjusted expenses decreased from 9.4% in 2019 to 9.1% in 2020, a 0.3 favorable percentage point change. More favorable freight and delivery rates from third-party over-the-road truck carriers, and certain operational and cost reduction initiatives, contributed to this favorable change.

The Company has foreign operating businesses in Mexico, Canada and Spain, and exports products to many foreign markets. The Company’s Spanish subsidiary (97% owned by the Company) incurred an operating loss of $691 in 2020 which was an improvement compared to its $1,102 loss in 2019. The Company provided approximately $889 and $1,399 of additional cash to finance these losses and certain capital expenditures in 2020 and 2019, respectively. Company management expects the competitive and business challenges in Spain to continue but believes that there will be continued reductions in operating losses in 2021 compared to 2020. Nonetheless, management believes that operating losses will likely continue beyond 2021 and that these future losses, as well as some capital expenditures, will likely require some additional cash financing.

The Company believes that the carrying values of its goodwill and trademarks have indefinite lives as they are expected to generate cash flows indefinitely. In accordance with current accounting guidance, these indefinite-lived intangible assets are assessed at least annually for impairment as of December 31 or whenever events or circumstances indicate that the carrying values may not be recoverable from future cash flows. No impairments were recorded in 2020, 2019 or 2018.

15

Current accounting guidance provides entities an option of performing a qualitative assessment (a "step-zero" test) before performing a quantitative analysis. If the entity determines, on the basis of certain qualitative factors, that it is more-likely-than-not that the intangibles (goodwill and certain trademarks) are not impaired, the entity would not need to proceed to the two step impairment testing process (quantitative analysis) as prescribed in the guidance. During fourth quarter 2020 (and fourth quarters 2019 and 2018), the Company performed a “step zero” test of its goodwill and certain trademarks, and concluded that there was no impairment based on this guidance. For the fair value assessment of certain trademarks where the “step-zero” analysis was not considered appropriate, impairment testing was performed in fourth quarter 2020 (and fourth quarter 2019 and 2018) using discounted cash flows and estimated royalty rates. For these trademarks, holding all other assumptions constant at the test date, a 100 basis point increase in the discount rate or a 100 basis point decrease in the royalty rate would reduce the fair value of these trademarks by approximately 18% and 10%, respectively. Individually, a 100 point increase in the discount rate or a 100 point decrease in the royalty rate would not result in a potential impairment as of December 31, 2020. 

Earnings from operations were $58,244 in 2020 compared to $69,214 in 2019, a decrease of $10,970. Earnings from operations include $12,519 and $11,292 in certain deferred compensation expense in 2020 and 2019, respectively, which are discussed above. Adjusting for these deferred compensation expenses, adjusted earnings from operations decreased from $80,506 in 2019 to $70,763 in 2019, a decrease of $9,743 or 12.1%. The above discussed decline in net product sales was the principal driver of lower operating income in 2020 compared to 2019, however, 2020 earnings from operations did benefit from some cost and expense reductions as discussed above.

Management believes the comparisons presented in the preceding paragraphs, after adjusting for changes in deferred compensation, are more reflective of the underlying operations of the Company.

Other income, net was $18,018 in 2020 compared to $16,190 in 2019, an increase of $1,828. Other income, net principally reflects $12,519 and $11,292 of aggregate net gains and investment income on trading securities in 2020 and 2019, respectively. These trading securities provide an economic hedge of the Company’s deferred compensation liabilities; and the related net gains and investment income were offset by a like amount of expense in aggregate product cost of goods sold and selling, marketing, and administrative expenses in the respective years as discussed above. Other income, net includes investment income on available for sale securities of $4,005 and $4,423 in 2020 and 2019, respectively. Other income, net also includes foreign exchange gains (losses) of $534 and $(533) in 2020 and 2019, respectively.

The Company’s effective income tax rate was 22.7% and 24.1% in 2020 and 2019, respectively. The decrease in the effective tax rate in 2020 reflects more favorable foreign tax rates, income tax credits and adjustments for reserves for uncertain tax positions. A reconciliation of the differences between the U.S. statutory rate and these effective tax rates is provided in Note 4 of the Company’s Notes to Consolidated Financial Statements.

The Company utilized $617 and $1,227 of Canadian tax carry-forward benefits in 2020 and 2019, respectively. At December 31, 2019, the Company’s deferred tax assets included $617 of income tax benefits relating to its Canadian subsidiary tax loss carry-forwards. The Company fully utilized this deferred tax asset in 2020 as expected. The Company has provided a full valuation allowance on its Spanish subsidiaries’ tax loss carry-forward benefits of $4,508 and $4,584 as of December 31, 2020 and 2019, respectively, because the Company has concluded that it is not more-likely-than-not that these losses will be utilized before their expiration dates. The Spanish subsidiary has a history of net operating losses and it is not known when and if they will generate taxable income in the future.

U.S. tax reform (US Tax Cuts and Jobs Act enacted in December 2017) changed the United States approach to the taxation of foreign earnings to a territorial system by providing a one hundred percent dividends received deduction for certain qualified dividends received from foreign subsidiaries. These provisions of U.S. tax reform significantly impact the accounting for the undistributed earnings of foreign subsidiaries, and as a result the Company distributed $8,200 of the earnings held in excess cash by its foreign subsidiaries in 2019. The tax costs associated with a future distribution, including foreign withholding taxes, are not material to the Company’s financial statements. After carefully considering these facts,

16

the Company determined that it would not be asserting permanent reinvestment of its foreign subsidiaries earnings as of December 31, 2017, and the Company continued to take this position as of December 31, 2020.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into U.S. law. The CARES Act has provided a substantial stimulus and assistance package intended to address the economic impact of the Covid-19 pandemic, including tax relief and government loans, grants and investments. The Canadian government also enacted a stimulus program, Canadian Emergency Wage Subsidy (“CEWS”), to respond to the economic impact of Covid-19 during 2020 The Company’s financial results in 2020 did reflect some benefits, primarily in the second and third quarters of 2020, from these stimulus programs. The Company continues to monitor any effects and related benefits that may result from the above discussed legislation and other proposed stimulus programs. Based on consultation with its tax advisors, the Company does not believe that it will be eligible for any significant benefits in 2021 under these stimulus programs.

Net earnings were $58,995 in 2020 compared to $64,920 in 2019, and net earnings per share were $0.89 and $0.96 in 2020 and 2019, respectively, a decrease of $0.07 per share of 7%. Earnings per share in 2020 benefited from the reduction in average shares outstanding resulting from purchases of the Company’s common stock in the open market by the Company. Average shares outstanding decreased from 67,416 in 2019 to 66,512 in 2020 which reflects share repurchases of $32,055 during 2020.

Fourth quarter 2020 and 2019 net earnings attributable to Tootsie Roll Industries, Inc. were $14,952 and $14,555, respectively, and net earnings per share were $0.23 and $0.22, respectively, an increase of $0.01 per share or 5%. Certain cost and expense reductions, including Company operational changes and initiatives to reduce costs as discussed above, did provide some benefit to fourth quarter 2020 results. Although unfavorable foreign exchange adversely affected fourth quarter 2020 results, a lower effective income tax rate contributed to the increase in net earnings in fourth quarter 2020 compared to fourth quarter 2019.

Beginning in 2012, the Company received periodic notices from the Bakery, Confectionery, Tobacco Workers and Grain Millers International Union Pension Plan (Plan), a multi-employer defined benefit pension plan for certain Company union employees, that the Plan’s actuary certified the Plan to be in “critical status”, as defined by the Pension Protection Act (PPA) and the Pension Benefit Guaranty Corporation (PBGC); and that a plan of rehabilitation was adopted by the trustees of the Plan in 2012. During 2015, the Company received notices that the Plan’s status was changed to “critical and declining status”, as defined by the PPA and PBGC, for the plan year beginning January 1, 2015, and that the Plan was projected to have an accumulated funding deficiency for the 2017 through 2024 plan years. A designation of “critical and declining status” implies that the Plan is expected to become insolvent in the next 20 years. The Company has continued to receive annual notices each year (2016 to 2020) that this Plan remains in “critical and declining status” and is projected to become insolvent within the next 20 years. These notices have also advised that the Plan trustees were considering the reduction or elimination of certain retirement benefits and may seek assistance from the PBGC. Plans in “critical and declining status” may elect to suspend (temporarily or permanently) some benefits payable to all categories of participants, including retired participants, except retirees that are disabled or over the age of 80. Suspensions must be equally distributed and cannot drop below 110% of what would otherwise be guaranteed by the PBGC.  

Based on these updated notices, the Plan’s funded percentage (plan investment assets as a percentage of plan liabilities), as defined, were 50.4%, 51.6%, and 54.7% as of the most recent valuation dates available, January 1, 2019, 2018, and 2017, respectively (these valuation dates are as of the beginning of each Plan year). These funded percentages are based on actuarial values, as defined, and do not reflect the actual market value of Plan investments as of these dates. If the market value of investments had been used as of January 1, 2019 the funded percentage would be 48.8% (not 50.4%). As of the January 1, 2019 valuation date (most recent valuation available), only 16% of Plan participants were current active employees, 53% were retired or separated from service and receiving benefits, and 31% were retired or separated from service and entitled to future benefits. The number of current active employee Plan participants as of January 1, 2019 fell 14% from the previous year and 17% over the past two years. When compared to the Plan valuation date of January 1, 2011 (eight years earlier), current active employee participants have declined 47%, whereas participants who were retired

17

or separated from service and receiving benefits increased 4% and participants who were retired or separated from service and entitled to future benefits increased 14%.

The Company has been advised that its withdrawal liability would have been $99,300, $99,800 and $81,600 if it had withdrawn from the Plan during 2020, 2019 and 2018, respectively. The Company’s relative share of the Plan’s contribution base, driven by employer withdrawals, has increased for the last several years, and management believes that this trend could continue indefinitely which will continue to add upward pressure on the Company’s withdrawal liability. In addition, the overall reduction in interest rates through the 12 months ended December 31, 2020, will increase the value of vested benefits and likely increase the Company’s withdrawal liability in 2020. Based on the above, including the Plan’s projected insolvency in the next 20 years, management believes that the Company’s withdrawal liability will increase further in future years.

Based on the Company’s updated actuarial study and certain provisions in ERISA and the law relating to withdrawal liability payments, management believes that the Company’s liability would likely be limited to twenty annual payments of $2,958 which have a present value in the range of $34,700 to $49,300 depending on the interest rate used to discount these payments. While the Company’s actuarial consultant does not believe that the Plan will suffer a future mass withdrawal (as defined) of participating employers, in the event of a mass withdrawal, the Company’s annual withdrawal payments would theoretically be payable in perpetuity. Based on the Company’s updated actuarial study, the present value of such perpetuities is in the range of $48,500 to $150,900 and would apply in the unlikely event that substantially all employers withdraw from the Plan. The aforementioned is based on a range of valuations and interest rates which the Company’s actuary has advised is provided under the statute. Should the Company actually withdraw from the Plan at a future date, a withdrawal liability, which could be higher than the above discussed amounts, could be payable to the Plan.

The Company and the union concluded a new labor contract in 2018 which requires the Company’s continued participation in this Plan through September 2022. The amended rehabilitation plan, which also continues, requires that employer contributions include 5% compounded annual surcharge increases each year for an unspecified period of time beginning in 2012 as well as certain plan benefit reductions. The Company’s pension expense for this Plan for 2020, 2019 and 2018 was $2,866, $2,961 and $2,836, respectively. The aforementioned expense includes surcharges of $1,010, $948 and $811 in 2020, 2019 and 2018, respectively, as required under the amended rehabilitation plan.

In fourth quarter 2020, the Plan Trustees advised the Company that the surcharges would no longer increase annually and therefore be “frozen” at the rates and amounts in effect as of December 31, 2020 provided that the local bargaining union and the Company executed a formal consent agreement by March 31, 2021. The Trustees advised that they have concluded that continuing increases in surcharges would likely have a long-term adverse effect on the solvency of the Plan. The Trustees concluded that further increases would result in increasing financial hardships and withdrawals of participating employers, and that this change will not have a material effect on the Plan’s insolvency date. Subsequent to December 31, 2020, the local bargaining union and the Company executed this agreement which resulted in the “freezing” of such surcharges as of December 31, 2020.

Company management understands that the US House of Representatives Ways and Means Committee is preparing legislation under President Biden’s proposed $1.9 trillion American Rescue Plan that would provide financial assistance to shore up struggling multi-employer plans for many years. The Ways and Means bill would create special assistance programs that would allow the PBGC to make direct cash payments to financially troubled multiemployer plans to ensure that they can remain solvent and continue to pay benefits to retirees through 2051. The Company is currently unable to determine the ultimate outcome of the above discussed multi-employer union pension matter and therefore is unable to determine the effects on its consolidated financial statements, but the ultimate outcome could be material to its consolidated results of operations or cash flows in one or more future periods. See also Note 7 in the Company’s Consolidated Financial Statements on Form 10-K for the year ended December 31, 2020.

18

2019 vs. 2018

Consolidated net product sales were $523,616 in 2019 compared to $515,251 in 2018, an increase of $8,365 or 1.6%. Fourth quarter 2019 net product sales were $134,663 compared to $127,264 in fourth quarter 2018, an increase of $7,399 or 5.8%. Successful marketing and sales programs contributed to the increases in sales for both fourth quarter and twelve months 2019 compared to the corresponding periods in the prior year. Fourth quarter 2019 sales also benefited from the timing of sales between the third and fourth quarters of 2019, however, foreign currency translation had some adverse effects on consolidated sales for the twelve months 2019 period compared to 2018.  

Product cost of goods sold were $329,102 in 2019 compared to $329,880 in 2018, a decrease of $778 or 0.2%. Product cost of goods sold includes $408 and $(39) in certain deferred compensation expenses (credits) in 2019 and 2018, respectively. These deferred compensation expenses principally result from changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years and are not reflective of current operating results. Adjusting for the aforementioned, product cost of goods sold decreased from $329,919 in 2018 to $328,694 in 2019, a decrease of $1,225 or 0.4%. As a percent of net product sales, these adjusted costs decreased from 64.0% in 2018 to 62.8% in 2019, a 1.3 favorable percentage point change.

Product cost of goods sold and resulting gross profit margins in 2019 benefited from increased sales and higher price realization which allowed the Company to recover some margin decline resulting from increases in certain input costs in recent years. Plant efficiencies driven by capital investments and ongoing cost containment programs contributed to the above discussed decreases in adjusted cost of goods sold as a percentage of sales in 2019. The prior year 2018 gross margin was adversely affected by the implementation and start-up of new manufacturing packaging lines and resulting operational inefficiencies, as well as unfavorable experience from self-insurance programs.

Selling, marketing and administrative expenses were $127,802 in 2019 compared to $117,691 in 2018, an increase of $10,111 or 8.6%. Selling, marketing and administrative expenses include $10,884 and $(1,064) in certain deferred compensation expenses (credits) in 2019 and 2018, respectively. These deferred compensation expenses principally result from changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years and are not reflective of current operating results. Adjusting for the aforementioned, selling, marketing and administrative expenses decreased from $118,755 in 2018 to $116,918 in 2019, a decrease of $1,837 or 1.5%. As a percent of net product sales, these adjusted expenses decreased from 23.0% of net product sales in 2018 to 22.3% of net product sales in 2019, a 0.7 favorable percentage point change. Higher price realization, lower general and administrative expenses, primarily legal and professional fees, and lower freight and delivery unit costs were the principal drivers in these favorable reductions, including reductions as a percentage of sales, in 2019.

Selling, marketing and administrative expenses include freight, delivery and warehousing expenses. These expenses decreased from $49,527 in 2018 to $49,288 in 2019, a decrease of $239 or 0.5%. As a percent of net product sales, these adjusted expenses decreased from 9.6% in 2018 to 9.4% in 2019, a 0.2 favorable percentage point change. During 2019, the Company implemented additional freight and delivery computer systems and carrier selection processes, including enhanced competitive bidding, which facilitated this favorable unit cost reduction in 2019.

Earnings from operations were $69,214 in 2019 compared to $70,482 in 2018, a decrease of $1,268. Earnings from operations include $11,292 and $(1,103) in certain deferred compensation expense (credits) in 2019 and 2018, respectively, which are discussed above. Adjusting for these deferred compensation expenses, adjusted earnings from operations increased from $69,379 in 2018 to $80,506 in 2019, an increase of $11,127 or 16.0%. Increased sales and higher price realization in 2019, as well as reductions in certain costs and expenses discussed above, contributed to these improved results.

Management believes the comparisons presented in the preceding paragraphs, after adjusting for changes in deferred compensation, are more reflective of the underlying operations of the Company.

Other income, net was $16,190 in 2019 compared to $2,724 in 2018, an increase of $13,466. Other income, net principally reflects $11,292 and $(1,103) of aggregate net gains (losses) and investment income on trading securities in 2019 and

19

2018, respectively. These trading securities provide an economic hedge of the Company’s deferred compensation liabilities; and the related net gains (losses) and investment income were offset by a like amount of expense in aggregate product cost of goods sold and selling, marketing, and administrative expenses in the respective years as discussed above. Other income, net includes investment income on available for sale securities of $4,423 and $3,535 in 2019 and 2018, respectively. Other income, net also includes foreign exchange losses of $533 and $659 in 2019 and 2018, respectively.

The Company’s effective income tax rate was 24.1% and 22.4% in 2019 and 2018, respectively. The increase in the effective tax rate for 2019 reflects higher state income taxes, including increases in reserves for uncertain state tax benefits, and increases in valuation allowances for state income tax credit carry-forwards which are not likely to be fully realized in the future.

Net earnings attributable to Tootsie Roll Industries, Inc. were $64,920 in 2019 compared to $56,893 in 2018, and net earnings per share were $0.96 and $0.84 in 2019 and 2018, respectively, an increase of $0.12 per share or 14%. Higher sales, including higher sales realization, and cost and expense reduction discussed above, were the principal drivers of this improvement in 2019 compared to 2018. Earnings per share in 2019 benefited from the reduction in average shares outstanding resulting from purchases of the Company’s common stock in the open market by the Company. Average shares outstanding decreased from 68,072 in 2018 to 67,416 in 2019 which reflects share repurchases of $34,116 during 2019. Net earnings attributable to Tootsie Roll Industries, Inc. were $14,555 in fourth quarter 2019 compared to $12,175 in fourth quarter 2018, and net earnings per share were $0.22 and $0.18 in fourth quarter 2019 and 2018, respectively an increase of $0.04 per share or 22%.

LIQUIDITY AND CAPITAL RESOURCES

Cash flows from operating activities were $74,710, $100,221 and $100,929 in 2020, 2019 and 2018, respectively. The $25,511 decrease in cash flows from operating activities from 2019 to 2020 primarily reflects decreases in net earnings and payments of deferred compensation in 2020. The $708 decrease in cash flows from operating activities from 2018 to 2019 primarily reflects the timing of payments and refunds of income taxes, combined with increases in prepaid expenses and inventories, offset by a decrease in accounts receivable as of December 31, 2019.

The Company manages and controls a VEBA trust, to fund the estimated future costs of certain union employee health, welfare and other benefits. A contribution of $20,024 was made to this trust in 2017; no contribution was made to the trust during 2018, 2019 or 2020. The Company uses these funds to pay the actual cost of such benefits over each union contract period. At December 31, 2020 and 2019, the VEBA trust held $8,272 and $12,085, respectively, of aggregate cash and cash equivalents, which the Company will use to pay certain union employee benefits through some time in 2022. This asset value is included in prepaid expenses and long-term other assets in the Company’s Consolidated Statement of Financial Position. These assets are categorized as Level 1 within the fair value hierarchy.

Cash flows from investing activities reflect capital expenditures of $17,970, $20,258, and $27,612 in 2020, 2019 and 2018, respectively. The changes in amounts from 2018 to 2019 principally reflect new manufacturing packaging lines in 2018 and the timing of expenditures relating to other plant manufacturing capital projects. Company management has committed approximately $25,000 to a rehabilitation upgrade and expansion of one of its manufacturing plants in the U.S.A. The Company spent approximately $6,000 and 2,000 in 2020 and 2019, respectively. Company management expects cash outlays for this project to approximate $17,000 in 2021. All capital expenditures are to be funded from the Company’s cash flow from operations and internal sources including available for sale securities. The repayment of $23,527 of previously paid premiums on split dollar life insurance policies did provide additional cash from investing activities in 2020 (see Note 1 to the Company’s Notes to Consolidated Financial Statements).

Other than the bank loans and the related restricted cash of the Company’s Spanish subsidiary which are discussed in Note 1 of the Company’s Notes to Consolidated Financial Statements, the Company had no bank borrowings or repayments in

20

2018, 2019, or 2020, and had no outstanding bank borrowings as of December 31, 2019 or 2020. Nonetheless, the Company would consider bank borrowing or other financing in the event that a business acquisition is completed.

Financing activities include Company common stock purchases and retirements of $32,055, $34,116, and $19,317 in 2020, 2019 and 2018, respectively. Cash dividends of $23,810, $23,460, and $22,978 were paid in 2020, 2019 and 2018, respectively.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Preparation of the Company’s financial statements involves judgments and estimates due to uncertainties affecting the application of accounting policies, and the likelihood that different amounts would be reported under different conditions or using different assumptions. The Company bases its estimates on historical experience and other assumptions, as discussed herein, that it believes are reasonable. If actual amounts are ultimately different from previous estimates, the revisions are included in the Company’s results of operations for the period in which the actual amounts become known. The Company’s significant accounting policies are discussed in Note 1 of the Company’s Notes to Consolidated Financial Statements.

Following is a summary and discussion of the more significant accounting policies and estimates which management believes to have a significant impact on the Company’s operating results, financial position, cash flows and footnote disclosure.

Revenue recognition

As more fully discussed in Note 1, the Company adopted the new accounting revenue recognition guidance (ASC 606) effective January 1, 2018. As a result of adoption, the cumulative impact to retained earnings at January 1, 2018 was a net after-tax increase of $3,319 ($4,378 pre-tax). The adoption principally changed the timing of recognition of certain trade promotions and related adjustments thereto which affect net product sales. The comparative prior information has not been restated and continues to be reported under the accounting standards in effect for such period. The adoption of the new standard in 2018 did not have a material effect on 2018, 2019 and 2020 results, and management does not believe that it will have a material effect on results in future years. Revenue for net product sales continues to be recognized at a point in time when products are delivered to or picked up by the customer, as designated by customers’ purchase orders, as discussed in Note 1.

Provisions for bad debts are recorded as selling, marketing and administrative expenses. Write-offs of bad debts did not exceed 0.1% of net product sales in each of 2020, 2019 and 2018, and accordingly, have not been significant to the Company’s financial position or results of operations.

Intangible assets

The Company’s intangible assets consist primarily of goodwill and acquired trademarks. In accordance with accounting guidance, goodwill and other indefinite-lived assets, trademarks, are not amortized, but are instead subjected to annual testing for impairment unless certain triggering events or circumstances are noted. The Company performs its annual impairment review and assessment as of December 31. All trademarks have been assessed by management to have indefinite lives because they are expected to generate cash flows indefinitely. The Company reviews and assesses certain trademarks (non-amortizable intangible assets) for impairment by comparing the fair value of each trademark with its carrying value. Current accounting guidance provides entities an option of performing a qualitative assessment (a "step-zero" test) before performing a quantitative analysis. If the entity determines, on the basis of certain qualitative factors, that it is more-likely-than-not that the intangibles (goodwill and certain trademarks) are not impaired, the entity would not need to proceed to the two step impairment testing process (quantitative analysis) as prescribed in the guidance. During

21

fourth quarter 2020, the Company performed a “step zero” test of its goodwill and certain trademarks, and concluded that there was no impairment based on this guidance.

The Company determines the fair value of certain trademarks using discounted cash flows and estimates of royalty rates. If the carrying value exceeds fair value, such trademarks are considered impaired and is reduced to fair value. The Company utilizes third-party professional valuation firms to assist in the determination of valuation of certain trademarks. Impairments have not generally been material to the Company’s historical operating results.

Cash flow projections require the Company to make assumptions and estimates regarding the Company’s future plans, including sales projections and profit margins, market based discount rates, competitive factors, and economic conditions; and the Company’s actual results and conditions may differ over time. A change in the assumptions relating to the impairment analysis including but not limited to a reduction in projected cash flows, the use of a different discount rate to discount future cash flows or a different royalty rate applied to such trademarks, could cause impairment in the future.

Customer incentive programs, advertising and marketing

Advertising and marketing costs are recorded in the period to which such costs relate. The Company does not defer the recognition of any amounts on its consolidated balance sheet with respect to such costs. Customer incentives and other promotional costs, including consumer coupon (price reduction) incentives, are recorded in accordance with ASU 606 at the time of the Company’s sale based upon incentive program terms and historical utilization statistics, which are generally consistent from year to year. The liabilities associated with these programs are reviewed quarterly and adjusted if utilization rates differ from management’s original estimates. Such adjustments have not historically been material to the Company’s operating results.

Split dollar officer life insurance

The Company provides split dollar life insurance benefits to an executive officer and records an asset principally equal to the cumulative premiums paid. During 2020, the Company recovered $23,527 of previously paid premiums on certain policies and will fully recover the remaining premiums in future years under the terms of the plan. The Company retains a collateral assignment of the cash surrender values and policy death benefits payable to insure recovery of these premiums.

Valuation of long-lived assets

Long-lived assets, primarily property, plant and equipment, are reviewed for impairment as events or changes in business circumstances occur indicating that the carrying value of the asset may not be recoverable. The estimated cash flows produced by assets or asset groups, are compared to the asset carrying value to determine whether impairment exists. Such estimates involve considerable management judgment and are based upon assumptions about expected future operating performance. As a result, actual cash flows could differ from management’s estimates due to changes in business conditions, operating performance, and economic and competitive conditions. Such impairments have not historically been material to the Company’s operating results.

Income taxes

Deferred income taxes are recognized for future tax effects of temporary differences between financial and income tax reporting using tax rates in effect for the years in which the differences are expected to reverse. The Company records valuation allowances in situations where the realization of deferred tax assets, including those relating to net operating tax losses, is not more-likely-than-not; and the Company adjusts and releases such valuation allowances when realization becomes more-likely-than-not as defined by accounting guidance. The Company periodically reviews assumptions and

22

estimates of the Company’s probable tax obligations and effects on its liability for uncertain tax positions, using informed judgment which may include the use of third-party consultants, advisors and legal counsel, as well as historical experience.

Valuation of investments

Investments primarily comprise high quality corporate bonds, including variable rate demand notes (generally long term bonds where interest rates are reset weekly, and provide a weekly “put” which allows the holder to also sell each week with no loss in principal), which are reviewed for impairment at each reporting period by comparing the carrying value or amortized cost to the fair market value. In the event that an investment security’s fair value is below carrying value or amortized cost, the Company will record an other-than-temporary impairment or a temporary impairment based on accounting guidance. The Company’s investment policy, which guides investment decisions, is focused on high quality investments which mitigates the risk of impairment. The Company does not invest in Level 3 securities, as defined, but may utilize third-party professional valuation firms as necessary to assist in the determination of the value of investments that utilize Level 3 inputs (as defined by guidance) should any of its investments be downgraded to Level 3.

Other matters

In the opinion of management, other than contracts for foreign currency forwards and raw materials, including currency and commodity hedges and outstanding purchase orders for packaging, ingredients, supplies, and operational services, all entered into in the ordinary course of business, the Company does not have any significant contractual obligations or future commitments. The Company’s outstanding contractual commitments as of December 31, 2020, all of which are generally normal and recurring in nature, are summarized in the chart which follows below.

RECENT ACCOUNTING PRONOUNCEMENTS

See Note 1 of the Company’s Notes to Consolidated Financial Statements.

MARKET RISKS

The Company is exposed to market risks related to commodity prices, interest rates, investments in marketable securities, equity price and foreign exchange.

The Company’s ability to forecast the direction and scope of changes to its major input costs is impacted by significant potential volatility in crude oil and energy, sugar, corn, edible oils, cocoa and cocoa powder, and dairy products markets. The prices of these commodities are influenced by changes in global demand, changes in weather and crop yields, including the effects of climate change, changes in import tariffs and governments’ farm policies, including mandates for ethanol and bio-fuels, environmental matters, fluctuations in the U.S. dollar relative to dollar-denominated commodities in world markets, and in some cases, geo-political risks. The Company believes that its competitors face the same or similar challenges.

In order to address the impact of changes in input and other costs, the Company periodically reviews each item in its product portfolio to ascertain if price realization adjustments or other actions should be taken. These reviews include an evaluation of the risk factors relating to market place acceptance of such changes and their potential effect on future sales volumes. In addition, the estimated cost of packaging modifications associated with weight changes, if applicable, is evaluated. The Company also maintains ongoing cost reduction and productivity improvement programs under which cost savings initiatives are encouraged and progress monitored. The Company is not able to accurately predict the outcome of these cost savings initiatives and their effects on its future results.

Commodity future and foreign currency forward contracts

Commodity price risks relate to ingredients, primarily sugar, cocoa and cocoa powder, chocolate, corn syrup, dextrose, edible oils, milk, whey and gum base ingredients. The Company believes its competitors face similar risks, and the industry has historically adjusted prices, and/or product weights, to compensate for adverse fluctuations in commodity costs. The Company, as well as competitors in the confectionery industry, has historically taken actions, including higher price

23

realization to mitigate rising input costs for ingredients, packaging, labor and fringe benefits, energy, and freight and delivery. Although management seeks to substantially recover cost increases over the long-term, there is risk that higher price realization cannot be fully passed on to customers and, to the extent they are passed on, they could adversely affect customer and consumer acceptance and resulting sales volume.

The Company utilizes commodity futures contracts, as well as annual supply agreements, to hedge and plan for anticipated purchases of certain ingredients, including sugar, in order to mitigate commodity cost fluctuation. The Company also may purchase forward foreign exchange contracts to hedge its costs of manufacturing certain products in Canada for sale and distribution in the United States (U.S.A.), and periodically does so for purchases of equipment or raw materials from foreign suppliers. Such commodity futures and currency forward contracts are cash flow hedges and are effective as hedges as defined by accounting guidance. The unrealized gains and losses on such contracts are deferred as a component of accumulated other comprehensive loss (or gain) and are recognized as a component of product cost of goods sold when the related inventory is sold.

The potential change in fair value of commodity and foreign currency derivative instruments held by the Company at December 31, 2020, assuming a 10% change in the underlying contract price, was $1,040. The analysis only includes commodity and foreign currency derivative instruments and, therefore, does not consider the offsetting effect of changes in the price of the underlying commodity or foreign currency. This amount is not significant compared with the net earnings and shareholders’ equity of the Company.

Interest rates

Interest rate risks primarily relate to the Company’s investments in marketable securities with maturities dates of generally up to three years.

The majority of the Company’s investments, which are classified as available for sale, have historically been held until their maturity which is up to about 3 years, which limits the Company’s exposure to interest rate fluctuations. The Company also invests in variable rate demand notes which have interest rates which are reset weekly and can be “put back” and sold each week through a remarketing agent, generally a large financial broker, which also substantially eliminates the Company’s exposure to interest rate fluctuations on the principal invested. The accompanying chart summarizes the maturities of the Company’s investments in debt securities at December 31, 2020.

Less than 1 year	$	42,090
1 – 2 years		42,022
2 – 3 years		104,170
Total	$	188,282

The Company’s outstanding debt at December 31, 2020 and 2019 was $7,500 in an industrial revenue bond in which interest rates reset each week based on the current market rate. Therefore, the Company does not believe that it has significant interest rate risk with respect to its interest bearing debt.

Investment in marketable securities

As stated above, the Company invests primarily in marketable securities including variable rate demand notes (VRDNs). The VRDNs have weekly “puts” which are collateralized by bank letters of credit or other assets, and interest rates are reset weekly. Except for VRDN’s the Company’s marketable securities are held to maturity with maturities generally not exceeding three years. The Company utilizes professional money managers and maintains investment policy guidelines which emphasize high quality and liquidity in order to minimize the potential loss exposures that could result in the event of a default or other adverse event. The Company continues to monitor these investments and markets, as well as its investment policies, however, the financial markets could experience unanticipated or unprecedented events and future outcomes may be less predictable than in the past.

24

Equity price

Equity price risk relates to the Company’s investments in mutual funds which are principally used to fund and hedge the Company’s deferred compensation liabilities. These investments in mutual funds are classified as trading securities. Any change in the fair value of these trading securities is completely offset by a corresponding change in the respective hedged deferred compensation liability, and therefore the Company does not believe that it has significant equity price risk with respect to these investments.

Foreign currency

Foreign currency risk principally relates to the Company’s foreign operations in Canada, Mexico and Spain, as well as periodic purchase commitments of machinery and equipment from foreign sources, generally the European Union where the EURO is the currency.

Certain of the Company’s Canadian manufacturing costs, including local payroll and plant operations, and a portion of its packaging and ingredients are sourced in Canadian dollars. The Company may purchase Canadian forward contracts to receive Canadian dollars at a specified date in the future and uses its Canadian dollar collections on Canadian sales as a partial hedge of its overall Canadian manufacturing obligations sourced in Canadian dollars. The Company also periodically purchases and holds Canadian dollars to facilitate the risk management of these currency changes.

From time to time, the Company may use foreign exchange forward contracts and derivative instruments to mitigate its exposure to foreign exchange risks, as well as those related to firm commitments to purchase equipment from foreign vendors. See Note 11 of the Company’s Notes to Consolidated Financial Statements for outstanding foreign exchange forward contracts as of December 31, 2020.

Open Contractual Commitments as of December 31, 2020:

			Less than		1 to 3		3 to 5		More than
Payable in	Total		1 Year		Years		Years		5 Years
Commodity hedges	$	4,010	$	4,010	$	—	$	—	$	—
Foreign currency hedges		6,391		3,195		3,196		—		—
Purchase obligations		5,958		5,958		—		—		—
Interest bearing debt		7,500		—		—		—		7,500
Operating leases		869		684		185		—		—
Total	$	24,728	$	13,847	$	3,381	$	—	$	7,500

Note: Commodity hedges and foreign currency hedges reflect the amounts at which the Company will settle the related contracts. The above amounts exclude deferred income tax liabilities of $47,900, liabilities for uncertain tax positions of $3,351, postretirement health care benefits of $13,487 and noncurrent deferred compensation of $79,665 because the timing of payments relating to these items cannot be reasonably determined.

25

ITEM 7A.           Quantitative and Qualitative Disclosures About Market Risk.

The information required by this item is included under the caption “Market Risk” in Item 7 above.

See also Note 1 of the Notes to Consolidated Financial Statements.

ITEM 8.               Financial Statements and Supplementary Data.

Management’s Report on Internal Control Over Financial Reporting

The management of Tootsie Roll Industries, Inc. is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in the Securities Exchange Act of 1934 (SEC) Rule 13a-15(f). Company management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020 as required by SEC Rule 13a-15(c). In making this assessment, the Company used the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Based on the Company’s evaluation under the COSO criteria, Company management concluded that its internal control over financial reporting was effective as of December 31, 2020.

The effectiveness of the Company’s internal control over financial reporting as of December 31, 2020 has been audited by Grant Thornton LLP, an independent registered public accounting firm, as stated in their report which is included herein.

26

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders

Tootsie Roll Industries, Inc.

Opinions on the financial statements and internal control over financial reporting

We have audited the accompanying consolidated balance sheets of Tootsie Roll Industries, Inc. (a Virginia corporation) and subsidiaries (the “Company”) as of December 31, 2020 and 2019, and the related consolidated statements of earnings and retained earnings, comprehensive income, changes in shareholders’ equity, and cash flows for the three years ended December 31, 2020, 2019 and 2018, and the related notes and financial statement schedule included under Item 15(a) (collectively referred to as the “financial statements”).  We also have audited the Company’s internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the periods ended December 31, 2020, 2019 and 2018 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 Internal Control - Integrated Framework issued by COSO.

Basis for opinions

The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

27

Definition and limitations of internal control over financial reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical audit matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Trademark Impairment Assessment

As described in Note 1 and Note 13 to the consolidated financial statements, the Company’s consolidated trademark balance was $175 million at December 31, 2020, which is allocated to the Company’s brands that were purchased. Indefinite-lived trademarks are tested for impairment at least annually. For several trademarks, a Step 0 approach is used to test for impairment based on relevant qualitative factors, as outlined within Accounting Standards Codifications (ASC) 350-20 and 350-30. For the fair value assessment of certain other trademarks where a Step 0 analysis was not considered appropriate, Step 1 impairment testing is performed annually using discounted cash flows, derived from projected revenue, operating margins and estimated discount rates. The determination of the fair value of the trademarks subjected to a Step 1 impairment test requires management to make significant estimates and assumptions related to forecasts of future revenues, operating margins and discount rates. As disclosed by management, changes in these assumptions could have a significant impact on either the fair value of the trademark, the amount of any trademark impairment charge, or both.

We identified the Step 1 trademark impairment assessment as a critical audit matter, as auditing management’s judgments regarding forecasts of future revenue, operating margin and discount rate involves a high degree of subjectivity.  

The primary procedures we performed to address this critical audit matter included:

● Testing the operating effectiveness of controls relating to management’s impairment tests, including controls over the determination of the fair value of these specific trademarks. Through these tests, we evaluated management’s review controls over the financial projections, including reperformance and approval of the reasonableness of the key assumptions and inputs to the analysis, such as discount rates, growth rates, and key performance indicators such as sales forecast and operating margins.

● Testing management’s process for determining the fair value of the trademarks. We evaluated the reasonableness of management’s forecasts of future revenue and operating margin by considering the impact that COVID-19 had on the year ended December 31, 2020, and its expected impact on future periods. We also considered whether such assumptions were consistent with historical forecasts and operating results for the Company, as well as evidence obtained in other areas of the audit. Additionally, a sensitivity analysis was performed using a Capital

28

Asset Pricing Model in order to ensure the assumptions used in management’s model fell within reasonable ranges based on third-party industry market data.

● Utilizing a valuation specialist to assist in evaluating the reasonableness of and testing the methodology used in the Company’s discounted cash flow model for the trademarks and certain significant assumptions, including the discount rate.

/s/ GRANT THORNTON LLP

We have served as the Company’s auditor since 2018.

Chicago, Illinois

March 1, 2021

29

CONSOLIDATED STATEMENTS OF

Earnings and Retained Earnings

TOOTSIE ROLL INDUSTRIES, INC. AND SUBSIDIARIES   (in thousands except per share data)

	For the year ended December 31,
	2020		2019		2018
Net product sales	$	467,427	$	523,616	$	515,251
Rental and royalty revenue		3,636		3,497		3,669
Total revenue		471,063		527,113		518,920
Product cost of goods sold		299,710		329,102		329,880
Rental and royalty cost		992		995		867
Total costs		300,702		330,097		330,747
Product gross margin		167,717		194,514		185,371
Rental and royalty gross margin		2,644		2,502		2,802
Total gross margin		170,361		197,016		188,173
Selling, marketing and administrative expenses		112,117		127,802		117,691
Earnings from operations		58,244		69,214		70,482
Other income, net		18,018		16,190		2,724
Earnings before income taxes		76,262		85,404		73,206
Provision for income taxes		17,288		20,565		16,401
Net earnings		58,974		64,839		56,805
Less: net earnings (loss) attributable to noncontrolling interests		(21)		(81)		(88)
Net earnings attributable to Tootsie Roll Industries, Inc.	$	58,995	$	64,920	$	56,893
Net earnings attributable to Tootsie Roll Industries, Inc. per share	$	0.89	$	0.96	$	0.84
Average number of shares outstanding		66,512		67,416		68,072
Retained earnings at beginning of period	$	40,809	$	33,767	$	57,225
Net earnings attributable to Tootsie Roll Industries, Inc.		58,995		64,920		56,893
Adopted ASU's (See Note 1)		—		—		2,726
Cash dividends		(23,739)		(23,371)		(22,929)
Stock dividends		(43,753)		(34,507)		(60,148)
Retained earnings at end of period	$	32,312	$	40,809	$	33,767

(The accompanying notes are an integral part of these statements.)

30

CONSOLIDATED STATEMENTS OF

Comprehensive Earnings

TOOTSIE ROLL INDUSTRIES, INC. AND SUBSIDIARIES   (in thousands)

	For the year ended December 31,
	2020		2019		2018
Net earnings	$	58,974	$	64,839	$	56,805
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments		(1,213)		791		103
Pension and postretirement reclassification adjustments:
Unrealized gains (losses) for the period on postretirement and pension benefits		467		(1,230)		1,558
Less: reclassification adjustment for (gains) losses to net earnings		(1,349)		(1,522)		(1,324)
Unrealized gains (losses) on postretirement and pension benefits		(882)		(2,752)		234
Investments:
Unrealized gains (losses) for the period on investments		1,463		3,130		(606)
Less: reclassification adjustment for (gains) losses to net earnings		—		34		—
Unrealized gains (losses) on investments		1,463		3,164		(606)
Derivatives:
Unrealized gains (losses) for the period on derivatives		1,259		451		(2,734)
Less: reclassification adjustment for (gains) losses to net earnings		325		677		1,630
Unrealized gains (losses) on derivatives		1,584		1,128		(1,104)
Total other comprehensive income (loss), before tax		952		2,331		(1,373)
Income tax benefit (expense) related to items of other comprehensive income		(522)		(354)		349
Total comprehensive earnings		59,404		66,816		55,781
Comprehensive earnings (loss) attributable to noncontrolling interests		(21)		(81)		(88)
Total comprehensive earnings attributable to Tootsie Roll Industries, Inc.	$	59,425	$	66,897	$	55,869

(The accompanying notes are an integral part of these statements.)

31

CONSOLIDATED STATEMENTS OF
Financial Position
TOOTSIE ROLL INDUSTRIES, INC. AND SUBSIDIARIES	(in thousands)

Assets

	December 31,
	2020		2019
CURRENT ASSETS:
Cash and cash equivalents	$	166,841	$	138,960
Restricted cash		415		380
Investments		42,090		100,444
Accounts receivable trade, less allowances of $1,694 and $1,949		41,209		45,044
Other receivables		3,894		3,418
Inventories:
Finished goods and work-in-process		35,583		35,909
Raw materials and supplies		23,996		23,179
Prepaid expenses		6,844		5,996
Total current assets		320,872		353,330
PROPERTY, PLANT AND EQUIPMENT, at cost:
Land		21,738		21,740
Buildings		123,883		122,843
Machinery and equipment		422,506		416,625
Construction in progress		14,347		4,427
Operating lease right-of-use assets		858		1,580
		583,332		567,215
Less — accumulated depreciation		396,004		378,760
Net property, plant and equipment		187,328		188,455
OTHER ASSETS:
Goodwill		73,237		73,237
Trademarks		175,024		175,024
Investments		220,020		153,031
Split dollar officer life insurance		2,514		26,042
Prepaid expenses and other assets		4,525		8,056
Deferred income taxes		1,038		689
Total other assets		476,358		436,079
Total assets	$	984,558	$	977,864

(The accompanying notes are an integral part of these statements.)

32

(in thousands except per share data)

Liabilities and Shareholders’ Equity

	December 31,
	2020		2019
CURRENT LIABILITIES:
Accounts payable	$	13,025	$	12,720
Bank loans		832		747
Dividends payable		5,948		5,861
Accrued liabilities		45,099		41,611
Postretirement health care benefits		544		598
Operating lease liabilities		780		1,062
Income taxes payable		3,793		—
Deferred compensation		—		16,945
Total current liabilities		70,021		79,544
NONCURRENT LIABILITIES:
Deferred income taxes		47,900		47,295
Postretirement health care benefits		12,943		13,145
Industrial development bonds		7,500		7,500
Liability for uncertain tax positions		3,351		4,240
Operating lease liabilities		78		518
Deferred compensation and other liabilities		79,665		65,973
Total noncurrent liabilities		151,437		138,671
TOOTSIE ROLL INDUSTRIES, INC. SHAREHOLDERS’ EQUITY:
Common stock, $.69-4/9 par value — 120,000 shares authorized —  39,073 and 38,836, respectively, issued		27,134		26,969
Class B common stock, $.69-4/9 par value — 40,000 shares authorized — 27,012 and 26,287, respectively, issued		18,758		18,254
Capital in excess of par value		706,930		696,059
Retained earnings		32,312		40,809
Accumulated other comprehensive loss		(19,815)		(20,245)
Treasury stock (at cost) — 93 shares and 90 shares, respectively		(1,992)		(1,992)
Total Tootsie Roll Industries, Inc. shareholders’ equity		763,327		759,854
Noncontrolling interests		(227)		(205)
Total equity		763,100		759,649
Total liabilities and shareholders' equity	$	984,558	$	977,864

(The accompanying notes are an integral part of these statements.)

33

CONSOLIDATED STATEMENTS OF
Cash Flows
TOOTSIE ROLL INDUSTRIES, INC. AND SUBSIDIARIES	(in thousands)

	For the year ended December 31,
	2020		2019		2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$	58,974	$	64,839	$	56,805
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation		18,184		18,779		18,669
Deferred income taxes		(279)		2,832		2,063
Impairment of majority-owned foreign subsidiaries		—		377		1,126
Amortization of marketable security premiums		1,404		1,282		1,755
Changes in operating assets and liabilities:
Accounts receivable		3,483		5,086		(2,445)
Other receivables		636		(313)		2,220
Inventories		(770)		(4,383)		303
Prepaid expenses and other assets		2,961		4,362		9,489
Accounts payable and accrued liabilities		3,849		1,080		1,648
Income taxes payable		3,012		4,336		7,953
Postretirement health care benefits		(1,041)		(1,478)		(2,484)
Deferred compensation and other liabilities		(15,703)		3,422		3,827
Net cash provided by operating activities		74,710		100,221		100,929
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures		(17,970)		(20,258)		(27,612)
Repayment of premiums on split dollar life insurance policies		23,527		—		—
Purchases of trading securities		(3,183)		(3,427)		(4,378)
Sales of trading securities		18,058		795		1,255
Purchase of available for sale securities		(109,816)		(67,730)		(78,377)
Sale and maturity of available for sale securities		98,885		75,611		64,602
Net cash used in investing activities		9,501		(15,009)		(44,510)
CASH FLOWS FROM FINANCING ACTIVITIES:
Shares purchased and retired		(32,055)		(34,116)		(19,317)
Dividends paid in cash		(23,810)		(23,460)		(22,978)
Proceeds from bank loans		3,902		3,582		2,491
Repayment of bank loans		(3,883)		(3,193)		(2,549)
Net cash used in financing activities		(55,846)		(57,187)		(42,353)
Effect of exchange rate changes on cash		(449)		28		501
Increase (decrease) in cash and cash equivalents		27,916		28,053		14,567
Cash, cash equivalents and restricted cash at beginning of year		139,340		111,287		96,720
Cash, cash equivalents and restricted cash at end of year	$	167,256	$	139,340	$	111,287
Supplemental cash flow information:
Income taxes paid	$	14,503	$	13,858	$	5,676
Interest paid	$	57	$	121	$	112
Stock dividend issued	$	63,402	$	70,557	$	60,538

(The accompanying notes are an integral part of these statements.)

34

Notes to Consolidated Financial Statements ($ in thousands except per share data)

TOOTSIE ROLL INDUSTRIES, INC. AND SUBSIDIARIES

NOTE 1—SIGNIFICANT ACCOUNTING POLICIES:

Basis of consolidation:

The consolidated financial statements include the accounts of Tootsie Roll Industries, Inc. and its wholly-owned and majority-owned subsidiaries (the Company), which are primarily engaged in the manufacture and sales of candy products. Non-controlling interests relating to majority-owned subsidiaries are reflected in the consolidated financial statements and all significant intercompany transactions have been eliminated. Certain amounts previously reported have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net earnings.

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue recognition:

The Company’s revenues, primarily net product sales, principally result from the sale of goods, reflect the consideration to which the Company expects to be entitled, generally based on customer purchase orders. The Company records revenue based on a five-step model in accordance with Accounting Standards Codification ("ASC") Topic 606 which became effective January, 1, 2018. Adjustments for estimated customer cash discounts upon payment, discounts for price adjustments, product returns, allowances, and certain advertising and promotional costs, including consumer coupons, are variable consideration and are recorded as a reduction of product sales revenue in the same period the related product sales are recorded. Such estimates are calculated using historical averages adjusted for any expected changes due to current business conditions and experience. A net product sale is recorded when the Company delivers the product to the customer, or in certain instances, the customer picks up the goods at the Company’s distribution centers, and thereby obtains control of such product. Amounts billed and due from our customers are classified as accounts receivables trade on the balance sheet and require payment on a short-term basis. Accounts receivable are unsecured. Shipping and handling costs of $42,593, $49,288, and $49,527 in 2020, 2019 and 2018, respectively, are included in selling, marketing and administrative expenses. A minor amount of royalty income (less than 0.2% of our consolidated net sales) is also recognized from sales-based licensing arrangements, pursuant to which revenue is recognized as the third-party licensee sales occur. Rental income (less than 1% of our consolidated net sales) is not considered revenue from contracts from customers.

Leases:

The Company identifies leases by evaluating our contracts to determine if the contract conveys the right to use an identified asset for a stated period of time in exchange for consideration. The Company considers whether it can control the underlying asset and has the right to obtain substantially all of the economic benefits or outputs from the asset. Leases with terms greater than 12 months are classified as either operating or finance leases at the commencement date.  For these leases, the Company capitalized the present value of the minimum lease payments over the lease terms as a right-of-use asset with an offsetting lease liability. The discount rate used to calculate the present value of the minimum lease payments is typically the Company’s incremental borrowing rate, as the rate implicit in the lease is generally not known or determinable. The lease term includes any noncancelable period for which the Company has the right to use the asset. Currently, all capitalized leases are classified as operating leases and the Company records lease expense on a straight-line basis over the term of the lease.

35

Cash and cash equivalents:

The Company considers short-term debt securities with an original maturity of three months or less to be cash equivalents. Substantially all cash and cash equivalents are held at a major U.S. money center bank or its foreign branches (Bank of America), or its investment broker affiliate (Merrill Lynch). The Company also holds certificates of deposit (CDs) of U.S. banks selected by this investment broker based on their financial ratings; substantially all such CDs are invested in separate individual banks which are generally not in excess of the Federal Deposit Insurance Corporation (FDIC) limit of $250 per bank. The cash in the Company's U.S. banks (primarily Bank of America) is not fully insured by the FDIC due to the statutory limit of $250. The Company had approximately $8,303 and $9,415 of cash in foreign banks, principally foreign branches of a U.S. bank (Bank of America), at December 31, 2020 and 2019, respectively. The Company's cash in its foreign bank accounts is also not fully insured.

Investments:

Investments consist of various marketable securities with maturities of generally up to three years, and variable rate demand notes with interest rates that are generally reset weekly and the security can be “put” back and sold weekly. The Company classifies debt and equity securities as either available for sale or trading. Available for sale debt securities are not actively traded by the Company and are carried at fair value. The Company follows current fair value measurement guidance and unrealized gains and losses on these securities are excluded from earnings and are reported as a separate component of shareholders’ equity, net of applicable taxes, until realized or other-than-temporarily impaired. Trading securities related to deferred compensation arrangements are carried at fair value with gains or losses included in other income, net. The Company invests in trading securities to economically hedge changes in its deferred compensation liabilities.

The Company regularly reviews its investments to determine whether a decline in fair value below the cost basis is other-than-temporary. If the decline in fair value is judged to be other-than-temporary, the cost basis of the security is written down to fair value and the amount of the write-down is included in other income, net. Further information regarding the fair value of the Company’s investments is included in Note 10 of the Company’s Notes to Consolidated Financial Statements.

Derivative instruments and hedging activities:

Authoritative guidance requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of derivative instruments and related gains and losses, and disclosures about credit-risk-related contingent features in derivative agreements.

From time to time, the Company enters into commodity futures and foreign currency forward contracts. Commodity futures are intended and are effective as hedges of market price risks associated with the anticipated purchase of certain raw materials (primarily sugar). Foreign currency forward contracts are intended and are effective as hedges of the Company’s exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of products manufactured in Canada and sold in the United States, and periodic equipment purchases from foreign suppliers denominated in a foreign currency. The Company does not engage in trading or other speculative use of derivative instruments. Further information regarding derivative instruments and hedging activities is included in Note 11 of the Company’s Notes to Consolidated Financial Statements.

Inventories:

Inventories are stated at lower of cost or net realizable value. The cost of substantially all of the Company’s inventories ($54,935 and $55,409 at December 31, 2020 and 2019, respectively) has been determined by the last-in, first-out (LIFO) method. The excess of current cost over LIFO cost of inventories approximates $19,339 and $19,174 at December 31, 2020 and 2019, respectively. The cost of certain foreign inventories ($4,644 and $3,679 at December 31, 2020 and 2019, respectively) has been determined by the first-in, first-out (FIFO) method. Rebates, discounts and other cash consideration received from vendors related to inventory purchases is reflected as a reduction in the cost of the related inventory item, and is, therefore, reflected in cost of sales when the related inventory item is sold.

36

Property, plant and equipment:

Depreciation is computed for financial reporting purposes by use of the straight-line method based on useful lives of 20 to 40 years for buildings and 5 to 20 years for machinery and equipment. Depreciation expense was $18,184, $18,779 and $18,669 in 2020, 2019 and 2018, respectively.

Carrying value of long-lived assets:

The Company reviews long-lived assets to determine if there are events or circumstances indicating that the amount of the asset reflected in the Company’s balance sheet may not be recoverable. When such indicators are present, the Company compares the carrying value of the long-lived asset, or asset group, to the future undiscounted cash flows of the underlying assets to determine if impairment exists. If applicable, an impairment charge would be recorded to write down the carrying value to its fair value. The determination of fair value involves the use of estimates of future cash flows that involve considerable management judgment and are based upon assumptions about expected future operating performance. The actual cash flows could differ from management’s estimates due to changes in business conditions, operating performance, and economic conditions. In fourth quarter 2019 and 2018, the Company recorded charges of $377 and $1,126, respectively, relating to the impairment of assets of a foreign subsidiary which is included in selling, marketing and administrative expense. Except for the aforementioned, no impairment charges of long-lived assets were recorded by the Company during 2020, 2019 or 2018.

Postretirement health care benefits:

The Company provides certain postretirement health care benefits to a group of “grandfathered” corporate office and management employees. The cost of these postretirement benefits is accrued during the employees’ working careers. See Note 7 of the Company’s Notes to Consolidated Financial Statements for additional information. The Company also provides split dollar life benefits to an executive officer. The Company records an asset equal to the cumulative insurance premiums paid that will be recovered upon the death of the covered executive officer or earlier under the terms of the plan. During 2020, the Company received $23,527 of previously paid premiums on these insurance policies which was recorded as a reduction to this asset. No premiums were paid in 2020, 2019 or 2018.

Goodwill and indefinite-lived intangible assets:

In accordance with authoritative guidance, goodwill and intangible assets with indefinite lives are not amortized, but rather reviewed and tested for impairment at least annually unless certain interim triggering events or circumstances require more frequent testing. All trademarks have been assessed by management to have indefinite lives because they are expected to generate cash flows indefinitely. Management believes that all assumptions used for the impairment review and testing are consistent with those utilized by market participants performing similar valuations. No impairments of intangibles, including trademarks and goodwill, were recorded in 2020, 2019 or 2018.

Current accounting guidance provides entities an option of performing a qualitative assessment (a "step-zero" test) before performing a quantitative analysis. If the entity determines, on the basis of certain qualitative factors, that it is more-likely-than-not that the intangibles (goodwill and certain trademarks) are not impaired, the entity would not need to proceed to the two step impairment testing process (quantitative analysis) as prescribed in the guidance. During fourth quarter 2020 and 2019, the Company performed a “step zero” test of its goodwill and certain trademarks, and concluded that there was no impairment based on this guidance. For the fair value assessment of certain trademarks where the “step-zero” analysis was not considered appropriate, impairment testing was performed in fourth quarter 2020 and 2019 using discounted cash flows and estimated royalty rates. For these trademarks, holding all other assumptions constant at the test date in 2020, a 100 basis point increase in the discount rate or a 100 basis point decrease in the royalty rate would reduce the fair value of these trademarks by approximately 18% and 10%, respectively. Individually, a 100 point increase in the discount rate or a 100 point decrease in the royalty rate would not result in a potential impairment as of December 31, 2020. 

37

Income taxes:

Deferred income taxes are recorded and recognized for future tax effects of temporary differences between financial and income tax reporting. The Company records valuation allowances in situations where the realization of deferred tax assets is not more-likely-than-not. The Company periodically reviews assumptions and estimates of the Company’s probable tax obligations and effects on its liability for uncertain tax positions, using informed judgment which may include the use of third-party consultants, advisors and legal counsel, as well as historical experience.

Further information regarding U.S. tax reform (U.S. Tax Cuts and Jobs Act) and other income tax matters are included in Note 4 of the Company’s Notes to Consolidated Financial Statements.

Foreign currency translation:

The U.S. dollar is used as the functional currency where a substantial portion of the subsidiary’s business is indexed to the U.S. dollar or where its manufactured products are principally sold in the U.S. All other foreign subsidiaries use the local currency as their functional currency. Where the U.S. dollar is used as the functional currency, foreign currency remeasurements are recorded as a charge or credit to other income, net in the statement of earnings. Where the foreign local currency is used as the functional currency, translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss).

Restricted cash:

Restricted cash comprises certain cash deposits of the Company’s majority-owned Spanish subsidiary with international banks that are pledged as collateral for letters of credit and bank borrowings.

VEBA trust:

The Company maintains a VEBA trust managed and controlled by the Company, to fund the estimated future costs of certain employee health, welfare and other benefits. The Company made a $20,024 contribution to the VEBA trust in 2017 but no contributions were made to the trust in 2020, 2019 or 2018. The Company will be using the VEBA trust funds to pay the actual cost of such benefits through 2022. At December 31, 2020 and 2019, the VEBA trust held $8,272 and $12,085, respectively, of aggregate cash and cash equivalents. This asset value is included in prepaid expenses and long-term other assets in the Company’s Consolidated Statement of Financial Position. These assets are categorized as Level 1 within the fair value hierarchy.

Bank loans:

Bank loans consist of short term (less than 120 days) borrowings by the Company’s Spanish subsidiary that are held by international banks. The weighted-average interest rate as of December 31, 2020 and 2019 was 3.0% and 3.0%, respectively.

Comprehensive earnings:

Comprehensive earnings include net earnings, foreign currency translation adjustments and unrealized gains/losses on commodity and/or foreign currency hedging contracts, available for sale securities and certain postretirement benefit obligations.

Earnings per share:

A dual presentation of basic and diluted earnings per share is not required due to the lack of potentially dilutive securities under the Company’s simple capital structure. Therefore, all earnings per share amounts represent basic earnings per share.

38

The Class B common stock has essentially the same rights as common stock, except that each share of Class B common stock has ten votes per share (compared to one vote per share of common stock), is not traded on any exchange, is restricted as to transfer and is convertible on a share-for-share basis, at any time and at no cost to the holders, into shares of common stock which are traded on the New York Stock Exchange.

Use of estimates:

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, allowances and incentives, product liabilities, assets recorded at fair value, income taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.

Recently adopted accounting pronouncements:

In June 2016, the FASB issued ASU No. 2016-13, (ASC Topic 326) which replaces the current incurred loss impairment method with a new method that reflects expected credit losses. Subsequent to the issuance of ASC Topic 326, the FASB clarified and amended guidance through several Accounting Standard Updates; hereinafter the collection of credit loss guidance is referred to as “ASC Topic 326”. Under this new guidance an entity would recognize an impairment allowance equal to its current estimate of credit losses on financial assets measured at amortized cost. The Company adopted ASU 2016-13 and related amendments (ASC Topic 326) on January 1, 2020. The adoption of this ASC did not have a material impact on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU 2018-14, (ASC Subtopic 715-20) which expands disclosure requirements for employer sponsored defined benefit pension and other retirement plans. The Company adopted ASU 2018-14 on January 1, 2020 because this ASU affects the Company’s post-retirement health benefits plan (see Note 7). The adoption of the new accounting rules did not have a material impact on the Company’s consolidated financial statements.

Recently issued accounting pronouncements - not yet adopted:

In December 2019, the FASB issued ASU No. 2019-12 which is designed to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU No. 2019-12 is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years; this ASU allows for early adoption in any interim period after issuance of the update. The Company is currently assessing the impact this ASU will have on its consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04 which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently evaluating our contracts and the optional expedients provided by the new standard.

39

NOTE 2—ACCRUED LIABILITIES:

Accrued liabilities are comprised of the following:

	December 31,
	2020		2019
Compensation	$	8,135	$	10,575
Other employee benefits		8,841		7,509
Taxes, other than income		3,169		3,170
Advertising and promotions		18,455		14,421
Other		6,499		5,936
	$	45,099	$	41,611

NOTE 3—INDUSTRIAL DEVELOPMENT BONDS:

Industrial development bonds are due in 2027. The average floating interest rate, which is reset weekly, was 0.7% and 1.6% in 2020 and 2019, respectively. See Note 10 of the Company’s Notes to Consolidated Financial Statements for fair value disclosures.

NOTE 4—INCOME TAXES:

The domestic and foreign components of pretax income are as follows:

	2020		2019		2018
Domestic	$	69,211	$	74,978	$	66,253
Foreign		7,051		10,426		6,953
	$	76,262	$	85,404	$	73,206

The provision for income taxes is comprised of the following:

	2020		2019		2018
Current:
Federal	$	14,831	$	15,133	$	12,414
Foreign		1,029		—		—
State		1,763		2,942		1,421
		17,623		18,075		13,835
Deferred:
Federal		(1,006)		(543)		(577)
Foreign		1,316		2,422		2,685
State		(645)		611		458
		(335)		2,490		2,566
	$	17,288	$	20,565	$	16,401

40

Significant components of the Company’s net deferred tax liability at year end were as follows:

	December 31,
	2020		2019
Deferred tax assets:
Accrued customer promotions	$	1,506	$	198
Deferred compensation		18,501		19,432
Postretirement benefits		3,355		3,439
Other accrued expenses		3,078		3,979
Foreign subsidiary tax loss carry forward		4,508		4,584
Outside basis difference in foreign subsidiary		365		365
Deductible state tax depreciation		471		512
Tax credit carry forward		3,288		3,059
		35,072		35,568
Valuation allowances		(5,593)		(4,985)
Total deferred tax assets	$	29,479	$	30,583
Deferred tax liabilities:
Depreciation	$	22,192	$	23,375
Deductible goodwill and trademarks		37,348		36,591
Accrued export company commissions		4,508		4,367
Employee benefit plans		1,767		2,700
Inventory reserves		1,994		2,526
Prepaid insurance		569		710
Unrealized capital gains		2,515		1,362
Deferred foreign exchange gain		179		260
Deferred gain on sale of real estate		5,269		5,298
Total deferred tax liabilities	$	76,341	$	77,189
Net deferred tax liability	$	46,862	$	46,606

At December 31, 2020, the Company has benefits related to state tax credit carry-forwards expiring by year as follows: $495 in 2020, $771 in 2021, $221 in 2023, $253 in 2024, $50 in 2028, $131 in 2029, $213 in 2030, $225 in 2031, $238 in 2032, $211 in 2033 and $234 in 2034. The Company expects that not all the credits will be utilized before their expiration and has provided a valuation allowance for the expired amounts. Such valuation allowances were $837 and $770 at December 31, 2020 and 2019, respectively.

At December 31, 2020, the amounts of the Company’s Spanish subsidiary loss carry-forwards expiring by year are as follows: $306 in 2026, $65 in 2027, $194 in 2028, $111 in 2029, $335 in 2030, $447 in 2031, $337 in 2032, $136 in 2033, $470 in 2034, $594 in 2035, $863 in 2036, $440 in 2037 and $210 in 2038. A full valuation allowance has been provided for these Spanish loss carry-forwards as the Company expects that the losses will not be utilized before their expiration.

The effective income tax rate differs from the statutory rate as follows:

	2020		2019		2018
U.S. statutory rate	21.0	%	21.0	%	21.0	%
State income taxes, net	2.1		2.2		2.2
Exempt municipal bond interest	—		(0.1)		(0.1)
Foreign income tax rates	1.0		(0.1)		0.5
Income tax credits and adjustments	(1.4)		0.5		—
Adjustment of deferred tax balances	(0.2)		—		0.1
Reserve for uncertain tax benefits	(0.8)		0.4		(1.0)
Other, net	1.0		0.2		(0.3)
Effective income tax rate	22.7	%	24.1	%	22.4	%

41

The 2017 Tax Cuts and Jobs Act changed the United States approach to the taxation of foreign earnings to a territorial system by providing a one hundred percent dividends received deduction for certain qualified dividends received from foreign subsidiaries. This provision of the Act significantly impacts the accounting for the undistributed earnings of foreign subsidiaries and as a result the Company intends to distribute the earnings of its foreign subsidiaries. The costs associated with a future distribution are not material to the Company’s financial statements. After carefully considering these facts, the Company has determined that effective December 31, 2017, it will not be asserting permanent reinvestment of its foreign subsidiaries earnings.

At December 31, 2020 and 2019, the Company had unrecognized tax benefits of $3,011 and $3,678, respectively. Included in this balance is $1,468 and $2,012, respectively, of unrecognized tax benefits that, if recognized, would favorably affect the annual effective income tax rate. As of December 31, 2020 and 2019, $340 and $562, respectively, of interest and penalties were included in the liability for uncertain tax positions.

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:

	2020		2019		2018
Unrecognized tax benefits at January 1	$	3,678	$	3,339	$	4,342
Increases in tax positions for the current year		377		1,164		448
Reductions in tax positions for lapse of statute of limitations		(501)		(576)		(751)
Reductions in tax positions for settlements and payments		(308)		(249)		—
Increases (decreases) in prior period unrecognized tax benefits due to change in judgment		(235)		—		(700)
Unrecognized tax benefits at December 31	$	3,011	$	3,678	$	3,339

The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes on the Consolidated Statements of Earnings and Retained Earnings.

The Company is subject to taxation in the U.S. and various state and foreign jurisdictions, primarily Canada and Mexico. The Company generally remains subject to examination by U.S. federal, state and foreign tax authorities for the years 2017 through 2019. With few exceptions, the Company is no longer subject to examinations by tax authorities for the years 2016 and prior.

42

NOTE 5—SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE:

										Capital in
				Class B						Excess
	Common Stock			Common Stock			Treasury Stock			of Par
	Shares	Amount		Shares	Amount		Shares	Amount		Value
	(000’s)			(000’s)			(000’s)
Balance at January 1, 2018	37,960	$	26,361	24,891	$	17,285	85	$	(1,992)	$	656,752
Issuance of 3% stock dividend	1,125		781	746		519	3		—		58,688
Conversion of Class B common shares to common shares	53		37	(53)		(37)	—		—		—
Purchase and retirement of common shares	(594)		(412)	—		—	—		—		(18,905)
Balance at December 31, 2018	38,544		26,767	25,584		17,767	88		(1,992)		696,535
Issuance of 3% stock dividend	1,150		798	768		532	2		—		32,999
Conversion of Class B common shares to common shares	65		45	(65)		(45)	—		—		—
Purchase and retirement of common shares	(923)		(641)	—		—	—		—		(33,475)
Balance at December 31, 2019	38,836		26,969	26,287		18,254	90		(1,992)		696,059
Issuance of 3% stock dividend	1,157		804	787		547	3		—		42,244
Conversion of Class B common shares to common shares	62		43	(62)		(43)	—		—		—
Purchase and retirement of common shares	(982)		(682)	—		—	—		—		(31,373)
Balance at December 31, 2020	39,073	$	27,134	27,012	$	18,758	93	$	(1,992)	$	706,930

Average shares outstanding and all per share amounts included in the financial statements and notes thereto have been adjusted retroactively to reflect annual three percent stock dividends.

While the Company does not have a formal or publicly announced Company common stock purchase program, the Company’s board of directors periodically authorizes a dollar amount for such share purchases.

Based upon this policy, shares were purchased and retired as follows:

	Total Number of Shares
Year	Purchased (000’s)	Average Price Paid Per Share
2020	982	$	32.59
2019	923	$	36.93
2018	594	$	32.48

NOTE 6—OTHER INCOME, NET:

Other income, net is comprised of the following:

	2020		2019		2018
Interest and dividend income	$	4,005	$	4,423	$	3,535
Gains (losses) on trading securities relating to deferred compensation plans		12,519		11,292		(1,103)
Interest expense		(164)		(220)		(181)
Foreign exchange gains (losses)		534		(533)		(659)
Capital gains (losses)		(6)		22		(11)
Miscellaneous, net		1,130		1,206		1,143
	$	18,018	$	16,190	$	2,724

43

NOTE 7—EMPLOYEE BENEFIT PLANS:

Pension plans:

The Company sponsors a defined contribution pension plan covering certain non-union employees with over one year of credited service. The Company’s policy is to fund pension costs accrued based on compensation levels. Total expense for this plan for 2020, 2019 and 2018 approximated $2,722, $3,114 and $2,988, respectively, for this defined contribution plan. The Company also maintains certain profit sharing and retirement savings-investment plans. Company contributions in 2020, 2019 and 2018 to these plans were $2,766, $2,858 and $2,734 respectively.

The Company also contributes to a multi-employer defined benefit pension plan for certain of its union employees under a collective bargaining agreement which is as follows:

Plan name: Bakery and Confectionery Union and Industry International Pension Fund

Employer Identification Number and plan number: 52-6118572, plan number 001

Funded Status as of the most recent year available: 50.40% funded as of January 1, 2019

The Company’s contributions to such plan: $2,850, $2,943 and $2,836 in 2020, 2019 and 2018, respectively

Plan status: Critical and declining as of December 31, 2019 (most recent date information is available)

Beginning in 2012, the Company received periodic notices from the Bakery, Confectionery, Tobacco Workers and Grain Millers International Union  Pension Plan (Plan), a multi-employer defined benefit pension plan for certain Company union employees, that the Plan’s actuary certified the Plan to be in “critical status”, as defined by the Pension Protection Act (PPA) and the Pension Benefit Guaranty Corporation (PBGC); and that a plan of rehabilitation was adopted by the trustees of the Plan in 2012. Beginning in 2015, the Company received new annual notices that the Plan was reclassified to “critical and declining status”, as defined by the PPA and PBGC, for the plan year beginning January 1, 2015. A designation of “critical and declining status” implies that the Plan is expected to become insolvent in the next 20 years. In 2016, the Company received new notices that the Plan’s trustees adopted an updated Rehabilitation Plan effective January 1, 2016, and all annual notices through 2020 have continued to classify the Plan in the “critical and declining status” category.

The Company has been advised that its withdrawal liability would have been $99,300, $99,800 and $81,600 if it had withdrawn from the Plan during 2020, 2019 and 2018, respectively. Should the Company actually withdraw from the Plan at a future date, a withdrawal liability, which could be higher than the above discussed amounts, could be payable to the Plan.

The amended rehabilitation plan, which continues, requires that employer contributions include 5% compounded annual surcharge increases each year for an unspecified period of time beginning January 2013 (in addition to the 5% interim surcharge initiated in 2012) as well as certain plan benefit reductions. In fourth quarter 2020, the Plan Trustees advised the Company that the surcharges would no longer increase and therefore be “frozen” at the rates and amounts in effect as of December 31, 2020 provided that the local bargaining union and the Company executed a formal consenting agreement by March 31, 2021. Subsequent to December 31, 2020, the local bargaining union and the Company executed this agreement which resulted in the “freezing” of such surcharges as of December 31, 2020. The Company’s pension expense for this Plan for 2020, 2019 and 2018 was $2,866, $2,961 and $2,836, respectively. The aforementioned expense includes surcharges of $1,010, $948 and $811 in 2020, 2019 and 2018, respectively, as required under the plan of rehabilitation as amended.

The Company is currently unable to determine the ultimate outcome of the above discussed matter and therefore is unable to determine the effects on its consolidated financial statements, but the ultimate outcome or the effects of any modifications to the current rehabilitation plan could be material to its consolidated results of operations or cash flows in one or more future periods.

44

Deferred compensation:

The Company sponsors three deferred compensation plans for selected executives and other employees: (i) the Excess Benefit Plan, which restores retirement benefits lost due to IRS limitations on contributions to tax-qualified plans, (ii) the Supplemental Plan, which allows eligible employees to defer the receipt of eligible compensation until designated future dates and (iii) the Career Achievement Plan, which provides a deferred annual incentive award to selected executives. Participants in these plans earn a return on amounts due them based on several investment options, which mirror returns on underlying investments (primarily mutual funds). The Company economically hedges its obligations under the plans by investing in the actual underlying investments. These investments are classified as trading securities and are carried at fair value. At December 31, 2020 and 2019, these investments totaled $73,828 and $76,183, respectively. All gains and losses and related investment income from these investments, which are recorded in other income, net, are equally offset by corresponding increases and decreases in the Company’s deferred compensation liabilities.

Postretirement health care benefit plans:

The Company maintains a post-retirement health benefits plan for a group of “grandfathered” corporate employees. The plan as amended in 2013, generally limited future annual cost increases in health benefits to 3%, restricted this benefit to current employees and retirees with long-term service with the Company, and eliminated all post-retirement benefits for future employees effective April 1, 2014. Post-retirement benefits liabilities (as amended) were $13,487and $13,743 at December 31, 2020 and 2019, respectively.

Amounts recognized in accumulated other comprehensive loss (pre-tax) at December 31, 2020 are as follows:

Prior service credit	$	(1,840)
Net actuarial gain		(1,196)
Net amount recognized in accumulated other comprehensive loss	$	(3,036)

The changes in the accumulated postretirement benefit obligation at December 31, 2020 and 2019 consist of the following:

	December 31,
	2020		2019
Benefit obligation, beginning of year	$	13,743	$	12,451
Service cost		288		270
Interest cost		403		499
Actuarial (gain)/loss		(510)		922
Benefits paid		(437)		(399)
Benefit obligation, end of year	$	13,487	$	13,743

The actuarial (gain) in 2020 is attributable to updated participation rates and participant spending as well as mortality table projections partially offset by an actuarial loss due to the decrease in discount rate for the year ended December 31, 2020. The actuarial loss in 2019 is attributable to a decrease in the discount rate partially offset by a change in the mortality table for year ended December 31, 2019.

Net periodic postretirement benefit cost (income) included the following components:

	2020		2019		2018
Service cost—benefits attributed to service during the period	$	288	$	270	$	337
Interest cost on the accumulated postretirement benefit obligation		403		499		455
Net amortization		(1,349)		(1,522)		(1,324)
Net periodic postretirement benefit cost (income)	$	(658)	$	(753)	$	(532)

45

The Company estimates future benefit payments will be $544, $564, $590, $614 and $634 in 2021 through 2025, respectively, and a total of $3,417 in 2026 through 2030.

NOTE 8—COMMITMENTS:

Lease expense aggregated $942, $1,032 and $793 in 2020, 2019 and 2018, respectively. Future operating lease commitments are as follows: $717, $137, and $4 in 2021, 2022 and 2023, respectively.

NOTE 9—SEGMENT AND GEOGRAPHIC INFORMATION:

The Company operates as a single reportable segment encompassing the manufacture and sale of confectionery products. Its principal manufacturing operations are located in the United States and Canada, and its principal market is the United States. The Company also manufactures confectionery products in Mexico, primarily for sale in Mexico, and exports products to Canada and other countries worldwide.

The following geographic data includes net product sales summarized on the basis of the customer location and long-lived assets based on their physical location:

	2020		2019		2018
Net product sales:
United States	$	431,024	$	478,790	$	471,561
Canada, Mexico and Other		36,403		44,826		43,690
	$	467,427	$	523,616	$	515,251
Long-lived assets:
United States	$	155,664	$	155,428	$	151,770
Canada		28,765		30,412		31,843
Mexico and Other		2,899		2,615		2,488
	$	187,328	$	188,455	$	186,101

Sales revenues from Wal-Mart Stores, Inc. aggregated approximately 23.5%, 24.2%, and 24.1% of net product sales during the year ended December 31, 2020, 2019 and 2018, respectively. Sales revenues from Dollar Tree, Inc. (which includes Family Dollar which was acquired by Dollar Tree) aggregated approximately 11.7%, 11.3%, and 11.2% of net product sales during the year ended December 31, 2020, 2019 and 2018, respectively. Some of the aforementioned sales to Wal-Mart and Dollar Tree are sold to McLane Company, a large national grocery wholesaler, which services and delivers certain of the Company’s products to Wal-Mart, Dollar Tree and other retailers in the U.S.A. Net product sales revenues from McLane, which includes these Wal-Mart and Dollar Tree sales as well as sales and deliveries to other Company customers, were 22.1% in 2020 and 17.7% in 2019 and 17.4% in 2018. At December 31, 2020 and 2019, the Company’s three largest customers discussed above accounted for approximately 21% and 30% of total accounts receivable, respectively.

NOTE 10—FAIR VALUE MEASUREMENTS:

Current accounting guidance defines fair value as the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Guidance requires disclosure of the extent to which fair value is used to measure financial assets and liabilities, the inputs utilized in calculating valuation measurements, and the effect of the measurement of significant unobservable inputs on earnings, or changes in net assets, as of the measurement date. Guidance establishes a three-level valuation hierarchy based upon the transparency of inputs utilized in the measurement and valuation of financial assets or liabilities as of the measurement date. Level 1 inputs include quoted prices for identical instruments and are the most observable. Level 2 inputs include quoted prices for similar assets and observable inputs such as interest rates, foreign currency exchange rates, commodity rates and yield curves. Level 3 inputs are not observable in the market and include management’s own judgments about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs is reflected in the hierarchy assessment disclosed in the table below.

46

As of December 31, 2020 and 2019, the Company held certain financial assets that are required to be measured at fair value on a recurring basis. These include derivative hedging instruments related to the foreign currency forward contracts and purchase of certain raw materials, investments in trading securities and available for sale securities. The Company’s available for sale and trading securities principally consist of corporate bonds and variable rate demand notes.

The following tables present information about the Company’s financial assets and liabilities measured at fair value as of December 31, 2020 and 2019, and indicate the fair value hierarchy and the valuation techniques utilized by the Company to determine such fair value:

	Estimated Fair Value December 31, 2020
	Total		Input Levels Used
	Fair Value		Level 1		Level 2		Level 3
Cash and equivalents	$	166,841	$	166,841	$	—	$	—
Available for sale securities		188,282		3,149		185,133		—
Foreign currency forward contracts		778		—		778		—
Commodity futures contracts, net		941		941		—		—
Trading securities		73,828		61,431		12,397		—
Total assets measured at fair value	$	430,670	$	232,362	$	198,308	$	—

	Estimated Fair Value December 31, 2019
	Total		Input Levels Used
	Fair Value		Level 1		Level 2		Level 3
Cash and equivalents	$	138,960	$	138,960	$	—	$	—
Available for sale securities		177,292		3,588		173,704		—
Foreign currency forward contracts		14		—		14		—
Commodity futures contracts, net		121		121		—		—
Trading securities		76,183		48,260		27,923		—
Total assets measured at fair value	$	392,570	$	190,929	$	201,641	$	—

Available for sale securities which utilize Level 2 inputs consist primarily of corporate bonds and variable rate demand notes, which are valued based on quoted market prices or alternative pricing sources with reasonable levels of price transparency.

A summary of the aggregate fair value, gross unrealized gains, gross unrealized losses, realized losses and amortized cost basis of the Company’s investment portfolio by major security type is as follows:

	December 31, 2020
	Amortized		Fair		Unrealized				Realized
Available for Sale:	Cost		Value		Gains		Losses		Losses
Municipal bonds	$	556	$	561	$	5	$	—	$	—
Variable rate demand notes		1,300		1,300		—		—		—
Corporate bonds		174,835		177,229		2,394		—		—
Government securities		3,049		3,149		100		—		—
Certificates of deposit		5,915		6,043		128		—		—
	$	185,655	$	188,282	$	2,627	$	—	$	—

	December 31, 2019
	Amortized		Fair		Unrealized				Realized
Available for Sale:	Cost		Value		Gains		Losses		Losses
Municipal bonds	$	—	$	—	$	—	$	—	$	—
Variable rate demand notes		25,845		25,845		—		—		—
Corporate bonds		139,803		140,797		994		—		—
Government securities		3,503		3,588		85		—		—
Certificates of deposit		6,978		7,062		84		—		—
	$	176,129	$	177,292	$	1,163	$	—	$	—

47

The fair value of the Company’s industrial revenue development bonds at December 31, 2020 and 2019 were valued using Level 2 inputs which approximates the carrying value of $7,500 for both periods. Interest rates on these bonds reset weekly based on current market conditions.

NOTE 11—DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES:

From time to time, the Company uses derivative instruments, including foreign currency forward contracts and commodity futures contracts to manage its exposures to foreign exchange and commodity prices. Commodity futures contracts are intended and effective as hedges of market price risks associated with the anticipated purchase of certain raw materials (primarily sugar). Foreign currency forward contracts are intended and effective as hedges of the Company’s exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of products manufactured in Canada and sold in the United States, and periodic equipment purchases from foreign suppliers denominated in a foreign currency. The Company does not engage in trading or other speculative use of derivative instruments.

The Company recognizes all derivative instruments as either assets or liabilities at fair value in the Consolidated Statements of Financial Position. Derivative assets are recorded in other receivables and derivative liabilities are recorded in accrued liabilities. The Company uses either hedge accounting or mark-to-market accounting for its derivative instruments. Derivatives that qualify for hedge accounting are designated as cash flow hedges by formally documenting the hedge relationships, including identification of the hedging instruments, the hedged items and other critical terms, as well as the Company’s risk management objectives and strategies for undertaking the hedge transaction.

Changes in the fair value of the Company’s cash flow hedges are recorded in accumulated other comprehensive loss, net of tax, and are reclassified to earnings in the periods in which earnings are affected by the hedged item. Substantially all amounts reported in accumulated other comprehensive loss for commodity derivatives are expected to be reclassified to cost of goods sold. Approximately $941 of this accumulated comprehensive gain is expected to be charged to earnings in 2021. Approximately $390 and $388 in accumulated other comprehensive gain for foreign currency derivatives is expected to be reclassified to other income, net in 2021 and 2022, respectively.

The following table summarizes the Company’s outstanding derivative contracts and their effects on its Consolidated Statements of Financial Position at December 31, 2020 and 2019:

	December 31, 2020
	Notional
	Amounts		Assets		Liabilities
Derivatives designated as hedging instruments:
Foreign currency forward contracts	$	6,391	$	778	$	—
Commodity futures contracts		4,010		941		—
Total derivatives			$	1,719	$	—

	December 31, 2019
	Notional
	Amounts		Assets		Liabilities
Derivatives designated as hedging instruments:
Foreign currency forward contracts	$	5,533	$	14	$	—
Commodity futures contracts		7,147		205		(84)
Total derivatives			$	219	$	(84)

48

The effects of derivative instruments on the Company’s Consolidated Statement of Earnings, Comprehensive Earnings and Retained Earnings for year ended December 31, 2019 and 2018 are as follows:

	For Year Ended December 31, 2020
					Gain (Loss)
			Gain (Loss)		on Amount Excluded
	Gain (Loss)		Reclassified from		from Effectiveness
	Recognized		Accumulated OCI		Testing Recognized
	in OCI		into Earnings		in Earnings
Foreign currency forward contracts	$	686	$	(78)	$	—
Commodity futures contracts		573		(247)		—
Total	$	1,259	$	(325)	$	—

	For Year Ended December 31, 2019
					Gain (Loss)
			Gain (Loss)		on Amount Excluded
	Gain (Loss)		Reclassified from		from Effectiveness
	Recognized		Accumulated OCI		Testing Recognized
	in OCI		into Earnings		in Earnings
Foreign currency forward contracts	$	359	$	(62)	$	—
Commodity futures contracts		92		(615)		—
Total	$	451	$	(677)	$	—

NOTE 12—ACCUMULATED OTHER COMPREHENSIVE LOSS:

The following table sets forth information with respect to accumulated other comprehensive earnings (loss):

											Accumulated
	Foreign				Foreign				Postretirement		Other
	Currency				Currency		Commodity		and Pension		Comprehensive
	Translation		Investments		Derivatives		Derivatives		Benefits		Earnings (Loss)
Balance at December 31, 2018	$	(24,159)	$	(1,516)	$	(309)	$	(444)	$	4,206	$	(22,222)
Other comprehensive earnings (loss) before reclassifications		791		2,372		272		70		(914)		2,591
Reclassifications from accumulated other comprehensive loss		—		26		47		466		(1,153)		(614)
Other comprehensive earnings (loss) net of tax		791		2,398		319		536		(2,067)		1,977
Balance at December 31, 2019	$	(23,368)	$	882	$	10	$	92	$	2,139	$	(20,245)
Other comprehensive earnings (loss) before reclassifications		(1,213)		1,110		520		434		356		1,207
Reclassifications from accumulated other comprehensive loss		—		—		59		187		(1,023)		(777)
Other comprehensive earnings (loss) net of tax		(1,213)		1,110		579		621		(667)		430
Balance at December 31, 2020	$	(24,581)	$	1,992	$	589	$	713	$	1,472	$	(19,815)

49

The amounts reclassified from accumulated other comprehensive income (loss) consisted of the following:

Details about Accumulated Other	Year to Date Ended
Comprehensive Income Components	December 31, 2020		December 31, 2019		Location of (Gain) Loss Recognized in Earnings
Investments	$	-	$	34	Other income, net
Foreign currency derivatives		78		62	Other income, net
Commodity derivatives		247		615	Product cost of goods sold
Postretirement and pension benefits		(1,350)		(1,522)	Other income, net
Total before tax		(1,025)		(811)
Tax expense (benefit)		248		197
Net of tax	$	(777)	$	(614)

NOTE 13—GOODWILL AND INTANGIBLE ASSETS:

All of the Company’s intangible indefinite-lived assets are trademarks.

The changes in the carrying amount of trademarks for 2020 and 2019 were as follows:

	2020		2019
Original cost	$	193,767	$	193,767
Accumulated impairment losses as of January 1		(18,743)		(18,743)
Balance at January 1	$	175,024	$	175,024
Current year impairment losses		—		—
Balance at December 31	$	175,024	$	175,024
Accumulated impairment losses as of December 31	$	(18,743)	$	(18,743)

The fair value of indefinite-lived intangible assets was primarily assessed using the present value of estimated future cash flows and relief-from-royalty method.

The Company has no accumulated impairment losses of goodwill.

Note 14 — LEASES:  

The Company leases certain buildings, land and equipment that are classified as operating leases. These leases have remaining lease terms of up to approximately 3 years. In the fourth quarter and twelve months of 2020 and 2019, operating lease cost and cash paid for operating lease liabilities totaled $271 and $258, respectively, and $1,023 and $1,004, respectively, which is classified in cash flows from operating activities. As of December 31, 2020 and 2019, operating lease right-of-use assets and operating lease liabilities were both $858 and $1,580, respectively. The weighted-average remaining lease term related to these operating leases was approximately 0.7 years and 1.6 years as of December 31, 2020 and 2019, respectively. The weighted-average discount rate related to the Company’s operating leases was 3.0% and 3.1% as of December 31, 2020 and 2019, respectively. Maturities of operating lease liabilities at December 31, 2020 are as follows: $717 in 2021, $137 in 2022, and $4 in 2023.

The Company, as lessor, rents certain commercial real estate to third party lessees. The December 31, 2020 and 2019 cost related to these leased properties was $51,426 and $36,378, respectively, and the accumulated depreciation related to these leased properties was $14,784 and $10,252, respectively. Terms of certain such leases, including renewal options, may be extended for up to approximately sixty years, many of which provide for periodic adjustment of rent payments based on changes in consumer or other price indices. The Company recognizes lease income on a straight-line basis over the lease term. Lease income in fourth quarter and twelve months 2020 and 2019 was $863 and $718, respectively, and $3,191 and $2,951, respectively, and is classified in cash flows from operating activities.

50

NOTE 15—QUARTERLY FINANCIAL DATA (UNAUDITED):

	(Thousands of dollars except per share data)
	First		Second		Third		Fourth		Year
2020
Net product sales	$	102,803	$	79,796	$	156,962	$	127,866	$	467,427
Product gross margin		36,360		29,417		57,775		44,165		167,717
Net earnings attributable to Tootsie Roll Industries, Inc.		11,982		7,388		24,673		14,952		58,995
Net earnings attributable to Tootsie Roll Industries, Inc. per share		0.18		0.11		0.37		0.23		0.89
2019
Net product sales	$	101,019	$	106,021	$	181,913	$	134,663	$	523,616
Product gross margin		36,163		40,076		69,046		49,229		194,514
Net earnings attributable to Tootsie Roll Industries, Inc.		8,955		11,556		29,854		14,555		64,920
Net earnings attributable to Tootsie Roll Industries, Inc. per share		0.13		0.17		0.44		0.22		0.96

Net earnings per share is based upon average outstanding shares as adjusted for 3%stock dividends issued during the second quarter of each year as discussed above. The sum of the quarterly per share amounts may not equal annual amounts due to rounding.

ITEM 9.               Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

ITEM 9A.            Controls and Procedures.

Disclosure Controls and Procedures

The Company’s Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) ) are effective to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is (i)  recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Internal Control over Financial Reporting

(a) See “Management’s Report on Internal Control Over Financial Reporting,” included in Item 8 “Financial Statements and Supplementary Data,” which is incorporated herein by reference.

(b) See “Report of Independent Registered Public Accounting Firm” included in Item 8 “Financial Statements and Supplementary Data” for the attestation report of the Company’s independent registered public accounting firm, which is incorporated herein by reference.

(c) There were no changes in the Company’s internal control over financial reporting during the quarter ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

ITEM 9B.            Other Information.

None.

51

PART III

ITEM 10.             Directors, Executive Officers and Corporate Governance.

See the information with respect to the Directors of the Company which is set forth in the section entitled “Election of Directors” of the 2021 Proxy Statement, which section of the 2021 Proxy Statement is incorporated herein by reference. See the information in the section entitled “Section 16(a) Beneficial Ownership Reporting Compliance” of the Company’s 2021 Proxy Statement, which section is incorporated herein by reference.

The following table sets forth the information with respect to the executive officers of the Company:

Name	Position (1)	Age
Ellen R. Gordon*	Chairman of the Board and Chief Executive Officer	89
G. Howard Ember Jr.	Vice President/Finance	68
Stephen P. Green	Vice President/Manufacturing	62
Kenneth D Naylor	Vice President/Marketing and Sales	61
Barry P. Bowen	Treasurer	65

*      A member of the Board of Directors of the Company.

(1) All of the above named officers have served in the positions set forth in the table as their principal occupations for more than the past five years except for Mr. Green and Mr. Naylor who were appointed to their current positions on January 16, 2017 and January 1, 2020, respectively. Previously, Mr. Green and Mr. Naylor held positions of Plant Manager and Vice President of USA Sales, respectively, during the past five-year period

Code of Ethics

The Company has a Code of Business Conduct and Ethics, which applies to all of the Company’s directors and employees, and which meets the Securities Exchange Commission criteria for a “code of ethics.” The Code of Business Conduct and Ethics is available on the Company’s website, located at www.tootsie.com, and the information in such is available in print to any shareholder who requests a copy.

ITEM 11.             Executive Compensation.

See the information set forth in the sections entitled “Executive Compensation” and “Director Compensation” of the Company’s 2021 Proxy Statement, which are incorporated herein by reference.

ITEM 12.             Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

For information with respect to the beneficial ownership of the Company’s common stock and Class B common stock by the beneficial owners of more than 5% of said shares and by the management of the Company, see the sections entitled “Ownership of Common Stock and Class B Common Stock by Certain Beneficial Owners” and “Ownership of Common Stock and Class B Common Stock by Management” of the 2021 Proxy Statement. These sections of the 2021 Proxy Statement are incorporated herein by reference. The Company does not have any compensation plans under which equity securities of the Company are authorized for issuance.

52

ITEM 13.             Certain Relationships and Related Transactions, and Director Independence.

See the section entitled “Related Person Transactions” of the 2021 Proxy Statement, which is incorporated herein by reference.

The Company’s board of directors has determined that its non-management directors, Mr. Seibert and Ms. Wardynski and Ms. Lewis-Brent, are independent under the New York Stock Exchange listing standards because they have no direct or indirect relationship with the Company other than through their service on the Board of Directors.

ITEM 14.             Principal Accounting Fees and Services.

See the section entitled “Independent Auditor Fees and Services” of the 2021 Proxy Statement, which is incorporated herein by reference.

ITEM 15.             Exhibits, Financial Statement Schedules.

                             (a) Financial Statements.

                             (1) The following financial statements are included in Item 8:

                                        Report of Independent Registered Public Accounting Firm

                                        Consolidated Statements of Earnings and Retained Earnings for each of the three years ended December 31, 2020, 2019 and 2018

                                        Consolidated Statements of Comprehensive Earnings for each of the three years ended December 31, 2020, 2019 and 2018

                                        Consolidated Statements of Financial Position at December 31, 2020 and 2019

                                        Consolidated Statements of Cash Flows for each of the three years ended in the period December 31, 2020, 2019 and 2018

                                        Notes to Consolidated Financial Statements

                             (2) Financial Statement Schedules.

The financial statement schedule included in this Form 10-K is Schedule II - Valuation and Qualifying Accounts and Reserves for the Year Ended December 31, 2020, 2019 and 2018 (see Schedule II immediately following ITEM 16 of this Form 10-K).

                             (3) Exhibits required by Item 601 of Regulation S-K:

                                   See Index to Exhibits which appears following Financial Schedule II.

ITEM 16. Form 10-K Summary.

None.

53

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS (in thousands)

DECEMBER 31, 2020, 2019 and 2018

			Additions
			(reductions)
	Balance at		charged				Balance at
	beginning		(credited) to				End of
Description	of year		expense		Deductions(1)		Year
2020:
Reserve for bad debts	$	1,337	$	123	$	352	$	1,108
Reserve for cash discounts		612		8,504		8,530		586
Deferred tax asset valuation		4,985		608		—		5,593
	$	6,934	$	9,235	$	8,882	$	7,287
2019:
Reserve for bad debts	$	1,128	$	676	$	467	$	1,337
Reserve for cash discounts		692		9,482		9,562		612
Deferred tax asset valuation		3,892		1,093		—		4,985
	$	5,712	$	11,251	$	10,029	$	6,934
2018:
Reserve for bad debts	$	1,197	$	38	$	107	$	1,128
Reserve for cash discounts		724		9,122		9,154		692
Deferred tax asset valuation		3,269		623		—		3,892
	$	5,190	$	9,783	$	9,261	$	5,712

(1) Deductions against reserve for bad debts consist of accounts receivable written off net of recoveries and exchange rate movements. Deductions against reserve for cash discounts consist of allowances to customers.

54

INDEX TO EXHIBITS

3.1	Restated Articles of Incorporation. Incorporated by reference to Exhibit 3.1 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 1997.
3.2	Amendment to Restated Articles of Incorporation. Incorporated by reference to Exhibit 3.2 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1999.
3.3	Amended and Restated By-Laws. Incorporated by reference to Exhibit 3.2 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1996.
4.1	Specimen Class B Common Stock Certificate. Incorporated by reference to Exhibit 1.1 of the Company’s Registration Statement on Form 8-A dated February 29, 1988.
4.2	Description of Common Stock.
10.1*	Excess Benefit Plan. Incorporated by reference to Exhibit 10.8.1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1990.
10.2*	Amended and Restated Career Achievement Plan of the Company. Incorporated by reference to Exhibit 10.8.2 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1998.
10.3*	Amendment to the Amended and Restated Career Achievement Plan of the Company. Incorporated by reference to Exhibit 10.8.3 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1999.
10.4*	Restatement of Split Dollar Agreement (Special Trust) between the Company and the trustee of the Gordon Family 1993 Special Trust dated January 31, 1997. Incorporated by reference to Exhibit 10.12 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1996.
10.5*	Form of Change In Control Agreement dated August, 1997 between the Company and certain executive officers. Incorporated by reference to Exhibit 10.25 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1997.
10.6*	Amendment to Split Dollar Agreement (Special Trust) dated April 2, 1998 between the Company and the trustee of the Gordon Family 1993 Special Trust, together with related Collateral Assignments. Incorporated by reference to Exhibit 10.27 of the Company’s Annual Report on Form 10-K for the year ended December 31, 1998.
10.7*	Form of Amendment to Change in Control Agreement between the Company and certain executive officers. Incorporated by reference to Exhibit 10.28 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
10.8*	Post 2004 Supplemental Savings Plan of the Company. Incorporated by reference to Exhibit 10.29 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
10.9*	Post 2004 Excess Benefit Plan of the Company. Incorporated by reference to Exhibit 10.30 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
10.10*	Amended and Restated Career Achievement Plan of the Company. Incorporated by reference to Exhibit 10.31 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
10.11*	Exhibit 10.1- Tootsie Roll Industries, Inc. Management Incentive Plan. Incorporated by reference to Appendix A to the Company’s definitive Proxy Statement filed with the Commission on March 24, 2006.

55

10.12*	Amendment 2015-1, to the Tootsie Roll Industries, Inc. Post 2004 Excess Benefit Plan. Incorporated by reference to Exhibit 10.12 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.
10.13*	Amendment 2015-1, to the Tootsie Roll Industries, Inc. Career Achievement Plan. Incorporated by reference to Exhibit 10.13 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.
21	List of Subsidiaries of the Company.
31.1	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
104	Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

*Management compensation plan or arrangement.

56

SIGNATURES

Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, Tootsie Roll Industries, Inc., has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TOOTSIE ROLL INDUSTRIES, INC.
By:	Ellen R. Gordon
	Ellen R. Gordon, Chairman of the Board of Directors and Chief Executive Officer
Date:	March 1, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Ellen R. Gordon	Chairman of the Board of Directors and Chief Executive Officer	March 1, 2021
Ellen R. Gordon	(principal executive officer)
Paula M. Wardynski	Director	March 1, 2021
Paula M. Wardynski
Lana Jane Lewis-Brent	Director	March 1, 2021
Lana Jane Lewis-Brent
Barre A. Seibert	Director	March 1, 2021
Barre A. Seibert
G. Howard Ember, Jr.	Vice President, Finance	March 1, 2021
G. Howard Ember, Jr.	(principal financial officer and principal accounting officer)

57

EX-21

EXHIBIT 21

LIST OF SUBSIDIARIES OF THE COMPANY

NAME	JURISDICTION OF INCORPORATION
Andes Candies LLC	Illinois
Andes Manufacturing LLC	Illinois
Andes Services LLC	Illinois
C. G. P., Inc.	Delaware
Cambridge Brands, Inc.	Delaware
Cambridge Brands Manufacturing, Inc.	Delaware
Cambridge Brands Services, Inc.	Delaware
Cambridge Brands Sales LLC	Illinois
Cella’s Confections, Inc.	Virginia
CGCLP, Inc.	Delaware
Charms LLC	Illinois
Concord Wax, Inc.	Delaware
Concord (GP) Inc.	Ontario
Concord Canada Holdings ULC	Nova Scotia
Concord Confections Holdings USA, Inc.	Delaware
Concord Partners LP	Ontario
Fleer Española,S.L.	Spain
Henry Eisen Advertising Agency, Inc.	New Jersey
Impel Movie Line, Inc.	Delaware
JT Company, Inc.	Delaware
Rizzle Inversiones 2014, S.L.	Spain
Tootsie Roll Industries LLC	Illinois
Tootsie Roll of Canada ULC	Alberta
The Tootsie Roll Company, Inc.	Illinois
Tootsie Roll Management, Inc.	Illinois
Tootsie Roll Mfg, LLC	Delaware
Tootsie Rolls - Latin America, Inc.	Delaware
Tootsie Roll Worldwide, Ltd.	Illinois
The Sweets Mix Company, Inc.	Illinois
TRI de Latinoamerica S.A. de C.V.	Mexico
TRI Captive Insurance Company, Inc.	Nevada
TRI Finance, Inc.	Delaware
TRI International, Inc.	Illinois
TRI-Mass, Inc.	Massachusetts
TRI Sales Co.	Delaware
TRI Sales Services, LLC	Illinois
Tutsi S. A. de C. V.	Mexico
World Trade & Marketing Ltd.	British West Indies

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Ellen R. Gordon, Chairman and Chief Executive Officer of Tootsie Roll Industries, Inc., certify that:

1. I have reviewed this annual report on Form 10-K of Tootsie Roll Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 1, 2021
	By:	/s/ Ellen R. Gordon
		Ellen R. Gordon
		Chairman and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, G. Howard Ember, Jr., Vice President/Finance and Chief Financial Officer of Tootsie Roll Industries, Inc., certify that:

1. I have reviewed this annual report on Form 10-K of Tootsie Roll Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

7
Date: March 1, 2021
	By:	/s/ G. Howard Ember, Jr.
		G. Howard Ember, Jr.
		Vice President/Finance and Chief Financial Officer

EX-32

Exhibit 32

Certificate Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Each of the undersigned officers of Tootsie Roll Industries, Inc. certifies that (i) the Annual Report on Form 10-K of Tootsie Roll Industries, Inc. for the year ended December 31, 2020 (the Form 10-K) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and (ii) the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Tootsie Roll Industries, Inc.

Dated:	March 1, 2021	/s/ Ellen R. Gordon
		Ellen R. Gordon
		Chairman and Chief Executive Officer
Dated:	March 1, 2021	/s/ G. Howard Ember, Jr.
		G. Howard Ember, Jr.
		Vice President/Finance and Chief Financial Officer

XML

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Feb. 18, 2021	Jun. 30, 2020
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2020
Entity File Number	1-1361
Entity Registrant Name	TOOTSIE ROLL INDUSTRIES, INC
Entity Incorporation, State or Country Code	VA
Entity Tax Identification Number	22-1318955
Entity Address, Address Line One	7401 South Cicero Avenue
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60629
City Area Code	773
Local Phone Number	838-3400
Title of 12(b) Security	Common Stock — Par Value $.69-4/9 Per Share
Trading Symbol	TR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Central Index Key	0000098677
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Public Float			$ 597,009,000
Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		38,989,889
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		27,011,521

XML

CONSOLIDATED STATEMENTS OF EARNINGS AND RETAINED EARNINGS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenue	$ 471,063	$ 527,113	$ 518,920
Costs	300,702	330,097	330,747
Gross Margin	170,361	197,016	188,173
Selling, marketing and administrative expenses	112,117	127,802	117,691
Earnings from operations	58,244	69,214	70,482
Other income, net	18,018	16,190	2,724
Earnings before income taxes	76,262	85,404	73,206
Provision for income taxes	17,288	20,565	16,401
Net earnings	58,974	64,839	56,805
Less: net earnings (loss) attributable to noncontrolling interests	(21)	(81)	(88)
Net earnings attributable to Tootsie Roll Industries, Inc.	$ 58,995	$ 64,920	$ 56,893
Net earnings attributable to Tootsie Roll Industries, Inc. per share (in dollars per share)	$ 0.89	$ 0.96	$ 0.84
Average number of shares outstanding (in shares)	66,512	67,416	68,072
Product
Revenue	$ 467,427	$ 523,616	$ 515,251
Costs	299,710	329,102	329,880
Gross Margin	167,717	194,514	185,371
Rental and Royalty
Revenue	3,636	3,497	3,669
Costs	992	995	867
Gross Margin	$ 2,644	$ 2,502	$ 2,802

XML

CONSOLIDATED STATEMENTS OF EARNINGS AND RETAINED EARNINGS (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Retained earnings at beginning of period	$ 40,809	$ 33,767	$ 57,225
Net earnings attributable to Tootsie Roll Industries, Inc.	58,995	64,920	56,893
Cash dividends	(23,739)	(23,371)	(22,929)
Stock dividends	(43,753)	(34,507)	(60,148)
Retained earnings at end of period	$ 32,312	$ 40,809	33,767
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained earnings at beginning of period			$ 2,726

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS
Net earnings	$ 58,974	$ 64,839	$ 56,805
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments	(1,213)	791	103
Pension and postretirement reclassification adjustments:
Unrealized gains (losses) for the period on postretirement and pension benefits	467	(1,230)	1,558
Less: reclassification adjustment for (gains) losses to net earnings	(1,349)	(1,522)	(1,324)
Unrealized gains (losses) on postretirement and pension benefits	(882)	(2,752)	234
Investments:
Unrealized gains (losses) for the period on investments	1,463	3,130	(606)
Less: reclassification adjustment for (gains) losses to net earnings		34
Unrealized gains (losses) on investments	1,463	3,164	(606)
Derivatives:
Unrealized gains (losses) for the period on derivatives	1,259	451	(2,734)
Less: reclassification adjustment for (gains) losses to net earnings	325	677	1,630
Unrealized gains (losses) on derivatives	1,584	1,128	(1,104)
Total other comprehensive income (loss), before tax	952	2,331	(1,373)
Income tax benefit (expense) related to items of other comprehensive income	(522)	(354)	349
Total comprehensive earnings	59,404	66,816	55,781
Comprehensive earnings (loss) attributable to noncontrolling interests	(21)	(81)	(88)
Total comprehensive earnings attributable to Tootsie Roll Industries, Inc.	$ 59,425	$ 66,897	$ 55,869

XML

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents	$ 166,841	$ 138,960
Restricted cash	415	380
Investments	42,090	100,444
Accounts receivable trade, less allowances of $1,694 and $1,949	41,209	45,044
Other receivables	3,894	3,418
Inventories:
Finished goods and work-in-process	35,583	35,909
Raw materials and supplies	23,996	23,179
Prepaid expenses	6,844	5,996
Total current assets	320,872	353,330
PROPERTY, PLANT AND EQUIPMENT, at cost:
Land	21,738	21,740
Buildings	123,883	122,843
Machinery and equipment	422,506	416,625
Construction in progress	14,347	4,427
Operating lease right-of-use assets	858	1,580
Property, plant and equipment, gross	583,332	567,215
Less - accumulated depreciation	396,004	378,760
Net property, plant and equipment	187,328	188,455
OTHER ASSETS:
Goodwill	73,237	73,237
Trademarks	175,024	175,024
Investments	220,020	153,031
Split dollar officer life insurance	2,514	26,042
Prepaid expenses and other assets	4,525	8,056
Deferred income taxes	1,038	689
Total other assets	476,358	436,079
Total assets	984,558	977,864
CURRENT LIABILITIES:
Accounts payable	13,025	12,720
Bank loans	832	747
Dividends payable	5,948	5,861
Accrued liabilities	45,099	41,611
Postretirement health care benefits	544	598
Operating lease liabilities	780	1,062
Income taxes payable	3,793
Deferred compensation		16,945
Total current liabilities	70,021	79,544
NONCURRENT LIABILITIES:
Deferred income taxes	47,900	47,295
Postretirement health care benefits	12,943	13,145
Industrial development bonds	7,500	7,500
Liability for uncertain tax positions	3,351	4,240
Operating lease liabilities	78	518
Deferred compensation and other liabilities	79,665	65,973
Total noncurrent liabilities	151,437	138,671
TOOTSIE ROLL INDUSTRIES, INC. SHAREHOLDERS' EQUITY:
Capital in excess of par value	706,930	696,059
Retained earnings	32,312	40,809
Accumulated other comprehensive loss	(19,815)	(20,245)
Treasury stock (at cost) - 93 shares and 90 shares, respectively	(1,992)	(1,992)
Total Tootsie Roll Industries, Inc. shareholders' equity	763,327	759,854
Noncontrolling interests	(227)	(205)
Total equity	763,100	759,649
Total liabilities and shareholders' equity	984,558	977,864
Common Stock
TOOTSIE ROLL INDUSTRIES, INC. SHAREHOLDERS' EQUITY:
Common stock, $.69-4/9 par value - 120,000 shares authorized - 39,073 and 38,836, respectively, issued. Class B common stock, $.69-4/9 par value - 40,000 shares authorized - 27,012 and 26,287, respectively, issued	27,134	26,969
Class B Common Stock
TOOTSIE ROLL INDUSTRIES, INC. SHAREHOLDERS' EQUITY:
Common stock, $.69-4/9 par value - 120,000 shares authorized - 39,073 and 38,836, respectively, issued. Class B common stock, $.69-4/9 par value - 40,000 shares authorized - 27,012 and 26,287, respectively, issued	$ 18,758	$ 18,254

XML

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Trade accounts receivable, allowances	$ 1,694	$ 1,949
Treasury stock, shares	93	90
Common Stock
Common stock, par value (in dollars per share)	$ 0.6944	$ 0.6944
Common stock, shares authorized	120,000	120,000
Common stock, shares issued	39,073	38,836
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.6944	$ 0.6944
Common stock, shares authorized	40,000	40,000
Common stock, shares issued	27,012	26,287

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 58,974	$ 64,839	$ 56,805
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	18,184	18,779	18,669
Deferred income taxes	(279)	2,832	2,063
Impairment of majority-owned foreign subsidiaries		377	1,126
Amortization of marketable security premiums	1,404	1,282	1,755
Changes in operating assets and liabilities:
Accounts receivable	3,483	5,086	(2,445)
Other receivables	636	(313)	2,220
Inventories	(770)	(4,383)	303
Prepaid expenses and other assets	2,961	4,362	9,489
Accounts payable and accrued liabilities	3,849	1,080	1,648
Income taxes payable	3,012	4,336	7,953
Postretirement health care benefits	(1,041)	(1,478)	(2,484)
Deferred compensation and other liabilities	(15,703)	3,422	3,827
Net cash provided by operating activities	74,710	100,221	100,929
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(17,970)	(20,258)	(27,612)
Repayment of premiums on split dollar life insurance policies	23,527
Purchases of trading securities	(3,183)	(3,427)	(4,378)
Sales of trading securities	18,058	795	1,255
Purchase of available for sale securities	(109,816)	(67,730)	(78,377)
Sale and maturity of available for sale securities	98,885	75,611	64,602
Net cash used in investing activities	9,501	(15,009)	(44,510)
CASH FLOWS FROM FINANCING ACTIVITIES:
Shares purchased and retired	(32,055)	(34,116)	(19,317)
Dividends paid in cash	(23,810)	(23,460)	(22,978)
Proceeds from bank loans	3,902	3,582	2,491
Repayment of bank loans	(3,883)	(3,193)	(2,549)
Net cash used in financing activities	(55,846)	(57,187)	(42,353)
Effect of exchange rate changes on cash	(449)	28	501
Increase (decrease) in cash and cash equivalents	27,916	28,053	14,567
Cash, cash equivalents and restricted cash at beginning of year	139,340	111,287	96,720
Cash, cash equivalents and restricted cash at end of year	167,256	139,340	111,287
Supplemental cash flow information:
Income taxes paid	14,503	13,858	5,676
Interest paid	57	121	112
Stock dividend issued	$ 63,402	$ 70,557	$ 60,538

XML

SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2020

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

NOTE 1—SIGNIFICANT ACCOUNTING POLICIES:

Basis of consolidation:

The consolidated financial statements include the accounts of Tootsie Roll Industries, Inc. and its wholly-owned and majority-owned subsidiaries (the Company), which are primarily engaged in the manufacture and sales of candy products. Non-controlling interests relating to majority-owned subsidiaries are reflected in the consolidated financial statements and all significant intercompany transactions have been eliminated. Certain amounts previously reported have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net earnings.

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue recognition:

The Company’s revenues, primarily net product sales, principally result from the sale of goods, reflect the consideration to which the Company expects to be entitled, generally based on customer purchase orders. The Company records revenue based on a five-step model in accordance with Accounting Standards Codification ("ASC") Topic 606 which became effective January, 1, 2018. Adjustments for estimated customer cash discounts upon payment, discounts for price adjustments, product returns, allowances, and certain advertising and promotional costs, including consumer coupons, are variable consideration and are recorded as a reduction of product sales revenue in the same period the related product sales are recorded. Such estimates are calculated using historical averages adjusted for any expected changes due to current business conditions and experience. A net product sale is recorded when the Company delivers the product to the customer, or in certain instances, the customer picks up the goods at the Company’s distribution centers, and thereby obtains control of such product. Amounts billed and due from our customers are classified as accounts receivables trade on the balance sheet and require payment on a short-term basis. Accounts receivable are unsecured. Shipping and handling costs of $42,593, $49,288, and $49,527 in 2020, 2019 and 2018, respectively, are included in selling, marketing and administrative expenses. A minor amount of royalty income (less than 0.2% of our consolidated net sales) is also recognized from sales-based licensing arrangements, pursuant to which revenue is recognized as the third-party licensee sales occur. Rental income (less than 1% of our consolidated net sales) is not considered revenue from contracts from customers.

Leases:

The Company identifies leases by evaluating our contracts to determine if the contract conveys the right to use an identified asset for a stated period of time in exchange for consideration. The Company considers whether it can control the underlying asset and has the right to obtain substantially all of the economic benefits or outputs from the asset. Leases with terms greater than 12 months are classified as either operating or finance leases at the commencement date.  For these leases, the Company capitalized the present value of the minimum lease payments over the lease terms as a right-of-use asset with an offsetting lease liability. The discount rate used to calculate the present value of the minimum lease payments is typically the Company’s incremental borrowing rate, as the rate implicit in the lease is generally not known or determinable. The lease term includes any noncancelable period for which the Company has the right to use the asset. Currently, all capitalized leases are classified as operating leases and the Company records lease expense on a straight-line basis over the term of the lease.

Cash and cash equivalents:

The Company considers short-term debt securities with an original maturity of three months or less to be cash equivalents. Substantially all cash and cash equivalents are held at a major U.S. money center bank or its foreign branches (Bank of America), or its investment broker affiliate (Merrill Lynch). The Company also holds certificates of deposit (CDs) of U.S. banks selected by this investment broker based on their financial ratings; substantially all such CDs are invested in separate individual banks which are generally not in excess of the Federal Deposit Insurance Corporation (FDIC) limit of $250 per bank. The cash in the Company's U.S. banks (primarily Bank of America) is not fully insured by the FDIC due to the statutory limit of $250. The Company had approximately $8,303 and $9,415 of cash in foreign banks, principally foreign branches of a U.S. bank (Bank of America), at December 31, 2020 and 2019, respectively. The Company's cash in its foreign bank accounts is also not fully insured.

Investments:

Investments consist of various marketable securities with maturities of generally up to three years, and variable rate demand notes with interest rates that are generally reset weekly and the security can be “put” back and sold weekly. The Company classifies debt and equity securities as either available for sale or trading. Available for sale debt securities are not actively traded by the Company and are carried at fair value. The Company follows current fair value measurement guidance and unrealized gains and losses on these securities are excluded from earnings and are reported as a separate component of shareholders’ equity, net of applicable taxes, until realized or other-than-temporarily impaired. Trading securities related to deferred compensation arrangements are carried at fair value with gains or losses included in other income, net. The Company invests in trading securities to economically hedge changes in its deferred compensation liabilities.

The Company regularly reviews its investments to determine whether a decline in fair value below the cost basis is other-than-temporary. If the decline in fair value is judged to be other-than-temporary, the cost basis of the security is written down to fair value and the amount of the write-down is included in other income, net. Further information regarding the fair value of the Company’s investments is included in Note 10 of the Company’s Notes to Consolidated Financial Statements.

Derivative instruments and hedging activities:

Authoritative guidance requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of derivative instruments and related gains and losses, and disclosures about credit-risk-related contingent features in derivative agreements.

From time to time, the Company enters into commodity futures and foreign currency forward contracts. Commodity futures are intended and are effective as hedges of market price risks associated with the anticipated purchase of certain raw materials (primarily sugar). Foreign currency forward contracts are intended and are effective as hedges of the Company’s exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of products manufactured in Canada and sold in the United States, and periodic equipment purchases from foreign suppliers denominated in a foreign currency. The Company does not engage in trading or other speculative use of derivative instruments. Further information regarding derivative instruments and hedging activities is included in Note 11 of the Company’s Notes to Consolidated Financial Statements.

Inventories:

Inventories are stated at lower of cost or net realizable value. The cost of substantially all of the Company’s inventories ($54,935 and $55,409 at December 31, 2020 and 2019, respectively) has been determined by the last-in, first-out (LIFO) method. The excess of current cost over LIFO cost of inventories approximates $19,339 and $19,174 at December 31, 2020 and 2019, respectively. The cost of certain foreign inventories ($4,644 and $3,679 at December 31, 2020 and 2019, respectively) has been determined by the first-in, first-out (FIFO) method. Rebates, discounts and other cash consideration received from vendors related to inventory purchases is reflected as a reduction in the cost of the related inventory item, and is, therefore, reflected in cost of sales when the related inventory item is sold.

Property, plant and equipment:

Depreciation is computed for financial reporting purposes by use of the straight-line method based on useful lives of 20 to 40 years for buildings and 5 to 20 years for machinery and equipment. Depreciation expense was $18,184, $18,779 and $18,669 in 2020, 2019 and 2018, respectively.

Carrying value of long-lived assets:

The Company reviews long-lived assets to determine if there are events or circumstances indicating that the amount of the asset reflected in the Company’s balance sheet may not be recoverable. When such indicators are present, the Company compares the carrying value of the long-lived asset, or asset group, to the future undiscounted cash flows of the underlying assets to determine if impairment exists. If applicable, an impairment charge would be recorded to write down the carrying value to its fair value. The determination of fair value involves the use of estimates of future cash flows that involve considerable management judgment and are based upon assumptions about expected future operating performance. The actual cash flows could differ from management’s estimates due to changes in business conditions, operating performance, and economic conditions. In fourth quarter 2019 and 2018, the Company recorded charges of $377 and $1,126, respectively, relating to the impairment of assets of a foreign subsidiary which is included in selling, marketing and administrative expense. Except for the aforementioned, no impairment charges of long-lived assets were recorded by the Company during 2020, 2019 or 2018.

Postretirement health care benefits:

The Company provides certain postretirement health care benefits to a group of “grandfathered” corporate office and management employees. The cost of these postretirement benefits is accrued during the employees’ working careers. See Note 7 of the Company’s Notes to Consolidated Financial Statements for additional information. The Company also provides split dollar life benefits to an executive officer. The Company records an asset equal to the cumulative insurance premiums paid that will be recovered upon the death of the covered executive officer or earlier under the terms of the plan. During 2020, the Company received $23,527 of previously paid premiums on these insurance policies which was recorded as a reduction to this asset. No premiums were paid in 2020, 2019 or 2018.

Goodwill and indefinite-lived intangible assets:

In accordance with authoritative guidance, goodwill and intangible assets with indefinite lives are not amortized, but rather reviewed and tested for impairment at least annually unless certain interim triggering events or circumstances require more frequent testing. All trademarks have been assessed by management to have indefinite lives because they are expected to generate cash flows indefinitely. Management believes that all assumptions used for the impairment review and testing are consistent with those utilized by market participants performing similar valuations. No impairments of intangibles, including trademarks and goodwill, were recorded in 2020, 2019 or 2018.

Current accounting guidance provides entities an option of performing a qualitative assessment (a "step-zero" test) before performing a quantitative analysis. If the entity determines, on the basis of certain qualitative factors, that it is more-likely-than-not that the intangibles (goodwill and certain trademarks) are not impaired, the entity would not need to proceed to the two step impairment testing process (quantitative analysis) as prescribed in the guidance. During fourth quarter 2020 and 2019, the Company performed a “step zero” test of its goodwill and certain trademarks, and concluded that there was no impairment based on this guidance. For the fair value assessment of certain trademarks where the “step-zero” analysis was not considered appropriate, impairment testing was performed in fourth quarter 2020 and 2019 using discounted cash flows and estimated royalty rates. For these trademarks, holding all other assumptions constant at the test date in 2020, a 100 basis point increase in the discount rate or a 100 basis point decrease in the royalty rate would reduce the fair value of these trademarks by approximately 18% and 10%, respectively. Individually, a 100 point increase in the discount rate or a 100 point decrease in the royalty rate would not result in a potential impairment as of December 31, 2020. 

Income taxes:

Deferred income taxes are recorded and recognized for future tax effects of temporary differences between financial and income tax reporting. The Company records valuation allowances in situations where the realization of deferred tax assets is not more-likely-than-not. The Company periodically reviews assumptions and estimates of the Company’s probable tax obligations and effects on its liability for uncertain tax positions, using informed judgment which may include the use of third-party consultants, advisors and legal counsel, as well as historical experience.

Further information regarding U.S. tax reform (U.S. Tax Cuts and Jobs Act) and other income tax matters are included in Note 4 of the Company’s Notes to Consolidated Financial Statements.

Foreign currency translation:

The U.S. dollar is used as the functional currency where a substantial portion of the subsidiary’s business is indexed to the U.S. dollar or where its manufactured products are principally sold in the U.S. All other foreign subsidiaries use the local currency as their functional currency. Where the U.S. dollar is used as the functional currency, foreign currency remeasurements are recorded as a charge or credit to other income, net in the statement of earnings. Where the foreign local currency is used as the functional currency, translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss).

Restricted cash:

Restricted cash comprises certain cash deposits of the Company’s majority-owned Spanish subsidiary with international banks that are pledged as collateral for letters of credit and bank borrowings.

VEBA trust:

The Company maintains a VEBA trust managed and controlled by the Company, to fund the estimated future costs of certain employee health, welfare and other benefits. The Company made a $20,024 contribution to the VEBA trust in 2017 but no contributions were made to the trust in 2020, 2019 or 2018. The Company will be using the VEBA trust funds to pay the actual cost of such benefits through 2022. At December 31, 2020 and 2019, the VEBA trust held $8,272 and $12,085, respectively, of aggregate cash and cash equivalents. This asset value is included in prepaid expenses and long-term other assets in the Company’s Consolidated Statement of Financial Position. These assets are categorized as Level 1 within the fair value hierarchy.

Bank loans:

Bank loans consist of short term (less than 120 days) borrowings by the Company’s Spanish subsidiary that are held by international banks. The weighted-average interest rate as of December 31, 2020 and 2019 was 3.0% and 3.0%, respectively.

Comprehensive earnings:

Comprehensive earnings include net earnings, foreign currency translation adjustments and unrealized gains/losses on commodity and/or foreign currency hedging contracts, available for sale securities and certain postretirement benefit obligations.

Earnings per share:

A dual presentation of basic and diluted earnings per share is not required due to the lack of potentially dilutive securities under the Company’s simple capital structure. Therefore, all earnings per share amounts represent basic earnings per share.

The Class B common stock has essentially the same rights as common stock, except that each share of Class B common stock has ten votes per share (compared to one vote per share of common stock), is not traded on any exchange, is restricted as to transfer and is convertible on a share-for-share basis, at any time and at no cost to the holders, into shares of common stock which are traded on the New York Stock Exchange.

Use of estimates:

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, allowances and incentives, product liabilities, assets recorded at fair value, income taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.

Recently adopted accounting pronouncements:

In June 2016, the FASB issued ASU No. 2016-13, (ASC Topic 326) which replaces the current incurred loss impairment method with a new method that reflects expected credit losses. Subsequent to the issuance of ASC Topic 326, the FASB clarified and amended guidance through several Accounting Standard Updates; hereinafter the collection of credit loss guidance is referred to as “ASC Topic 326”. Under this new guidance an entity would recognize an impairment allowance equal to its current estimate of credit losses on financial assets measured at amortized cost. The Company adopted ASU 2016-13 and related amendments (ASC Topic 326) on January 1, 2020. The adoption of this ASC did not have a material impact on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU 2018-14, (ASC Subtopic 715-20) which expands disclosure requirements for employer sponsored defined benefit pension and other retirement plans. The Company adopted ASU 2018-14 on January 1, 2020 because this ASU affects the Company’s post-retirement health benefits plan (see Note 7). The adoption of the new accounting rules did not have a material impact on the Company’s consolidated financial statements.

Recently issued accounting pronouncements - not yet adopted:

In December 2019, the FASB issued ASU No. 2019-12 which is designed to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU No. 2019-12 is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years; this ASU allows for early adoption in any interim period after issuance of the update. The Company is currently assessing the impact this ASU will have on its consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04 which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently evaluating our contracts and the optional expedients provided by the new standard.

XML

ACCRUED LIABILITIES

12 Months Ended

Dec. 31, 2020

ACCRUED LIABILITIES

ACCRUED LIABILITIES

NOTE 2—ACCRUED LIABILITIES:

Accrued liabilities are comprised of the following:

	December 31,
	2020		2019
Compensation	$	8,135	$	10,575
Other employee benefits		8,841		7,509
Taxes, other than income		3,169		3,170
Advertising and promotions		18,455		14,421
Other		6,499		5,936
	$	45,099	$	41,611

XML

INDUSTRIAL DEVELOPMENT BONDS

12 Months Ended

Dec. 31, 2020

INDUSTRIAL DEVELOPMENT BONDS

INDUSTRIAL DEVELOPMENT BONDS

NOTE 3—INDUSTRIAL DEVELOPMENT BONDS:

Industrial development bonds are due in 2027. The average floating interest rate, which is reset weekly, was 0.7% and 1.6% in 2020 and 2019, respectively. See Note 10 of the Company’s Notes to Consolidated Financial Statements for fair value disclosures.

XML

INCOME TAXES

12 Months Ended

Dec. 31, 2020

INCOME TAXES

INCOME TAXES

NOTE 4—INCOME TAXES:

The domestic and foreign components of pretax income are as follows:

	2020		2019		2018
Domestic	$	69,211	$	74,978	$	66,253
Foreign		7,051		10,426		6,953
	$	76,262	$	85,404	$	73,206

The provision for income taxes is comprised of the following:

	2020		2019		2018
Current:
Federal	$	14,831	$	15,133	$	12,414
Foreign		1,029		—		—
State		1,763		2,942		1,421
		17,623		18,075		13,835
Deferred:
Federal		(1,006)		(543)		(577)
Foreign		1,316		2,422		2,685
State		(645)		611		458
		(335)		2,490		2,566
	$	17,288	$	20,565	$	16,401

Significant components of the Company’s net deferred tax liability at year end were as follows:

	December 31,
	2020		2019
Deferred tax assets:
Accrued customer promotions	$	1,506	$	198
Deferred compensation		18,501		19,432
Postretirement benefits		3,355		3,439
Other accrued expenses		3,078		3,979
Foreign subsidiary tax loss carry forward		4,508		4,584
Outside basis difference in foreign subsidiary		365		365
Deductible state tax depreciation		471		512
Tax credit carry forward		3,288		3,059
		35,072		35,568
Valuation allowances		(5,593)		(4,985)
Total deferred tax assets	$	29,479	$	30,583
Deferred tax liabilities:
Depreciation	$	22,192	$	23,375
Deductible goodwill and trademarks		37,348		36,591
Accrued export company commissions		4,508		4,367
Employee benefit plans		1,767		2,700
Inventory reserves		1,994		2,526
Prepaid insurance		569		710
Unrealized capital gains		2,515		1,362
Deferred foreign exchange gain		179		260
Deferred gain on sale of real estate		5,269		5,298
Total deferred tax liabilities	$	76,341	$	77,189
Net deferred tax liability	$	46,862	$	46,606

At December 31, 2020, the Company has benefits related to state tax credit carry-forwards expiring by year as follows: $495 in 2020, $771 in 2021, $221 in 2023, $253 in 2024, $50 in 2028, $131 in 2029, $213 in 2030, $225 in 2031, $238 in 2032, $211 in 2033 and $234 in 2034. The Company expects that not all the credits will be utilized before their expiration and has provided a valuation allowance for the expired amounts. Such valuation allowances were $837 and $770 at December 31, 2020 and 2019, respectively.

At December 31, 2020, the amounts of the Company’s Spanish subsidiary loss carry-forwards expiring by year are as follows: $306 in 2026, $65 in 2027, $194 in 2028, $111 in 2029, $335 in 2030, $447 in 2031, $337 in 2032, $136 in 2033, $470 in 2034, $594 in 2035, $863 in 2036, $440 in 2037 and $210 in 2038. A full valuation allowance has been provided for these Spanish loss carry-forwards as the Company expects that the losses will not be utilized before their expiration.

The effective income tax rate differs from the statutory rate as follows:

	2020		2019		2018
U.S. statutory rate	21.0	%	21.0	%	21.0	%
State income taxes, net	2.1		2.2		2.2
Exempt municipal bond interest	—		(0.1)		(0.1)
Foreign income tax rates	1.0		(0.1)		0.5
Income tax credits and adjustments	(1.4)		0.5		—
Adjustment of deferred tax balances	(0.2)		—		0.1
Reserve for uncertain tax benefits	(0.8)		0.4		(1.0)
Other, net	1.0		0.2		(0.3)
Effective income tax rate	22.7	%	24.1	%	22.4	%

The 2017 Tax Cuts and Jobs Act changed the United States approach to the taxation of foreign earnings to a territorial system by providing a one hundred percent dividends received deduction for certain qualified dividends received from foreign subsidiaries. This provision of the Act significantly impacts the accounting for the undistributed earnings of foreign subsidiaries and as a result the Company intends to distribute the earnings of its foreign subsidiaries. The costs associated with a future distribution are not material to the Company’s financial statements. After carefully considering these facts, the Company has determined that effective December 31, 2017, it will not be asserting permanent reinvestment of its foreign subsidiaries earnings.

At December 31, 2020 and 2019, the Company had unrecognized tax benefits of $3,011 and $3,678, respectively. Included in this balance is $1,468 and $2,012, respectively, of unrecognized tax benefits that, if recognized, would favorably affect the annual effective income tax rate. As of December 31, 2020 and 2019, $340 and $562, respectively, of interest and penalties were included in the liability for uncertain tax positions.

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:

	2020		2019		2018
Unrecognized tax benefits at January 1	$	3,678	$	3,339	$	4,342
Increases in tax positions for the current year		377		1,164		448
Reductions in tax positions for lapse of statute of limitations		(501)		(576)		(751)
Reductions in tax positions for settlements and payments		(308)		(249)		—
Increases (decreases) in prior period unrecognized tax benefits due to change in judgment		(235)		—		(700)
Unrecognized tax benefits at December 31	$	3,011	$	3,678	$	3,339

The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes on the Consolidated Statements of Earnings and Retained Earnings.

The Company is subject to taxation in the U.S. and various state and foreign jurisdictions, primarily Canada and Mexico. The Company generally remains subject to examination by U.S. federal, state and foreign tax authorities for the years 2017 through 2019. With few exceptions, the Company is no longer subject to examinations by tax authorities for the years 2016 and prior.

XML

SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE

12 Months Ended

Dec. 31, 2020

SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE

SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE

NOTE 5—SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE:

										Capital in
				Class B						Excess
	Common Stock			Common Stock			Treasury Stock			of Par
	Shares	Amount		Shares	Amount		Shares	Amount		Value
	(000’s)			(000’s)			(000’s)
Balance at January 1, 2018	37,960	$	26,361	24,891	$	17,285	85	$	(1,992)	$	656,752
Issuance of 3% stock dividend	1,125		781	746		519	3		—		58,688
Conversion of Class B common shares to common shares	53		37	(53)		(37)	—		—		—
Purchase and retirement of common shares	(594)		(412)	—		—	—		—		(18,905)
Balance at December 31, 2018	38,544		26,767	25,584		17,767	88		(1,992)		696,535
Issuance of 3% stock dividend	1,150		798	768		532	2		—		32,999
Conversion of Class B common shares to common shares	65		45	(65)		(45)	—		—		—
Purchase and retirement of common shares	(923)		(641)	—		—	—		—		(33,475)
Balance at December 31, 2019	38,836		26,969	26,287		18,254	90		(1,992)		696,059
Issuance of 3% stock dividend	1,157		804	787		547	3		—		42,244
Conversion of Class B common shares to common shares	62		43	(62)		(43)	—		—		—
Purchase and retirement of common shares	(982)		(682)	—		—	—		—		(31,373)
Balance at December 31, 2020	39,073	$	27,134	27,012	$	18,758	93	$	(1,992)	$	706,930

Average shares outstanding and all per share amounts included in the financial statements and notes thereto have been adjusted retroactively to reflect annual three percent stock dividends.

While the Company does not have a formal or publicly announced Company common stock purchase program, the Company’s board of directors periodically authorizes a dollar amount for such share purchases.

Based upon this policy, shares were purchased and retired as follows:

	Total Number of Shares
Year	Purchased (000’s)	Average Price Paid Per Share
2020	982	$	32.59
2019	923	$	36.93
2018	594	$	32.48

XML

OTHER INCOME, NET

12 Months Ended

Dec. 31, 2020

OTHER INCOME, NET

OTHER INCOME, NET

NOTE 6—OTHER INCOME, NET:

Other income, net is comprised of the following:

	2020		2019		2018
Interest and dividend income	$	4,005	$	4,423	$	3,535
Gains (losses) on trading securities relating to deferred compensation plans		12,519		11,292		(1,103)
Interest expense		(164)		(220)		(181)
Foreign exchange gains (losses)		534		(533)		(659)
Capital gains (losses)		(6)		22		(11)
Miscellaneous, net		1,130		1,206		1,143
	$	18,018	$	16,190	$	2,724

XML

EMPLOYEE BENEFIT PLANS

12 Months Ended

Dec. 31, 2020

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS

NOTE 7—EMPLOYEE BENEFIT PLANS:

Pension plans:

The Company sponsors a defined contribution pension plan covering certain non-union employees with over one year of credited service. The Company’s policy is to fund pension costs accrued based on compensation levels. Total expense for this plan for 2020, 2019 and 2018 approximated $2,722, $3,114 and $2,988, respectively, for this defined contribution plan. The Company also maintains certain profit sharing and retirement savings-investment plans. Company contributions in 2020, 2019 and 2018 to these plans were $2,766, $2,858 and $2,734 respectively.

The Company also contributes to a multi-employer defined benefit pension plan for certain of its union employees under a collective bargaining agreement which is as follows:

Plan name: Bakery and Confectionery Union and Industry International Pension Fund

Employer Identification Number and plan number: 52-6118572, plan number 001

Funded Status as of the most recent year available: 50.40% funded as of January 1, 2019

The Company’s contributions to such plan: $2,850, $2,943 and $2,836 in 2020, 2019 and 2018, respectively

Plan status: Critical and declining as of December 31, 2019 (most recent date information is available)

Beginning in 2012, the Company received periodic notices from the Bakery, Confectionery, Tobacco Workers and Grain Millers International Union  Pension Plan (Plan), a multi-employer defined benefit pension plan for certain Company union employees, that the Plan’s actuary certified the Plan to be in “critical status”, as defined by the Pension Protection Act (PPA) and the Pension Benefit Guaranty Corporation (PBGC); and that a plan of rehabilitation was adopted by the trustees of the Plan in 2012. Beginning in 2015, the Company received new annual notices that the Plan was reclassified to “critical and declining status”, as defined by the PPA and PBGC, for the plan year beginning January 1, 2015. A designation of “critical and declining status” implies that the Plan is expected to become insolvent in the next 20 years. In 2016, the Company received new notices that the Plan’s trustees adopted an updated Rehabilitation Plan effective January 1, 2016, and all annual notices through 2020 have continued to classify the Plan in the “critical and declining status” category.

The Company has been advised that its withdrawal liability would have been $99,300, $99,800 and $81,600 if it had withdrawn from the Plan during 2020, 2019 and 2018, respectively. Should the Company actually withdraw from the Plan at a future date, a withdrawal liability, which could be higher than the above discussed amounts, could be payable to the Plan.

The amended rehabilitation plan, which continues, requires that employer contributions include 5% compounded annual surcharge increases each year for an unspecified period of time beginning January 2013 (in addition to the 5% interim surcharge initiated in 2012) as well as certain plan benefit reductions. In fourth quarter 2020, the Plan Trustees advised the Company that the surcharges would no longer increase and therefore be “frozen” at the rates and amounts in effect as of December 31, 2020 provided that the local bargaining union and the Company executed a formal consenting agreement by March 31, 2021. Subsequent to December 31, 2020, the local bargaining union and the Company executed this agreement which resulted in the “freezing” of such surcharges as of December 31, 2020. The Company’s pension expense for this Plan for 2020, 2019 and 2018 was $2,866, $2,961 and $2,836, respectively. The aforementioned expense includes surcharges of $1,010, $948 and $811 in 2020, 2019 and 2018, respectively, as required under the plan of rehabilitation as amended.

The Company is currently unable to determine the ultimate outcome of the above discussed matter and therefore is unable to determine the effects on its consolidated financial statements, but the ultimate outcome or the effects of any modifications to the current rehabilitation plan could be material to its consolidated results of operations or cash flows in one or more future periods.

Deferred compensation:

The Company sponsors three deferred compensation plans for selected executives and other employees: (i) the Excess Benefit Plan, which restores retirement benefits lost due to IRS limitations on contributions to tax-qualified plans, (ii) the Supplemental Plan, which allows eligible employees to defer the receipt of eligible compensation until designated future dates and (iii) the Career Achievement Plan, which provides a deferred annual incentive award to selected executives. Participants in these plans earn a return on amounts due them based on several investment options, which mirror returns on underlying investments (primarily mutual funds). The Company economically hedges its obligations under the plans by investing in the actual underlying investments. These investments are classified as trading securities and are carried at fair value. At December 31, 2020 and 2019, these investments totaled $73,828 and $76,183, respectively. All gains and losses and related investment income from these investments, which are recorded in other income, net, are equally offset by corresponding increases and decreases in the Company’s deferred compensation liabilities.

Postretirement health care benefit plans:

The Company maintains a post-retirement health benefits plan for a group of “grandfathered” corporate employees. The plan as amended in 2013, generally limited future annual cost increases in health benefits to 3%, restricted this benefit to current employees and retirees with long-term service with the Company, and eliminated all post-retirement benefits for future employees effective April 1, 2014. Post-retirement benefits liabilities (as amended) were $13,487and $13,743 at December 31, 2020 and 2019, respectively.

Amounts recognized in accumulated other comprehensive loss (pre-tax) at December 31, 2020 are as follows:

Prior service credit	$	(1,840)
Net actuarial gain		(1,196)
Net amount recognized in accumulated other comprehensive loss	$	(3,036)

The changes in the accumulated postretirement benefit obligation at December 31, 2020 and 2019 consist of the following:

	December 31,
	2020		2019
Benefit obligation, beginning of year	$	13,743	$	12,451
Service cost		288		270
Interest cost		403		499
Actuarial (gain)/loss		(510)		922
Benefits paid		(437)		(399)
Benefit obligation, end of year	$	13,487	$	13,743

The actuarial (gain) in 2020 is attributable to updated participation rates and participant spending as well as mortality table projections partially offset by an actuarial loss due to the decrease in discount rate for the year ended December 31, 2020. The actuarial loss in 2019 is attributable to a decrease in the discount rate partially offset by a change in the mortality table for year ended December 31, 2019.

Net periodic postretirement benefit cost (income) included the following components:

	2020		2019		2018
Service cost—benefits attributed to service during the period	$	288	$	270	$	337
Interest cost on the accumulated postretirement benefit obligation		403		499		455
Net amortization		(1,349)		(1,522)		(1,324)
Net periodic postretirement benefit cost (income)	$	(658)	$	(753)	$	(532)

The Company estimates future benefit payments will be $544, $564, $590, $614 and $634 in 2021 through 2025, respectively, and a total of $3,417 in 2026 through 2030.

XML

COMMITMENTS

12 Months Ended

Dec. 31, 2020

COMMITMENTS

COMMITMENTS

NOTE 8—COMMITMENTS:

Lease expense aggregated $942, $1,032 and $793 in 2020, 2019 and 2018, respectively. Future operating lease commitments are as follows: $717, $137, and $4 in 2021, 2022 and 2023, respectively.

XML

SEGMENT AND GEOGRAPHIC INFORMATION

12 Months Ended

Dec. 31, 2020

SEGMENT AND GEOGRAPHIC INFORMATION

SEGMENT AND GEOGRAPHIC INFORMATION

NOTE 9—SEGMENT AND GEOGRAPHIC INFORMATION:

The Company operates as a single reportable segment encompassing the manufacture and sale of confectionery products. Its principal manufacturing operations are located in the United States and Canada, and its principal market is the United States. The Company also manufactures confectionery products in Mexico, primarily for sale in Mexico, and exports products to Canada and other countries worldwide.

The following geographic data includes net product sales summarized on the basis of the customer location and long-lived assets based on their physical location:

	2020		2019		2018
Net product sales:
United States	$	431,024	$	478,790	$	471,561
Canada, Mexico and Other		36,403		44,826		43,690
	$	467,427	$	523,616	$	515,251
Long-lived assets:
United States	$	155,664	$	155,428	$	151,770
Canada		28,765		30,412		31,843
Mexico and Other		2,899		2,615		2,488
	$	187,328	$	188,455	$	186,101

Sales revenues from Wal-Mart Stores, Inc. aggregated approximately 23.5%, 24.2%, and 24.1% of net product sales during the year ended December 31, 2020, 2019 and 2018, respectively. Sales revenues from Dollar Tree, Inc. (which includes Family Dollar which was acquired by Dollar Tree) aggregated approximately 11.7%, 11.3%, and 11.2% of net product sales during the year ended December 31, 2020, 2019 and 2018, respectively. Some of the aforementioned sales to Wal-Mart and Dollar Tree are sold to McLane Company, a large national grocery wholesaler, which services and delivers certain of the Company’s products to Wal-Mart, Dollar Tree and other retailers in the U.S.A. Net product sales revenues from McLane, which includes these Wal-Mart and Dollar Tree sales as well as sales and deliveries to other Company customers, were 22.1% in 2020 and 17.7% in 2019 and 17.4% in 2018. At December 31, 2020 and 2019, the Company’s three largest customers discussed above accounted for approximately 21% and 30% of total accounts receivable, respectively.

XML

FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2020

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

NOTE 10—FAIR VALUE MEASUREMENTS:

Current accounting guidance defines fair value as the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Guidance requires disclosure of the extent to which fair value is used to measure financial assets and liabilities, the inputs utilized in calculating valuation measurements, and the effect of the measurement of significant unobservable inputs on earnings, or changes in net assets, as of the measurement date. Guidance establishes a three-level valuation hierarchy based upon the transparency of inputs utilized in the measurement and valuation of financial assets or liabilities as of the measurement date. Level 1 inputs include quoted prices for identical instruments and are the most observable. Level 2 inputs include quoted prices for similar assets and observable inputs such as interest rates, foreign currency exchange rates, commodity rates and yield curves. Level 3 inputs are not observable in the market and include management’s own judgments about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs is reflected in the hierarchy assessment disclosed in the table below.

As of December 31, 2020 and 2019, the Company held certain financial assets that are required to be measured at fair value on a recurring basis. These include derivative hedging instruments related to the foreign currency forward contracts and purchase of certain raw materials, investments in trading securities and available for sale securities. The Company’s available for sale and trading securities principally consist of corporate bonds and variable rate demand notes.

The following tables present information about the Company’s financial assets and liabilities measured at fair value as of December 31, 2020 and 2019, and indicate the fair value hierarchy and the valuation techniques utilized by the Company to determine such fair value:

	Estimated Fair Value December 31, 2020
	Total		Input Levels Used
	Fair Value		Level 1		Level 2		Level 3
Cash and equivalents	$	166,841	$	166,841	$	—	$	—
Available for sale securities		188,282		3,149		185,133		—
Foreign currency forward contracts		778		—		778		—
Commodity futures contracts, net		941		941		—		—
Trading securities		73,828		61,431		12,397		—
Total assets measured at fair value	$	430,670	$	232,362	$	198,308	$	—

	Estimated Fair Value December 31, 2019
	Total		Input Levels Used
	Fair Value		Level 1		Level 2		Level 3
Cash and equivalents	$	138,960	$	138,960	$	—	$	—
Available for sale securities		177,292		3,588		173,704		—
Foreign currency forward contracts		14		—		14		—
Commodity futures contracts, net		121		121		—		—
Trading securities		76,183		48,260		27,923		—
Total assets measured at fair value	$	392,570	$	190,929	$	201,641	$	—

Available for sale securities which utilize Level 2 inputs consist primarily of corporate bonds and variable rate demand notes, which are valued based on quoted market prices or alternative pricing sources with reasonable levels of price transparency.

A summary of the aggregate fair value, gross unrealized gains, gross unrealized losses, realized losses and amortized cost basis of the Company’s investment portfolio by major security type is as follows:

	December 31, 2020
	Amortized		Fair		Unrealized				Realized
Available for Sale:	Cost		Value		Gains		Losses		Losses
Municipal bonds	$	556	$	561	$	5	$	—	$	—
Variable rate demand notes		1,300		1,300		—		—		—
Corporate bonds		174,835		177,229		2,394		—		—
Government securities		3,049		3,149		100		—		—
Certificates of deposit		5,915		6,043		128		—		—
	$	185,655	$	188,282	$	2,627	$	—	$	—

	December 31, 2019
	Amortized		Fair		Unrealized				Realized
Available for Sale:	Cost		Value		Gains		Losses		Losses
Municipal bonds	$	—	$	—	$	—	$	—	$	—
Variable rate demand notes		25,845		25,845		—		—		—
Corporate bonds		139,803		140,797		994		—		—
Government securities		3,503		3,588		85		—		—
Certificates of deposit		6,978		7,062		84		—		—
	$	176,129	$	177,292	$	1,163	$	—	$	—

The fair value of the Company’s industrial revenue development bonds at December 31, 2020 and 2019 were valued using Level 2 inputs which approximates the carrying value of $7,500 for both periods. Interest rates on these bonds reset weekly based on current market conditions.

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

12 Months Ended

Dec. 31, 2020

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

NOTE 11—DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES:

From time to time, the Company uses derivative instruments, including foreign currency forward contracts and commodity futures contracts to manage its exposures to foreign exchange and commodity prices. Commodity futures contracts are intended and effective as hedges of market price risks associated with the anticipated purchase of certain raw materials (primarily sugar). Foreign currency forward contracts are intended and effective as hedges of the Company’s exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of products manufactured in Canada and sold in the United States, and periodic equipment purchases from foreign suppliers denominated in a foreign currency. The Company does not engage in trading or other speculative use of derivative instruments.

The Company recognizes all derivative instruments as either assets or liabilities at fair value in the Consolidated Statements of Financial Position. Derivative assets are recorded in other receivables and derivative liabilities are recorded in accrued liabilities. The Company uses either hedge accounting or mark-to-market accounting for its derivative instruments. Derivatives that qualify for hedge accounting are designated as cash flow hedges by formally documenting the hedge relationships, including identification of the hedging instruments, the hedged items and other critical terms, as well as the Company’s risk management objectives and strategies for undertaking the hedge transaction.

Changes in the fair value of the Company’s cash flow hedges are recorded in accumulated other comprehensive loss, net of tax, and are reclassified to earnings in the periods in which earnings are affected by the hedged item. Substantially all amounts reported in accumulated other comprehensive loss for commodity derivatives are expected to be reclassified to cost of goods sold. Approximately $941 of this accumulated comprehensive gain is expected to be charged to earnings in 2021. Approximately $390 and $388 in accumulated other comprehensive gain for foreign currency derivatives is expected to be reclassified to other income, net in 2021 and 2022, respectively.

The following table summarizes the Company’s outstanding derivative contracts and their effects on its Consolidated Statements of Financial Position at December 31, 2020 and 2019:

	December 31, 2020
	Notional
	Amounts		Assets		Liabilities
Derivatives designated as hedging instruments:
Foreign currency forward contracts	$	6,391	$	778	$	—
Commodity futures contracts		4,010		941		—
Total derivatives			$	1,719	$	—

	December 31, 2019
	Notional
	Amounts		Assets		Liabilities
Derivatives designated as hedging instruments:
Foreign currency forward contracts	$	5,533	$	14	$	—
Commodity futures contracts		7,147		205		(84)
Total derivatives			$	219	$	(84)

The effects of derivative instruments on the Company’s Consolidated Statement of Earnings, Comprehensive Earnings and Retained Earnings for year ended December 31, 2019 and 2018 are as follows:

	For Year Ended December 31, 2020
					Gain (Loss)
			Gain (Loss)		on Amount Excluded
	Gain (Loss)		Reclassified from		from Effectiveness
	Recognized		Accumulated OCI		Testing Recognized
	in OCI		into Earnings		in Earnings
Foreign currency forward contracts	$	686	$	(78)	$	—
Commodity futures contracts		573		(247)		—
Total	$	1,259	$	(325)	$	—

	For Year Ended December 31, 2019
					Gain (Loss)
			Gain (Loss)		on Amount Excluded
	Gain (Loss)		Reclassified from		from Effectiveness
	Recognized		Accumulated OCI		Testing Recognized
	in OCI		into Earnings		in Earnings
Foreign currency forward contracts	$	359	$	(62)	$	—
Commodity futures contracts		92		(615)		—
Total	$	451	$	(677)	$	—

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS

12 Months Ended

Dec. 31, 2020

ACCUMULATED OTHER COMPREHENSIVE LOSS

ACCUMULATED OTHER COMPREHENSIVE LOSS

NOTE 12—ACCUMULATED OTHER COMPREHENSIVE LOSS:

The following table sets forth information with respect to accumulated other comprehensive earnings (loss):

											Accumulated
	Foreign				Foreign				Postretirement		Other
	Currency				Currency		Commodity		and Pension		Comprehensive
	Translation		Investments		Derivatives		Derivatives		Benefits		Earnings (Loss)
Balance at December 31, 2018	$	(24,159)	$	(1,516)	$	(309)	$	(444)	$	4,206	$	(22,222)
Other comprehensive earnings (loss) before reclassifications		791		2,372		272		70		(914)		2,591
Reclassifications from accumulated other comprehensive loss		—		26		47		466		(1,153)		(614)
Other comprehensive earnings (loss) net of tax		791		2,398		319		536		(2,067)		1,977
Balance at December 31, 2019	$	(23,368)	$	882	$	10	$	92	$	2,139	$	(20,245)
Other comprehensive earnings (loss) before reclassifications		(1,213)		1,110		520		434		356		1,207
Reclassifications from accumulated other comprehensive loss		—		—		59		187		(1,023)		(777)
Other comprehensive earnings (loss) net of tax		(1,213)		1,110		579		621		(667)		430
Balance at December 31, 2020	$	(24,581)	$	1,992	$	589	$	713	$	1,472	$	(19,815)

The amounts reclassified from accumulated other comprehensive income (loss) consisted of the following:

Details about Accumulated Other	Year to Date Ended
Comprehensive Income Components	December 31, 2020		December 31, 2019		Location of (Gain) Loss Recognized in Earnings
Investments	$	-	$	34	Other income, net
Foreign currency derivatives		78		62	Other income, net
Commodity derivatives		247		615	Product cost of goods sold
Postretirement and pension benefits		(1,350)		(1,522)	Other income, net
Total before tax		(1,025)		(811)
Tax expense (benefit)		248		197
Net of tax	$	(777)	$	(614)

XML

GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Dec. 31, 2020

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

NOTE 13—GOODWILL AND INTANGIBLE ASSETS:

All of the Company’s intangible indefinite-lived assets are trademarks.

The changes in the carrying amount of trademarks for 2020 and 2019 were as follows:

	2020		2019
Original cost	$	193,767	$	193,767
Accumulated impairment losses as of January 1		(18,743)		(18,743)
Balance at January 1	$	175,024	$	175,024
Current year impairment losses		—		—
Balance at December 31	$	175,024	$	175,024
Accumulated impairment losses as of December 31	$	(18,743)	$	(18,743)

The fair value of indefinite-lived intangible assets was primarily assessed using the present value of estimated future cash flows and relief-from-royalty method.

The Company has no accumulated impairment losses of goodwill.

XML

LEASES

12 Months Ended

Dec. 31, 2020

LEASES

LEASES

Note 14 — LEASES:  

The Company leases certain buildings, land and equipment that are classified as operating leases. These leases have remaining lease terms of up to approximately 3 years. In the fourth quarter and twelve months of 2020 and 2019, operating lease cost and cash paid for operating lease liabilities totaled $271 and $258, respectively, and $1,023 and $1,004, respectively, which is classified in cash flows from operating activities. As of December 31, 2020 and 2019, operating lease right-of-use assets and operating lease liabilities were both $858 and $1,580, respectively. The weighted-average remaining lease term related to these operating leases was approximately 0.7 years and 1.6 years as of December 31, 2020 and 2019, respectively. The weighted-average discount rate related to the Company’s operating leases was 3.0% and 3.1% as of December 31, 2020 and 2019, respectively. Maturities of operating lease liabilities at December 31, 2020 are as follows: $717 in 2021, $137 in 2022, and $4 in 2023.

The Company, as lessor, rents certain commercial real estate to third party lessees. The December 31, 2020 and 2019 cost related to these leased properties was $51,426 and $36,378, respectively, and the accumulated depreciation related to these leased properties was $14,784 and $10,252, respectively. Terms of certain such leases, including renewal options, may be extended for up to approximately sixty years, many of which provide for periodic adjustment of rent payments based on changes in consumer or other price indices. The Company recognizes lease income on a straight-line basis over the lease term. Lease income in fourth quarter and twelve months 2020 and 2019 was $863 and $718, respectively, and $3,191 and $2,951, respectively, and is classified in cash flows from operating activities.

XML

QUARTERLY FINANCIAL DATA (UNAUDITED)

12 Months Ended

Dec. 31, 2020

QUARTERLY FINANCIAL DATA (UNAUDITED)

QUARTERLY FINANCIAL DATA (UNAUDITED)

NOTE 15—QUARTERLY FINANCIAL DATA (UNAUDITED):

	(Thousands of dollars except per share data)
	First		Second		Third		Fourth		Year
2020
Net product sales	$	102,803	$	79,796	$	156,962	$	127,866	$	467,427
Product gross margin		36,360		29,417		57,775		44,165		167,717
Net earnings attributable to Tootsie Roll Industries, Inc.		11,982		7,388		24,673		14,952		58,995
Net earnings attributable to Tootsie Roll Industries, Inc. per share		0.18		0.11		0.37		0.23		0.89
2019
Net product sales	$	101,019	$	106,021	$	181,913	$	134,663	$	523,616
Product gross margin		36,163		40,076		69,046		49,229		194,514
Net earnings attributable to Tootsie Roll Industries, Inc.		8,955		11,556		29,854		14,555		64,920
Net earnings attributable to Tootsie Roll Industries, Inc. per share		0.13		0.17		0.44		0.22		0.96

Net earnings per share is based upon average outstanding shares as adjusted for 3%stock dividends issued during the second quarter of each year as discussed above. The sum of the quarterly per share amounts may not equal annual amounts due to rounding.

XML

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Dec. 31, 2020

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS (in thousands)

DECEMBER 31, 2020, 2019 and 2018

			Additions
			(reductions)
	Balance at		charged				Balance at
	beginning		(credited) to				End of
Description	of year		expense		Deductions(1)		Year
2020:
Reserve for bad debts	$	1,337	$	123	$	352	$	1,108
Reserve for cash discounts		612		8,504		8,530		586
Deferred tax asset valuation		4,985		608		—		5,593
	$	6,934	$	9,235	$	8,882	$	7,287
2019:
Reserve for bad debts	$	1,128	$	676	$	467	$	1,337
Reserve for cash discounts		692		9,482		9,562		612
Deferred tax asset valuation		3,892		1,093		—		4,985
	$	5,712	$	11,251	$	10,029	$	6,934
2018:
Reserve for bad debts	$	1,197	$	38	$	107	$	1,128
Reserve for cash discounts		724		9,122		9,154		692
Deferred tax asset valuation		3,269		623		—		3,892
	$	5,190	$	9,783	$	9,261	$	5,712

(1) Deductions against reserve for bad debts consist of accounts receivable written off net of recoveries and exchange rate movements. Deductions against reserve for cash discounts consist of allowances to customers.

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2020

SIGNIFICANT ACCOUNTING POLICIES

Basis of consolidation

Basis of consolidation:

The consolidated financial statements include the accounts of Tootsie Roll Industries, Inc. and its wholly-owned and majority-owned subsidiaries (the Company), which are primarily engaged in the manufacture and sales of candy products. Non-controlling interests relating to majority-owned subsidiaries are reflected in the consolidated financial statements and all significant intercompany transactions have been eliminated. Certain amounts previously reported have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net earnings.

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue recognition

Revenue recognition:

The Company’s revenues, primarily net product sales, principally result from the sale of goods, reflect the consideration to which the Company expects to be entitled, generally based on customer purchase orders. The Company records revenue based on a five-step model in accordance with Accounting Standards Codification ("ASC") Topic 606 which became effective January, 1, 2018. Adjustments for estimated customer cash discounts upon payment, discounts for price adjustments, product returns, allowances, and certain advertising and promotional costs, including consumer coupons, are variable consideration and are recorded as a reduction of product sales revenue in the same period the related product sales are recorded. Such estimates are calculated using historical averages adjusted for any expected changes due to current business conditions and experience. A net product sale is recorded when the Company delivers the product to the customer, or in certain instances, the customer picks up the goods at the Company’s distribution centers, and thereby obtains control of such product. Amounts billed and due from our customers are classified as accounts receivables trade on the balance sheet and require payment on a short-term basis. Accounts receivable are unsecured. Shipping and handling costs of $42,593, $49,288, and $49,527 in 2020, 2019 and 2018, respectively, are included in selling, marketing and administrative expenses. A minor amount of royalty income (less than 0.2% of our consolidated net sales) is also recognized from sales-based licensing arrangements, pursuant to which revenue is recognized as the third-party licensee sales occur. Rental income (less than 1% of our consolidated net sales) is not considered revenue from contracts from customers.

Leases

Leases:

The Company identifies leases by evaluating our contracts to determine if the contract conveys the right to use an identified asset for a stated period of time in exchange for consideration. The Company considers whether it can control the underlying asset and has the right to obtain substantially all of the economic benefits or outputs from the asset. Leases with terms greater than 12 months are classified as either operating or finance leases at the commencement date.  For these leases, the Company capitalized the present value of the minimum lease payments over the lease terms as a right-of-use asset with an offsetting lease liability. The discount rate used to calculate the present value of the minimum lease payments is typically the Company’s incremental borrowing rate, as the rate implicit in the lease is generally not known or determinable. The lease term includes any noncancelable period for which the Company has the right to use the asset. Currently, all capitalized leases are classified as operating leases and the Company records lease expense on a straight-line basis over the term of the lease.

Cash and cash equivalents

Cash and cash equivalents:

The Company considers short-term debt securities with an original maturity of three months or less to be cash equivalents. Substantially all cash and cash equivalents are held at a major U.S. money center bank or its foreign branches (Bank of America), or its investment broker affiliate (Merrill Lynch). The Company also holds certificates of deposit (CDs) of U.S. banks selected by this investment broker based on their financial ratings; substantially all such CDs are invested in separate individual banks which are generally not in excess of the Federal Deposit Insurance Corporation (FDIC) limit of $250 per bank. The cash in the Company's U.S. banks (primarily Bank of America) is not fully insured by the FDIC due to the statutory limit of $250. The Company had approximately $8,303 and $9,415 of cash in foreign banks, principally foreign branches of a U.S. bank (Bank of America), at December 31, 2020 and 2019, respectively. The Company's cash in its foreign bank accounts is also not fully insured.

Investments

Investments:

Investments consist of various marketable securities with maturities of generally up to three years, and variable rate demand notes with interest rates that are generally reset weekly and the security can be “put” back and sold weekly. The Company classifies debt and equity securities as either available for sale or trading. Available for sale debt securities are not actively traded by the Company and are carried at fair value. The Company follows current fair value measurement guidance and unrealized gains and losses on these securities are excluded from earnings and are reported as a separate component of shareholders’ equity, net of applicable taxes, until realized or other-than-temporarily impaired. Trading securities related to deferred compensation arrangements are carried at fair value with gains or losses included in other income, net. The Company invests in trading securities to economically hedge changes in its deferred compensation liabilities.

The Company regularly reviews its investments to determine whether a decline in fair value below the cost basis is other-than-temporary. If the decline in fair value is judged to be other-than-temporary, the cost basis of the security is written down to fair value and the amount of the write-down is included in other income, net. Further information regarding the fair value of the Company’s investments is included in Note 10 of the Company’s Notes to Consolidated Financial Statements.

Derivative instruments and hedging activities

Derivative instruments and hedging activities:

Authoritative guidance requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of derivative instruments and related gains and losses, and disclosures about credit-risk-related contingent features in derivative agreements.

From time to time, the Company enters into commodity futures and foreign currency forward contracts. Commodity futures are intended and are effective as hedges of market price risks associated with the anticipated purchase of certain raw materials (primarily sugar). Foreign currency forward contracts are intended and are effective as hedges of the Company’s exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of products manufactured in Canada and sold in the United States, and periodic equipment purchases from foreign suppliers denominated in a foreign currency. The Company does not engage in trading or other speculative use of derivative instruments. Further information regarding derivative instruments and hedging activities is included in Note 11 of the Company’s Notes to Consolidated Financial Statements.

Inventories

Inventories:

Inventories are stated at lower of cost or net realizable value. The cost of substantially all of the Company’s inventories ($54,935 and $55,409 at December 31, 2020 and 2019, respectively) has been determined by the last-in, first-out (LIFO) method. The excess of current cost over LIFO cost of inventories approximates $19,339 and $19,174 at December 31, 2020 and 2019, respectively. The cost of certain foreign inventories ($4,644 and $3,679 at December 31, 2020 and 2019, respectively) has been determined by the first-in, first-out (FIFO) method. Rebates, discounts and other cash consideration received from vendors related to inventory purchases is reflected as a reduction in the cost of the related inventory item, and is, therefore, reflected in cost of sales when the related inventory item is sold.

Property, plant and equipment

Property, plant and equipment:

Depreciation is computed for financial reporting purposes by use of the straight-line method based on useful lives of 20 to 40 years for buildings and 5 to 20 years for machinery and equipment. Depreciation expense was $18,184, $18,779 and $18,669 in 2020, 2019 and 2018, respectively.

Carrying value of long-lived assets

Carrying value of long-lived assets:

The Company reviews long-lived assets to determine if there are events or circumstances indicating that the amount of the asset reflected in the Company’s balance sheet may not be recoverable. When such indicators are present, the Company compares the carrying value of the long-lived asset, or asset group, to the future undiscounted cash flows of the underlying assets to determine if impairment exists. If applicable, an impairment charge would be recorded to write down the carrying value to its fair value. The determination of fair value involves the use of estimates of future cash flows that involve considerable management judgment and are based upon assumptions about expected future operating performance. The actual cash flows could differ from management’s estimates due to changes in business conditions, operating performance, and economic conditions. In fourth quarter 2019 and 2018, the Company recorded charges of $377 and $1,126, respectively, relating to the impairment of assets of a foreign subsidiary which is included in selling, marketing and administrative expense. Except for the aforementioned, no impairment charges of long-lived assets were recorded by the Company during 2020, 2019 or 2018.

Postretirement health care benefits

Postretirement health care benefits:

The Company provides certain postretirement health care benefits to a group of “grandfathered” corporate office and management employees. The cost of these postretirement benefits is accrued during the employees’ working careers. See Note 7 of the Company’s Notes to Consolidated Financial Statements for additional information. The Company also provides split dollar life benefits to an executive officer. The Company records an asset equal to the cumulative insurance premiums paid that will be recovered upon the death of the covered executive officer or earlier under the terms of the plan. During 2020, the Company received $23,527 of previously paid premiums on these insurance policies which was recorded as a reduction to this asset. No premiums were paid in 2020, 2019 or 2018.

Goodwill and indefinite-lived intangible assets

Goodwill and indefinite-lived intangible assets:

In accordance with authoritative guidance, goodwill and intangible assets with indefinite lives are not amortized, but rather reviewed and tested for impairment at least annually unless certain interim triggering events or circumstances require more frequent testing. All trademarks have been assessed by management to have indefinite lives because they are expected to generate cash flows indefinitely. Management believes that all assumptions used for the impairment review and testing are consistent with those utilized by market participants performing similar valuations. No impairments of intangibles, including trademarks and goodwill, were recorded in 2020, 2019 or 2018.

Current accounting guidance provides entities an option of performing a qualitative assessment (a "step-zero" test) before performing a quantitative analysis. If the entity determines, on the basis of certain qualitative factors, that it is more-likely-than-not that the intangibles (goodwill and certain trademarks) are not impaired, the entity would not need to proceed to the two step impairment testing process (quantitative analysis) as prescribed in the guidance. During fourth quarter 2020 and 2019, the Company performed a “step zero” test of its goodwill and certain trademarks, and concluded that there was no impairment based on this guidance. For the fair value assessment of certain trademarks where the “step-zero” analysis was not considered appropriate, impairment testing was performed in fourth quarter 2020 and 2019 using discounted cash flows and estimated royalty rates. For these trademarks, holding all other assumptions constant at the test date in 2020, a 100 basis point increase in the discount rate or a 100 basis point decrease in the royalty rate would reduce the fair value of these trademarks by approximately 18% and 10%, respectively. Individually, a 100 point increase in the discount rate or a 100 point decrease in the royalty rate would not result in a potential impairment as of December 31, 2020. 

Income taxes

Income taxes:

Deferred income taxes are recorded and recognized for future tax effects of temporary differences between financial and income tax reporting. The Company records valuation allowances in situations where the realization of deferred tax assets is not more-likely-than-not. The Company periodically reviews assumptions and estimates of the Company’s probable tax obligations and effects on its liability for uncertain tax positions, using informed judgment which may include the use of third-party consultants, advisors and legal counsel, as well as historical experience.

Further information regarding U.S. tax reform (U.S. Tax Cuts and Jobs Act) and other income tax matters are included in Note 4 of the Company’s Notes to Consolidated Financial Statements.

Foreign currency translation

Foreign currency translation:

The U.S. dollar is used as the functional currency where a substantial portion of the subsidiary’s business is indexed to the U.S. dollar or where its manufactured products are principally sold in the U.S. All other foreign subsidiaries use the local currency as their functional currency. Where the U.S. dollar is used as the functional currency, foreign currency remeasurements are recorded as a charge or credit to other income, net in the statement of earnings. Where the foreign local currency is used as the functional currency, translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss).

Restricted cash

Restricted cash:

Restricted cash comprises certain cash deposits of the Company’s majority-owned Spanish subsidiary with international banks that are pledged as collateral for letters of credit and bank borrowings.

VEBA trust

VEBA trust:

The Company maintains a VEBA trust managed and controlled by the Company, to fund the estimated future costs of certain employee health, welfare and other benefits. The Company made a $20,024 contribution to the VEBA trust in 2017 but no contributions were made to the trust in 2020, 2019 or 2018. The Company will be using the VEBA trust funds to pay the actual cost of such benefits through 2022. At December 31, 2020 and 2019, the VEBA trust held $8,272 and $12,085, respectively, of aggregate cash and cash equivalents. This asset value is included in prepaid expenses and long-term other assets in the Company’s Consolidated Statement of Financial Position. These assets are categorized as Level 1 within the fair value hierarchy.

Bank loans

Bank loans:

Bank loans consist of short term (less than 120 days) borrowings by the Company’s Spanish subsidiary that are held by international banks. The weighted-average interest rate as of December 31, 2020 and 2019 was 3.0% and 3.0%, respectively.

Comprehensive earnings

Comprehensive earnings:

Comprehensive earnings include net earnings, foreign currency translation adjustments and unrealized gains/losses on commodity and/or foreign currency hedging contracts, available for sale securities and certain postretirement benefit obligations.

Earnings per share

Earnings per share:

A dual presentation of basic and diluted earnings per share is not required due to the lack of potentially dilutive securities under the Company’s simple capital structure. Therefore, all earnings per share amounts represent basic earnings per share.

The Class B common stock has essentially the same rights as common stock, except that each share of Class B common stock has ten votes per share (compared to one vote per share of common stock), is not traded on any exchange, is restricted as to transfer and is convertible on a share-for-share basis, at any time and at no cost to the holders, into shares of common stock which are traded on the New York Stock Exchange.

Use of estimates

Use of estimates:

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, allowances and incentives, product liabilities, assets recorded at fair value, income taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.

Recent accounting pronouncements

Recently adopted accounting pronouncements:

In June 2016, the FASB issued ASU No. 2016-13, (ASC Topic 326) which replaces the current incurred loss impairment method with a new method that reflects expected credit losses. Subsequent to the issuance of ASC Topic 326, the FASB clarified and amended guidance through several Accounting Standard Updates; hereinafter the collection of credit loss guidance is referred to as “ASC Topic 326”. Under this new guidance an entity would recognize an impairment allowance equal to its current estimate of credit losses on financial assets measured at amortized cost. The Company adopted ASU 2016-13 and related amendments (ASC Topic 326) on January 1, 2020. The adoption of this ASC did not have a material impact on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU 2018-14, (ASC Subtopic 715-20) which expands disclosure requirements for employer sponsored defined benefit pension and other retirement plans. The Company adopted ASU 2018-14 on January 1, 2020 because this ASU affects the Company’s post-retirement health benefits plan (see Note 7). The adoption of the new accounting rules did not have a material impact on the Company’s consolidated financial statements.

Recently issued accounting pronouncements - not yet adopted:

In December 2019, the FASB issued ASU No. 2019-12 which is designed to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. ASU No. 2019-12 is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years; this ASU allows for early adoption in any interim period after issuance of the update. The Company is currently assessing the impact this ASU will have on its consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04 which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is currently evaluating our contracts and the optional expedients provided by the new standard.

XML

ACCRUED LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2020

ACCRUED LIABILITIES

Schedule of accrued liabilities

	December 31,
	2020		2019
Compensation	$	8,135	$	10,575
Other employee benefits		8,841		7,509
Taxes, other than income		3,169		3,170
Advertising and promotions		18,455		14,421
Other		6,499		5,936
	$	45,099	$	41,611

XML

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2020

INCOME TAXES

Schedule of domestic and foreign components of pretax income

	2020		2019		2018
Domestic	$	69,211	$	74,978	$	66,253
Foreign		7,051		10,426		6,953
	$	76,262	$	85,404	$	73,206

Schedule of components of provision of income taxes

	2020		2019		2018
Current:
Federal	$	14,831	$	15,133	$	12,414
Foreign		1,029		—		—
State		1,763		2,942		1,421
		17,623		18,075		13,835
Deferred:
Federal		(1,006)		(543)		(577)
Foreign		1,316		2,422		2,685
State		(645)		611		458
		(335)		2,490		2,566
	$	17,288	$	20,565	$	16,401

Schedule of significant components of net deferred tax liability

	December 31,
	2020		2019
Deferred tax assets:
Accrued customer promotions	$	1,506	$	198
Deferred compensation		18,501		19,432
Postretirement benefits		3,355		3,439
Other accrued expenses		3,078		3,979
Foreign subsidiary tax loss carry forward		4,508		4,584
Outside basis difference in foreign subsidiary		365		365
Deductible state tax depreciation		471		512
Tax credit carry forward		3,288		3,059
		35,072		35,568
Valuation allowances		(5,593)		(4,985)
Total deferred tax assets	$	29,479	$	30,583
Deferred tax liabilities:
Depreciation	$	22,192	$	23,375
Deductible goodwill and trademarks		37,348		36,591
Accrued export company commissions		4,508		4,367
Employee benefit plans		1,767		2,700
Inventory reserves		1,994		2,526
Prepaid insurance		569		710
Unrealized capital gains		2,515		1,362
Deferred foreign exchange gain		179		260
Deferred gain on sale of real estate		5,269		5,298
Total deferred tax liabilities	$	76,341	$	77,189
Net deferred tax liability	$	46,862	$	46,606

Schedule of reconciliation of statutory and effective income tax rate

	2020		2019		2018
U.S. statutory rate	21.0	%	21.0	%	21.0	%
State income taxes, net	2.1		2.2		2.2
Exempt municipal bond interest	—		(0.1)		(0.1)
Foreign income tax rates	1.0		(0.1)		0.5
Income tax credits and adjustments	(1.4)		0.5		—
Adjustment of deferred tax balances	(0.2)		—		0.1
Reserve for uncertain tax benefits	(0.8)		0.4		(1.0)
Other, net	1.0		0.2		(0.3)
Effective income tax rate	22.7	%	24.1	%	22.4	%

Schedule of reconciliation of beginning and ending balances of total amounts of unrecognized tax benefits

	2020		2019		2018
Unrecognized tax benefits at January 1	$	3,678	$	3,339	$	4,342
Increases in tax positions for the current year		377		1,164		448
Reductions in tax positions for lapse of statute of limitations		(501)		(576)		(751)
Reductions in tax positions for settlements and payments		(308)		(249)		—
Increases (decreases) in prior period unrecognized tax benefits due to change in judgment		(235)		—		(700)
Unrecognized tax benefits at December 31	$	3,011	$	3,678	$	3,339

XML

SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE (Tables)

12 Months Ended

Dec. 31, 2020

SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE

Schedule of changes in share capital and capital in excess of par value

										Capital in
				Class B						Excess
	Common Stock			Common Stock			Treasury Stock			of Par
	Shares	Amount		Shares	Amount		Shares	Amount		Value
	(000’s)			(000’s)			(000’s)
Balance at January 1, 2018	37,960	$	26,361	24,891	$	17,285	85	$	(1,992)	$	656,752
Issuance of 3% stock dividend	1,125		781	746		519	3		—		58,688
Conversion of Class B common shares to common shares	53		37	(53)		(37)	—		—		—
Purchase and retirement of common shares	(594)		(412)	—		—	—		—		(18,905)
Balance at December 31, 2018	38,544		26,767	25,584		17,767	88		(1,992)		696,535
Issuance of 3% stock dividend	1,150		798	768		532	2		—		32,999
Conversion of Class B common shares to common shares	65		45	(65)		(45)	—		—		—
Purchase and retirement of common shares	(923)		(641)	—		—	—		—		(33,475)
Balance at December 31, 2019	38,836		26,969	26,287		18,254	90		(1,992)		696,059
Issuance of 3% stock dividend	1,157		804	787		547	3		—		42,244
Conversion of Class B common shares to common shares	62		43	(62)		(43)	—		—		—
Purchase and retirement of common shares	(982)		(682)	—		—	—		—		(31,373)
Balance at December 31, 2020	39,073	$	27,134	27,012	$	18,758	93	$	(1,992)	$	706,930

Schedule of shares purchased and retired

	Total Number of Shares
Year	Purchased (000’s)	Average Price Paid Per Share
2020	982	$	32.59
2019	923	$	36.93
2018	594	$	32.48

XML

OTHER INCOME, NET (Tables)

12 Months Ended

Dec. 31, 2020

OTHER INCOME, NET

Schedule of other income, net

	2020		2019		2018
Interest and dividend income	$	4,005	$	4,423	$	3,535
Gains (losses) on trading securities relating to deferred compensation plans		12,519		11,292		(1,103)
Interest expense		(164)		(220)		(181)
Foreign exchange gains (losses)		534		(533)		(659)
Capital gains (losses)		(6)		22		(11)
Miscellaneous, net		1,130		1,206		1,143
	$	18,018	$	16,190	$	2,724

XML

EMPLOYEE BENEFIT PLANS (Tables)

12 Months Ended

Dec. 31, 2020

EMPLOYEE BENEFIT PLANS

Schedule of amounts recognized in accumulated other comprehensive loss (pre-tax)

Prior service credit	$	(1,840)
Net actuarial gain		(1,196)
Net amount recognized in accumulated other comprehensive loss	$	(3,036)

Schedule of changes in accumulated postretirement benefit obligation

	December 31,
	2020		2019
Benefit obligation, beginning of year	$	13,743	$	12,451
Service cost		288		270
Interest cost		403		499
Actuarial (gain)/loss		(510)		922
Benefits paid		(437)		(399)
Benefit obligation, end of year	$	13,487	$	13,743

The actuarial (gain) in 2020 is attributable to updated participation rates and participant spending as well as mortality table projections partially offset by an actuarial loss due to the decrease in discount rate for the year ended December 31, 2020. The actuarial loss in 2019 is attributable to a decrease in the discount rate partially offset by a change in the mortality table for year ended December 31, 2019.

Schedule of net periodic postretirement benefit cost (income)

	2020		2019		2018
Service cost—benefits attributed to service during the period	$	288	$	270	$	337
Interest cost on the accumulated postretirement benefit obligation		403		499		455
Net amortization		(1,349)		(1,522)		(1,324)
Net periodic postretirement benefit cost (income)	$	(658)	$	(753)	$	(532)

XML

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2020

SEGMENT AND GEOGRAPHIC INFORMATION

Schedule of geographic data

	2020		2019		2018
Net product sales:
United States	$	431,024	$	478,790	$	471,561
Canada, Mexico and Other		36,403		44,826		43,690
	$	467,427	$	523,616	$	515,251
Long-lived assets:
United States	$	155,664	$	155,428	$	151,770
Canada		28,765		30,412		31,843
Mexico and Other		2,899		2,615		2,488
	$	187,328	$	188,455	$	186,101

XML

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2020

FAIR VALUE MEASUREMENTS

Schedule of financial assets and liabilities measured at fair value

	Estimated Fair Value December 31, 2020
	Total		Input Levels Used
	Fair Value		Level 1		Level 2		Level 3
Cash and equivalents	$	166,841	$	166,841	$	—	$	—
Available for sale securities		188,282		3,149		185,133		—
Foreign currency forward contracts		778		—		778		—
Commodity futures contracts, net		941		941		—		—
Trading securities		73,828		61,431		12,397		—
Total assets measured at fair value	$	430,670	$	232,362	$	198,308	$	—

	Estimated Fair Value December 31, 2019
	Total		Input Levels Used
	Fair Value		Level 1		Level 2		Level 3
Cash and equivalents	$	138,960	$	138,960	$	—	$	—
Available for sale securities		177,292		3,588		173,704		—
Foreign currency forward contracts		14		—		14		—
Commodity futures contracts, net		121		121		—		—
Trading securities		76,183		48,260		27,923		—
Total assets measured at fair value	$	392,570	$	190,929	$	201,641	$	—

Summary of the aggregate fair value, gross unrealized gains, gross unrealized losses, realized losses and amortized cost basis of investment portfolio by major security type

	December 31, 2020
	Amortized		Fair		Unrealized				Realized
Available for Sale:	Cost		Value		Gains		Losses		Losses
Municipal bonds	$	556	$	561	$	5	$	—	$	—
Variable rate demand notes		1,300		1,300		—		—		—
Corporate bonds		174,835		177,229		2,394		—		—
Government securities		3,049		3,149		100		—		—
Certificates of deposit		5,915		6,043		128		—		—
	$	185,655	$	188,282	$	2,627	$	—	$	—

	December 31, 2019
	Amortized		Fair		Unrealized				Realized
Available for Sale:	Cost		Value		Gains		Losses		Losses
Municipal bonds	$	—	$	—	$	—	$	—	$	—
Variable rate demand notes		25,845		25,845		—		—		—
Corporate bonds		139,803		140,797		994		—		—
Government securities		3,503		3,588		85		—		—
Certificates of deposit		6,978		7,062		84		—		—
	$	176,129	$	177,292	$	1,163	$	—	$	—

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

12 Months Ended

Dec. 31, 2020

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

Summary of the Company's outstanding derivative contracts and their effects on the Consolidated Statements of Financial Position

	December 31, 2020
	Notional
	Amounts		Assets		Liabilities
Derivatives designated as hedging instruments:
Foreign currency forward contracts	$	6,391	$	778	$	—
Commodity futures contracts		4,010		941		—
Total derivatives			$	1,719	$	—

	December 31, 2019
	Notional
	Amounts		Assets		Liabilities
Derivatives designated as hedging instruments:
Foreign currency forward contracts	$	5,533	$	14	$	—
Commodity futures contracts		7,147		205		(84)
Total derivatives			$	219	$	(84)

Effects of derivative instruments on the Consolidated Statement of Earnings and Retained Earnings, and the Condensed Consolidated Statement of Comprehensive Earnings

	For Year Ended December 31, 2020
					Gain (Loss)
			Gain (Loss)		on Amount Excluded
	Gain (Loss)		Reclassified from		from Effectiveness
	Recognized		Accumulated OCI		Testing Recognized
	in OCI		into Earnings		in Earnings
Foreign currency forward contracts	$	686	$	(78)	$	—
Commodity futures contracts		573		(247)		—
Total	$	1,259	$	(325)	$	—

	For Year Ended December 31, 2019
					Gain (Loss)
			Gain (Loss)		on Amount Excluded
	Gain (Loss)		Reclassified from		from Effectiveness
	Recognized		Accumulated OCI		Testing Recognized
	in OCI		into Earnings		in Earnings
Foreign currency forward contracts	$	359	$	(62)	$	—
Commodity futures contracts		92		(615)		—
Total	$	451	$	(677)	$	—

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

12 Months Ended

Dec. 31, 2020

ACCUMULATED OTHER COMPREHENSIVE LOSS

Schedule of accumulated other comprehensive earnings (loss):

											Accumulated
	Foreign				Foreign				Postretirement		Other
	Currency				Currency		Commodity		and Pension		Comprehensive
	Translation		Investments		Derivatives		Derivatives		Benefits		Earnings (Loss)
Balance at December 31, 2018	$	(24,159)	$	(1,516)	$	(309)	$	(444)	$	4,206	$	(22,222)
Other comprehensive earnings (loss) before reclassifications		791		2,372		272		70		(914)		2,591
Reclassifications from accumulated other comprehensive loss		—		26		47		466		(1,153)		(614)
Other comprehensive earnings (loss) net of tax		791		2,398		319		536		(2,067)		1,977
Balance at December 31, 2019	$	(23,368)	$	882	$	10	$	92	$	2,139	$	(20,245)
Other comprehensive earnings (loss) before reclassifications		(1,213)		1,110		520		434		356		1,207
Reclassifications from accumulated other comprehensive loss		—		—		59		187		(1,023)		(777)
Other comprehensive earnings (loss) net of tax		(1,213)		1,110		579		621		(667)		430
Balance at December 31, 2020	$	(24,581)	$	1,992	$	589	$	713	$	1,472	$	(19,815)

Amount reclassified from accumulated other comprehensive income (loss)

Details about Accumulated Other	Year to Date Ended
Comprehensive Income Components	December 31, 2020		December 31, 2019		Location of (Gain) Loss Recognized in Earnings
Investments	$	-	$	34	Other income, net
Foreign currency derivatives		78		62	Other income, net
Commodity derivatives		247		615	Product cost of goods sold
Postretirement and pension benefits		(1,350)		(1,522)	Other income, net
Total before tax		(1,025)		(811)
Tax expense (benefit)		248		197
Net of tax	$	(777)	$	(614)

XML

GOODWILL AND INTANGIBLE ASSETS (Tables)

12 Months Ended

Dec. 31, 2020

GOODWILL AND INTANGIBLE ASSETS

Schedule of changes in carrying amount of trademarks

	2020		2019
Original cost	$	193,767	$	193,767
Accumulated impairment losses as of January 1		(18,743)		(18,743)
Balance at January 1	$	175,024	$	175,024
Current year impairment losses		—		—
Balance at December 31	$	175,024	$	175,024
Accumulated impairment losses as of December 31	$	(18,743)	$	(18,743)

XML

QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)

12 Months Ended

Dec. 31, 2020

QUARTERLY FINANCIAL DATA (UNAUDITED)

Schedule of quarterly results

	(Thousands of dollars except per share data)
	First		Second		Third		Fourth		Year
2020
Net product sales	$	102,803	$	79,796	$	156,962	$	127,866	$	467,427
Product gross margin		36,360		29,417		57,775		44,165		167,717
Net earnings attributable to Tootsie Roll Industries, Inc.		11,982		7,388		24,673		14,952		58,995
Net earnings attributable to Tootsie Roll Industries, Inc. per share		0.18		0.11		0.37		0.23		0.89
2019
Net product sales	$	101,019	$	106,021	$	181,913	$	134,663	$	523,616
Product gross margin		36,163		40,076		69,046		49,229		194,514
Net earnings attributable to Tootsie Roll Industries, Inc.		8,955		11,556		29,854		14,555		64,920
Net earnings attributable to Tootsie Roll Industries, Inc. per share		0.13		0.17		0.44		0.22		0.96

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Concentration of Risk
Selling, marketing and administrative expenses	$ 112,117	$ 127,802	$ 117,691
Cash and cash equivalents:
Cash and cash equivalents	$ 166,841	138,960
Investments:
Marketable securities, maximum maturity period	3 years
Inventories:
Inventories at cost, last-in, first-out (LIFO) method	$ 54,935	55,409
Excess of current cost over LIFO cost of inventories	19,339	19,174
Foreign inventories at cost, first-in, first-out (FIFO) method	4,644	3,679
Foreign Banks
Cash and cash equivalents:
Cash and cash equivalents	$ 8,303	9,415
Royalty | Maximum
Concentration of Risk
Revenues (as a percent)	0.20%
Rental | Maximum
Concentration of Risk
Revenues (as a percent)	1.00%
Shipping and Handling
Concentration of Risk
Selling, marketing and administrative expenses	$ 42,593	$ 49,288	$ 49,527

XML

SIGNIFICANT ACCOUNTING POLICIES - Property (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Property, plant and equipment:
Depreciation expense			$ 18,184	$ 18,779	$ 18,669
Impairment charges of long-lived assets				$ 377	$ 1,126
Buildings | Minimum
Property, plant and equipment:
Useful lives			20 years
Buildings | Maximum
Property, plant and equipment:
Useful lives			40 years
Machinery and equipment | Minimum
Property, plant and equipment:
Useful lives			5 years
Machinery and equipment | Maximum
Property, plant and equipment:
Useful lives			20 years
Selling, Marketing, and Administrative Expense
Property, plant and equipment:
Impairment charges of long-lived assets	$ 377	$ 1,126

XML

SIGNIFICANT ACCOUNTING POLICIES - Benefits and Investment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
SIGNIFICANT ACCOUNTING POLICIES
Amount of previously paid premiums received	$ 23,527
Premium paid for split dollar life insurance agreements	$ 0	$ 0	$ 0

XML

SIGNIFICANT ACCOUNTING POLICIES - Invest, VEBA, NP (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
VEBA trust
Contribution by entity to VEBA trust		$ 0	$ 0	$ 0	$ 20,024
Cash and cash equivalents held by VEBA trust	$ 166,841	$ 166,841	$ 138,960
Bank loans
Weighted interest rate (as a percent)	3.00%	3.00%	3.00%
Goodwill and indefinite-lived intangible assets:
Impairments of intangibles		$ 0	$ 0	$ 0
Trademarks
Goodwill and indefinite-lived intangible assets:
Number of basis points increase in discount rate	100.00%
Number of basis points decrease in royalty rate	100.00%
Percentage of reduction of fair value due to increase in discount rate	18.00%
Percentage of reduction of fair value due to decrease in royalty rate	10.00%
VEBA Trust | Level 1
VEBA trust
Cash and cash equivalents held by VEBA trust	$ 8,272	$ 8,272	$ 12,085

XML

SIGNIFICANT ACCOUNTING POLICIES - EPS (Details)	12 Months Ended
	Dec. 31, 2020 item
Common Stock
Earnings per share:
Voting right per share (in votes per share)	1
Class B Common Stock
Earnings per share:
Voting right per share (in votes per share)	10

XML

ACCRUED LIABILITIES (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
ACCRUED LIABILITIES
Compensation	$ 8,135	$ 10,575
Other employee benefits	8,841	7,509
Taxes, other than income	3,169	3,170
Advertising and promotions	18,455	14,421
Other	6,499	5,936
Total accrued liabilities	$ 45,099	$ 41,611

XML

INDUSTRIAL DEVELOPMENT BONDS (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
INDUSTRIAL DEVELOPMENT BONDS
Industrial development bonds, average floating interest rate (as a percent)	0.70%	1.60%

XML

INCOME TAXES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Domestic and foreign components of pretax income
Domestic	$ 69,211	$ 74,978	$ 66,253
Foreign	7,051	10,426	6,953
Earnings before income taxes	76,262	85,404	73,206
Current:
Federal	14,831	15,133	12,414
Foreign	1,029
State	1,763	2,942	1,421
Total current	17,623	18,075	13,835
Deferred:
Federal	(1,006)	(543)	(577)
Foreign	1,316	2,422	2,685
State	(645)	611	458
Total deferred	(335)	2,490	2,566
Total provision for income taxes	17,288	20,565	$ 16,401
Deferred tax assets:
Accrued customer promotions	1,506	198
Deferred compensation	18,501	19,432
Postretirement benefits	3,355	3,439
Other accrued expenses	3,078	3,979
Foreign subsidiary tax loss carry forward	4,508	4,584
Outside basis difference in foreign subsidiary	365	365
Deductible state tax depreciation	471	512
Tax credit carry forward	3,288	3,059
Deferred tax assets, gross	35,072	35,568
Valuation allowance	(5,593)	(4,985)
Total deferred tax assets	29,479	30,583
Deferred tax liabilities:
Depreciation	22,192	23,375
Deductible goodwill and trademarks	37,348	36,591
Accrued export company commissions	4,508	4,367
Employee benefit plans	1,767	2,700
Inventory reserves	1,994	2,526
Prepaid insurance	569	710
Unrealized capital gain	2,515	1,362
Deferred foreign exchange gain	179	260
Deferred gain on sale of real estate	5,269	5,298
Total deferred tax liabilities	76,341	77,189
Net deferred tax liability	46,862	$ 46,606
State tax credit carry-forwards expiring in 2020	495
State tax credit carry-forwards expiring in 2021	771
State tax credit carry-forwards expiring in 2023	221
State tax credit carry-forwards expiring in 2024	253
State tax credit carry-forwards expiring in 2028	50
State tax credit carry-forwards expiring in 2029	131
State tax credit carry-forwards expiring in 2030	213
State tax credit carry-forwards expiring in 2031	225
State tax credit carry-forwards expiring in 2032	238
State tax credit carry-forwards expiring in 2033	211
State tax credit carry-forwards expiring in 2034	$ 234
U.S. statutory rate (as a percent)	21.00%	21.00%	21.00%
Valuation allowance for the expired amounts	$ 837	$ 770

XML

INCOME TAXES - Effective tax rate - (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Effective income tax rate differs from the statutory rate
U.S. statutory rate (as a percent)	21.00%	21.00%	21.00%
State income taxes, net (as a percent)	2.10%	2.20%	2.20%
Exempt municipal bond interest (as a percent)		(0.10%)	(0.10%)
Foreign tax rates (as a percent)	1.00%	(0.10%)	0.50%
Income tax credits and adjustments (as a percent)	(1.40%)	0.50%
Adjustment of deferred tax balances (as a percent)	(0.20%)		0.10%
Reserve for uncertain tax benefits (as a percent)	(0.80%)	0.40%	(1.00%)
Other, net (as a percent)	1.00%	0.20%	(0.30%)
Effective income tax rate (as a percent)	22.70%	24.10%	22.40%
Unrecognized tax benefits	$ 3,678	$ 3,339	$ 3,339	$ 3,011	$ 3,678
Portion of unrecognized tax benefits that, if recognized, would favorably affect annual effective income tax rate				1,468	2,012
Interest and penalties included in liability for uncertain tax positions				340	$ 562
Reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits
Unrecognized tax benefits at the beginning of the period	3,678	3,339	4,342
Increases in tax positions for the current year	377	1,164	448
Reductions in tax positions for lapse of statute of limitations	(501)	(576)	(751)
Reductions in tax positions for settlements and payments	(308)	(249)
Decreases in prior period unrecognized tax benefits	(235)		(700)
Unrecognized tax benefits at the end of the period	$ 3,011	$ 3,678	$ 3,339
Spain
Effective income tax rate differs from the statutory rate
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2026				306
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2027				65
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2028				194
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2029				111
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2030				335
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2031				447
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2032				337
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2033				136
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2034				470
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2035				594
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2036				863
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2037				440
Tax benefits of foreign subsidiary tax loss carry forwards expiring in 2038				$ 210

XML

SHARE CAPITAL AND CAPITAL IN EXCESS OF PAR VALUE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Changes in share capital and capital in excess of par value
Balance at the beginning of the period	$ 759,649
Balance at the beginning of the period (in shares)	90
Balance at the end of the period	$ 763,100	$ 759,649
Balance at the end of the period (in shares)	93	90
Total Number of Shares Purchased	982	923	594
Average Price Paid Per Share (in dollars per share)	$ 32.59	$ 36.93	$ 32.48
Stock dividends (as a percent)	3.00%	3.00%	3.00%
Common Stock.
Changes in share capital and capital in excess of par value
Balance at the beginning of the period	$ 26,969	$ 26,767	$ 26,361
Balance at the beginning of the period (in shares)	38,836	38,544	37,960
Issuance of 3% stock dividend	$ 804	$ 798	$ 781
Issuance of 3% stock dividend (in shares)	1,157	1,150	1,125
Conversion of Class B common shares to common shares	$ 43	$ 45	$ 37
Conversion of Class B common shares to common shares (in shares)	62	65	53
Purchase and retirement of common shares and other	$ (682)	$ (641)	$ (412)
Purchase and retirement of common shares and other (in shares)	(982)	(923)	(594)
Balance at the end of the period	$ 27,134	$ 26,969	$ 26,767
Balance at the end of the period (in shares)	39,073	38,836	38,544
Treasury Stock
Changes in share capital and capital in excess of par value
Balance at the beginning of the period	$ (1,992)	$ (1,992)	$ (1,992)
Balance at the beginning of the period (in shares)	90	88	85
Issuance of 3% stock dividend (in shares)	3	2	3
Balance at the end of the period	$ (1,992)	$ (1,992)	$ (1,992)
Balance at the end of the period (in shares)	93	90	88
Capital in Excess of Par Value
Changes in share capital and capital in excess of par value
Balance at the beginning of the period	$ 696,059	$ 696,535	$ 656,752
Issuance of 3% stock dividend	42,244	32,999	58,688
Purchase and retirement of common shares and other	(31,373)	(33,475)	(18,905)
Balance at the end of the period	706,930	696,059	696,535
Class B Common Stock | Common Stock.
Changes in share capital and capital in excess of par value
Balance at the beginning of the period	$ 18,254	$ 17,767	$ 17,285
Balance at the beginning of the period (in shares)	26,287	25,584	24,891
Issuance of 3% stock dividend	$ 547	$ 532	$ 519
Issuance of 3% stock dividend (in shares)	787	768	746
Conversion of Class B common shares to common shares	$ (43)	$ (45)	$ (37)
Conversion of Class B common shares to common shares (in shares)	(62)	(65)	(53)
Balance at the end of the period	$ 18,758	$ 18,254	$ 17,767
Balance at the end of the period (in shares)	27,012	26,287	25,584

XML

OTHER INCOME, NET (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
OTHER INCOME, NET
Interest and dividend income	$ 4,005	$ 4,423	$ 3,535
Gains (losses) on trading securities relating to deferred compensation plans	12,519	11,292	(1,103)
Interest expense	(164)	(220)	(181)
Foreign exchange gains (losses)	534	(533)	(659)
Capital gains (losses)	(6)	22	(11)
Miscellaneous, net	1,130	1,206	1,143
Total other income, net	$ 18,018	$ 16,190	$ 2,724

XML

EMPLOYEE BENEFIT PLANS (Details) - Pension Plan - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Defined Contribution Plan Disclosure [Line Items]
Credited service period	1 year
Pension expense	$ 2,722	$ 3,114	$ 2,988
Employer contributions to profit sharing and retirement savings-investment plan	$ 2,766	$ 2,858	$ 2,734

XML

EMPLOYEE BENEFIT PLANS - Multi-employer (Details) - Pension Plan - USD ($) $ in Thousands		12 Months Ended
	Jun. 12, 2012	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jan. 01, 2019
Pension Plans
Pension expense		$ 2,722	$ 3,114	$ 2,988
Consenting agreement entered with local bargaining union
Pension Plans
Percentage of funded status					50.40%
Employer contributions to multi-employer defined benefit pension plans		$ 2,850	2,943	2,836
Insolvent period		20 years
Estimated liability upon withdrawal from plan		$ 99,300	99,800	81,600
Percentage of annual compounded surcharge for rehabilitation		5.00%
Percentage of interim surcharge	5.00%
Pension expense		$ 2,866	2,961	2,836
Surcharges		$ 1,010	$ 948	$ 811

XML

EMPLOYEE BENEFIT PLANS - Deferred compensation (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($) item	Dec. 31, 2019 USD ($)
Deferred compensation
Number of deferred compensation plans | item	3
Trading securities | $	$ 73,828	$ 76,183

XML

EMPLOYEE BENEFIT PLANS - Postretirement (Details) - Postretirement benefit plans - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Postretirement benefit plan disclosure
Assumed ultimate health care cost trend rate (as a percent)	3.00%
Accumulated benefit obligation after plan amendment	$ 13,487	$ 13,743
Amounts recognized in accumulated other comprehensive loss (pre-tax)
Prior service credit	(1,840)
Net actuarial gain	(1,196)
Net amount recognized in accumulated other comprehensive loss	(3,036)
Changes in the accumulated postretirement benefit obligation
Benefit obligation, beginning of the period	13,743	12,451
Service cost	288	270	$ 337
Interest cost	403	499	455
Actuarial (gain)/loss	(510)	922
Benefits paid	(437)	(399)
Benefit obligation, end of the period	13,487	13,743	12,451
Net periodic postretirement benefit cost
Service cost-benefits attributed to service during the period	288	270	337
Interest cost on the accumulated postretirement benefit obligation	403	499	455
Net amortization	(1,349)	(1,522)	(1,324)
Net periodic postretirement benefit cost (income)	$ (658)	$ (753)	$ (532)

XML

EMPLOYEE BENEFIT PLANS - Expected future benefit payments (Details) - Postretirement benefit plans $ in Thousands	Dec. 31, 2020 USD ($)
Estimated future benefit payments
2021	$ 544
2022	564
2023	590
2024	614
2025	634
2026 through 2030	$ 3,417

XML

COMMITMENTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
COMMITMENTS
Rental expense	$ 942	$ 1,032	$ 793
Operating lease commitments, due 2021	717
Operating lease commitments, due 2022	137
Operating lease commitments, due 2023	$ 4

XML

SEGMENT AND GEOGRAPHIC INFORMATION (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
SEGMENT AND GEOGRAPHIC INFORMATION
Revenue									$ 471,063	$ 527,113	$ 518,920
Long-lived assets:	$ 187,328				$ 188,455				187,328	188,455	186,101
United States
SEGMENT AND GEOGRAPHIC INFORMATION
Long-lived assets:	155,664				155,428				155,664	155,428	151,770
Canada
SEGMENT AND GEOGRAPHIC INFORMATION
Long-lived assets:	28,765				30,412				28,765	30,412	31,843
Mexico and Other
SEGMENT AND GEOGRAPHIC INFORMATION
Long-lived assets:	2,899				2,615				2,899	2,615	2,488
Product
SEGMENT AND GEOGRAPHIC INFORMATION
Revenue	$ 127,866	$ 156,962	$ 79,796	$ 102,803	$ 134,663	$ 181,913	$ 106,021	$ 101,019	467,427	523,616	515,251
Product | United States
SEGMENT AND GEOGRAPHIC INFORMATION
Revenue									431,024	478,790	471,561
Product | Canada, Mexico, and Other
SEGMENT AND GEOGRAPHIC INFORMATION
Revenue									$ 36,403	$ 44,826	$ 43,690

XML

SEGMENT AND GEOGRAPHIC INFORMATION - Concentration (Details) - item	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Wal-Mart | Net product sales | A major customer
Concentration of Risk
Percentage of concentration risk	23.50%	24.20%	24.10%
Dollar Tree | Net product sales | A major customer
Concentration of Risk
Percentage of concentration risk	11.70%	11.30%	11.20%
McLane | Net product sales | A major customer
Concentration of Risk
Percentage of concentration risk	22.10%	17.70%	17.40%
Three Largest Customers | Accounts receivable
Concentration of Risk
Number of customers	3	3
Three Largest Customers | Accounts receivable | A major customer
Concentration of Risk
Percentage of concentration risk	21.00%	30.00%

XML

FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Fair value measurements
Cash and cash equivalents	$ 166,841	$ 138,960
Available for sale securities	188,282	177,292
Trading securities	73,828	76,183
Fair value measured on a recurring basis
Fair value measurements
Cash and cash equivalents	166,841	138,960
Available for sale securities	188,282	177,292
Trading securities	73,828	76,183
Total assets measured at fair value	430,670	392,570
Fair value measured on a recurring basis | Foreign currency forward contracts
Fair value measurements
Derivative instruments, net	778	14
Fair value measured on a recurring basis | Commodity futures contracts
Fair value measurements
Derivative instruments, net	941	121
Fair value measured on a recurring basis | Level 1
Fair value measurements
Cash and cash equivalents	166,841	138,960
Available for sale securities	3,149	3,588
Trading securities	61,431	48,260
Total assets measured at fair value	232,362	190,929
Fair value measured on a recurring basis | Level 1 | Commodity futures contracts
Fair value measurements
Derivative instruments, net	941	121
Fair value measured on a recurring basis | Level 2
Fair value measurements
Available for sale securities	185,133	173,704
Trading securities	12,397	27,923
Total assets measured at fair value	198,308	201,641
Fair value measured on a recurring basis | Level 2 | Foreign currency forward contracts
Fair value measurements
Derivative instruments, net	$ 778	$ 14

XML

FAIR VALUE MEASUREMENTS - Bonds (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Fair value on a recurring basis
Industrial revenue development bonds, carrying amount, approximates fair value	$ 7,500	$ 7,500
Cost Basis | Level 2
Fair value on a recurring basis
Industrial revenue development bonds, carrying amount, approximates fair value	7,500	7,500
Estimated Fair Value | Level 2
Fair value on a recurring basis
Industrial revenue development bonds, carrying amount, approximates fair value	$ 7,500	$ 7,500

XML

FAIR VALUE MEASUREMENTS AFS (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Available for Sale:
Amortized Cost	$ 185,655	$ 176,129
Fair Value	188,282	177,292
Unrealized Gains	2,627	1,163
Municipal bonds
Available for Sale:
Amortized Cost	556
Fair Value	561
Unrealized Gains	5
Variable rate demand notes
Available for Sale:
Amortized Cost	1,300	25,845
Fair Value	1,300	25,845
Corporate bonds
Available for Sale:
Amortized Cost	174,835	139,803
Fair Value	177,229	140,797
Unrealized Gains	2,394	994
Government securities
Available for Sale:
Amortized Cost	3,049	3,503
Fair Value	3,149	3,588
Unrealized Gains	100	85
Certificates of deposit
Available for Sale:
Amortized Cost	5,915	6,978
Fair Value	6,043	7,062
Unrealized Gains	$ 128	$ 84

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative contracts
Assets			$ 1,719	$ 219
Liabilities				(84)
Derivatives designated as hedging instruments: | Foreign currency forward contracts
Derivative contracts
Notional Amounts			6,391	5,533
Assets			778	14
Derivatives designated as hedging instruments: | Commodity futures contracts
Derivative contracts
Notional Amounts			4,010	7,147
Assets			$ 941	205
Liabilities				$ (84)
Forecast
Derivative contracts
Accumulated comprehensive gain to be reclassified		$ 941
Forecast | Foreign currency forward contracts
Derivative contracts
Accumulated other comprehensive gain to be reclassified	$ 388	$ 390

XML

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - OCI (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Effect of derivative instruments on earnings
Gain (Loss) Recognized in OCI	$ 1,259	$ 451	$ (2,734)
Reclassified from Accumulated OCI into Earnings
Effect of derivative instruments on earnings
Gain (Loss) Reclassified from Accumulated OCI into Earnings	(325)	(677)
Foreign currency forward contracts
Effect of derivative instruments on earnings
Gain (Loss) Recognized in OCI	686	359
Foreign currency forward contracts | Reclassified from Accumulated OCI into Earnings
Effect of derivative instruments on earnings
Gain (Loss) Reclassified from Accumulated OCI into Earnings	(78)	(62)
Commodity futures contracts
Effect of derivative instruments on earnings
Gain (Loss) Recognized in OCI	573	92
Commodity futures contracts | Reclassified from Accumulated OCI into Earnings
Effect of derivative instruments on earnings
Gain (Loss) Reclassified from Accumulated OCI into Earnings	$ (247)	$ (615)

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	$ 759,854
Balance at the end of the period	763,327	$ 759,854
Foreign Currency Translation
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	(23,368)	(24,159)
Other comprehensive earnings (loss) before reclassifications	(1,213)	791
Other comprehensive earnings (loss) net of tax	(1,213)	791
Balance at the end of the period	(24,581)	(23,368)
Investments
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	882	(1,516)
Other comprehensive earnings (loss) before reclassifications	1,110	2,372
Reclassifications from accumulated other comprehensive loss		26
Other comprehensive earnings (loss) net of tax	1,110	2,398
Balance at the end of the period	1,992	882
Foreign Currency Derivatives
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	10	(309)
Other comprehensive earnings (loss) before reclassifications	520	272
Reclassifications from accumulated other comprehensive loss	59	47
Other comprehensive earnings (loss) net of tax	579	319
Balance at the end of the period	589	10
Commodity Derivatives
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	92	(444)
Other comprehensive earnings (loss) before reclassifications	434	70
Reclassifications from accumulated other comprehensive loss	187	466
Other comprehensive earnings (loss) net of tax	621	536
Balance at the end of the period	713	92
Postretirement and Pension Benefits
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	2,139	4,206
Other comprehensive earnings (loss) before reclassifications	356	(914)
Reclassifications from accumulated other comprehensive loss	(1,023)	(1,153)
Other comprehensive earnings (loss) net of tax	(667)	(2,067)
Balance at the end of the period	1,472	2,139
Accumulated Other Comprehensive Earnings ( Loss )
Accumulated other comprehensive earnings (loss), net of tax
Balance at the beginning of the period	(20,245)	(22,222)
Other comprehensive earnings (loss) before reclassifications	1,207	2,591
Reclassifications from accumulated other comprehensive loss	(777)	(614)
Other comprehensive earnings (loss) net of tax	430	1,977
Balance at the end of the period	$ (19,815)	$ (20,245)

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Reclassification from AOCI (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Other income, net	$ (18,018)	$ (16,190)	$ (2,724)
Cost of goods sold	300,702	330,097	330,747
Total before tax	(76,262)	(85,404)	(73,206)
Tax expense (benefit)	17,288	20,565	16,401
Net of tax	(58,974)	(64,839)	$ (56,805)
Reclassified from Accumulated OCI into Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Total before tax	(1,025)	(811)
Tax expense (benefit)	248	197
Net of tax	(777)	(614)
Investments | Reclassified from Accumulated OCI into Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Other income, net		34
Foreign Currency Derivatives | Reclassified from Accumulated OCI into Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Other income, net	78	62
Commodity Derivatives | Reclassified from Accumulated OCI into Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Cost of goods sold	$ 247	$ 615
Type of Cost, Good or Service [Extensible List]	Product [Member]	Product [Member]
Postretirement and Pension Benefits | Reclassified from Accumulated OCI into Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Other income, net	$ (1,350)	$ (1,522)

XML

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Changes in carrying amount of trademarks
Accumulated impairment losses of goodwill	$ 0
Trademarks
Changes in carrying amount of trademarks
Original cost	193,767	$ 193,767
Accumulated impairment losses, balance at the beginning of the period	(18,743)	(18,743)
Carrying amount, balance at the beginning of the period	175,024	175,024
Current year impairment losses
Carrying amount, balance at the end of the period	175,024	175,024
Accumulated impairment losses, balance at the end of the period	$ (18,743)	$ (18,743)

XML

LEASES (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Lessee, Lease, Description [Line Items]
Operating lease cost	$ 271	$ 271	$ 258	$ 258
Operating lease payments	1,023	1,023	1,004	1,004
Operating lease right-of-use assets	858	1,580	858	1,580
Operating lease liabilities	$ 858	$ 1,580	$ 858	$ 1,580
Weighted average remaining lease term	8 months 12 days	1 year 7 months 6 days	8 months 12 days	1 year 7 months 6 days
Weighted average discount rate	3.00%	3.10%	3.00%	3.10%
2021	$ 717		$ 717
2022	137		137
2023	4		$ 4
Lessor, Operating Lease, Existence of Option to Extend [true false]			true
Property, plant and equipment, gross	583,332	$ 567,215	$ 583,332	$ 567,215
Lease income	$ 863	$ 3,191	$ 718	$ 2,951
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	3 years	3 years	3 years	3 years
Commercial real estate leased to third parties
Lessee, Lease, Description [Line Items]
Property, plant and equipment, gross	$ 51,426	$ 36,378	$ 51,426	$ 36,378
Depreciation			$ 14,784	$ 10,252
Commercial real estate leased to third parties | Maximum
Lessee, Lease, Description [Line Items]
Lessor, renewal term	60 years		60 years

XML

QUARTERLY FINANCIAL DATA (UNAUDITED) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenue									$ 471,063	$ 527,113	$ 518,920
Gross Margin									170,361	197,016	188,173
Net earnings attributable to Tootsie Roll Industries, Inc.	$ 14,952	$ 24,673	$ 7,388	$ 11,982	$ 14,555	$ 29,854	$ 11,556	$ 8,955	$ 58,995	$ 64,920	$ 56,893
Net earnings attributable to Tootsie Roll Industries, Inc. per share (in dollars per share)	$ 0.23	$ 0.37	$ 0.11	$ 0.18	$ 0.22	$ 0.44	$ 0.17	$ 0.13	$ 0.89	$ 0.96	$ 0.84
Stock dividends (as a percent)									3.00%	3.00%	3.00%
Product
Revenue	$ 127,866	$ 156,962	$ 79,796	$ 102,803	$ 134,663	$ 181,913	$ 106,021	$ 101,019	$ 467,427	$ 523,616	$ 515,251
Gross Margin	$ 44,165	$ 57,775	$ 29,417	$ 36,360	$ 49,229	$ 69,046	$ 40,076	$ 36,163	$ 167,717	$ 194,514	$ 185,371

XML

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Description
Balance at beginning of year	$ 6,934	$ 5,712	$ 5,190
Additions charged to expense	9,235	11,251	9,783
Deductions	8,882	10,029	9,261
Balance at End of Year	7,287	6,934	5,712
Reserve for bad debts
Description
Balance at beginning of year	1,337	1,128	1,197
Additions charged to expense	123	676	38
Deductions	352	467	107
Balance at End of Year	1,108	1,337	1,128
Reserve for cash discounts
Description
Balance at beginning of year	612	692	724
Additions charged to expense	8,504	9,482	9,122
Deductions	8,530	9,562	9,154
Balance at End of Year	586	612	692
Deferred tax asset valuation
Description
Balance at beginning of year	4,985	3,892	3,269
Additions charged to expense	608	1,093	623
Balance at End of Year	$ 5,593	$ 4,985	$ 3,892